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Summary 
 
Ubiquitin-like proteins (UBLs) have broad activities including modification of 
proteins, lipids, and tRNA. Analysis of both UBL conjugation sites and characterisation 
of system wide proteome responses is essential to understanding the impact UBLs have 
on regulating cellular systems. While mass spectrometry is a powerful analytical 
technique, identifying UBL isopeptides can be particularly challenging due their low 
abundance and the spectral complexity of UBL isopeptides with very long tryptic 
remnants. Furthermore, the complexity of whole proteomes delivers limitations to the 
throughput and depth of quantitative discovery proteomics. This thesis addresses some 
of the major technical challenges in UBL research. Biochemical and bioinformatic 
methodologies have been developed for the selective enrichment proteomics datasets, 
with a common theme of overcoming proteome complexity. 
 
In the first instance, enrichment of diglycine isopeptides has been achieved through 
a novel method exploiting the polyglycine specificity of the bacterial protease-
transpeptidase Sortase A (SrtA). Using a mutant with increased catalytic activity, SrtA 
mediates biotinylation of diglycine tryptic remnants, and also acts as a specific protease 
for release of isopeptides from streptavidin for analysis by mass spectrometry. This 
cost-effective approach to isopeptide enrichment is also applicable to linear N-terminal 
ubiquitylation. The method is demonstrated to offer greater than 100x enrichment and is 
exemplified on an in vitro ubiquitylation of MIRO1 by PINK1-activated PARKIN. 
 
In contrast to a physical enrichment, a dataset enrichment of isopeptide 
identifications has been achieved through UBL isotope labelling.  In vitro substrate 
modification with isotopically light and heavy UBL generates a characteristic isotopic 
doublet enabling isopeptides to be distinguished at the MS1 level.  Candidate peptide 
identity can be assigned using high-resolution precursor mass and complementary MS2-
level spectral interpretation with SUMmOn adds further confidence to isopeptide 
identities. Application to SUMO2 modification of putative substrate RNA guanine-7 
methyltransferase (RNMT) revealed widespread SUMOylation at 16 different lysines 
by UBC9 despite lacking a consensus motif. 
 
Finally, a quantitative proteomics workflow is presented that enriches whole 
proteome datasets by combining peptide identifications from unlabelled and SILAC 
proteomes. A software implementation, with additional tools for improved data quality 
management, is demonstrated to significantly improve proteome coverage and 
quantitative precision in unfractionated proteomes. An exemplification on elp3Δ/wt 
unfractionated yeast proteome reveals a subset of ELP-dependent uridine-34 tRNA 
modifications to be particularly important for efficient translation.  Interestingly, the 
three mcm5s2U tRNAs which are co-modified by the UBL URM1, have a much greater 
impact on protein translation efficiency than the ELP-only modified mcm5U tRNAs. 
 
 1 
Chapter I: 
General Introduction 
 
1.1 The ubiquitin family 
 
1.1.1 Ubiquitin 
Ubiquitin was discovered in 1975 and was recognised as being a ubiquitous 
polypeptide and a highly conserved protein present throughout eukaryotes (Goldstein et 
al., 1975).  In almost 40 years since its discovery, ubiquitin has been well characterised 
as a key player in a vast number of cellular processes.  The most characterised role is in 
protein recycling where ubiquitylation directs substrate proteins to the 26S proteasome 
for degradation.  Protein half life is also regulated by the N-end rule mechanisms 
whereby a protein’s N-terminus influences the degree of ubiquitylation and degradation 
(Varshavsky, 2011).  Many misfolded proteins are recycled by ubiquitylation via E3-
chaperone interactions (Kriegenburg et al., 2012).  For instance, the endoplasmic 
reticulum associated protein degradation (ERAD) pathway retrotranslocates misfolded 
proteins from the ER back to the cytosol for degradation (Vembar and Brodsky, 2008).  
Crosstalk between the ubiquitin and autophagy pathways is also essential for cargo 
recognition and autophagic clearance of protein aggregates (Kraft et al., 2010).  In 
contrast to bulk degradation mechanisms, the ubiquitin system can provide a highly 
specific targeting system.  Through specific substrate recognition, a wide range of 
cellular processes are modulated, such as cell cycle, transcription, signal transduction, 
and development (Petroski and Deshaies, 2005).  Furthermore, defects in the ubiquitin 
system are implicated in a wide range of human diseases including cancer and 
neurodegenerative diseases (Petroski, 2008). 
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Ubiquitin has a β-grasp fold and C-terminal glycine, which are common throughout 
the ubiquitin family.  Ubiquitin functions by covalently attaching to substrate proteins 
which is mediated by a series of enzymes; an E1 activating enzyme, E2 conjugating 
enzyme, and E3 ligase.  Ubiquitin can also be deconjugated from substrates by 
deubiquitylating enzymes  (Figure 1.1).  The conjugation reaction forms a covalent 
bond between the C-terminal carboxyl group of ubiquitin and an ε-amino group of a 
substrate lysine (Figure 1.2).  Ubiquitin-like proteins (UBLs) are unique among post-
translational modifications (PTMs) in that the modifying group is itself a protein, and 
the isopeptide bond formed is an amide bond with similar chemical properties to the 
peptide backbone. Ubiquitylation on cysteine, serine, and threonine residues have been 
reported, however their study has been limited due to the labile nature of esters and 
thioesters (Wang et al., 2012). 
 
 
Figure 1.1 The ubiquitin conjugation pathway 
Ubiquitin (Ub) is activated by an E1 enzyme to form a thioester intermediate, 
transferred to an E2 conjugating enzyme, also as a thioester intermediate, and then with 
the help from a substrate-recruiting E3 ligase, ubiquitin is transferred to a lysine on the 
substrate protein.  Ubiquitin can also be deconjugated by a deubiquitylating enzyme 
(DUB) to reconstitute the original substrate and ubiquitin. 
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Figure 1.2 Ubiquitin is conjugated to a substrate lysine to form an isopeptide 
bond 
Ubiquitin conjugation results in a covalent bond between the ubiquitin C-terminal 
carboxyl group and an ε-amino lysine on a substrate protein. Note that the isopeptide 
bond and the peptide bond are both amides and are chemically indistinguishable. 
 
Ubiquitin can in fact be a substrate for itself by conjugating to one of its 7 lysines to 
form polyubiquitin chains.  These chains can be homogenous, mixed, or even branched 
(Kirkpatrick et al., 2005).  Ubiquitin chains can also form via the N-terminal α-amino 
group, which forms a typical peptide bond rather than an isopeptide.  K48 chains and 
branched chains signal for degradation by the proteasome (Meyer and Rape, 2014), 
whereas monoubiquitylation and K63 linkages have non-proteolytic roles such as in 
DNA repair and protein sorting (Ikeda and Dikic, 2008; Lauwers et al., 2009; Spence et 
al., 1995).  The function of K6, K11, K27, K29, and K33 ubiquitin chains are not well 
understood (Xu et al., 2009).  The complexity of this modification becomes obvious 
when considering that a substrate can be monoubiquitylated, multi-monoubiquitylated, 
or modified with ubiquitin chains of various lengths and linkages. 
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Substrate lysines for ubiquitylation do not fall within a consensus motif (Xu et al., 
2010).  Instead, substrate specificity is mediated by more than 600 E3 ligases in the 
mammalian genome which act to recruit substrates and modulate E2 conjugation (David 
et al., 2011; Li et al., 2008).  Most E3 ligases belong to the really interesting new gene 
(RING) ligase or related families and do not form a catalytic intermediate with 
ubiquitin.  Cullin RING ligases are a multi-subunit family where the cullin acts as a 
scaffold for the formation of a highly dynamic E3 ligase (Mimura et al., 2010).  The 
cullin complex itself is modified by another member of the UBL family, NEDD8.  In 
contrast to the RING family of ligases, homologous to the E6AP carboxyl terminus 
(HECT) domain family of E3s do form a thioeseter intermediate with ubiquitin 
(Metzger et al., 2012).   
 
1.1.2 NEDD8 
NEDD8, or the yeast orthologue Rub1p, is a UBL with ~60% sequence identity to 
ubiquitin (Kumar et al., 1993).  Like ubiquitin, NEDD8 is conjugated to target proteins 
in a similar manner but has its own set of E1, E2, and E3 enzymes.  The primary target 
of NEDD8 is the cullin backbone of the cullin RING ligases, and the modification 
induces a conformational change to activate E3 ligase activity (Merlet et al., 2009).  
Cullin RING ligase regulation by NEDD8 exemplifies the interaction between members 
of the UBL family.  NEDD8 is essential in mammals, but surprisingly, RUB1 is not 
essential in yeast (Liakopoulos et al., 1998).  Although ubiquitin and NEDD8 have 
distinct enzymes mediating their conjugation, a high NEDD8 to ubiquitin ratio can 
results in NEDDylation via the ubiquitylation machinery (Hjerpe et al., 2012). 
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1.1.3 SUMO 
There are 4 human small-ubiquitin-related modifier (SUMO) orthologues which 
share only a low sequence identity with ubiquitin (Figure 1.3).  Despite the low primary 
sequence similarity they conform to the same β-grasp fold structure common to the 
ubiquitin family (Figure 1.4).  The functionality of SUMO4 is questioned, although 
SUMO1-3 are conjugated by an E1 (SAE1/SAE2 dimer) and an E2 (UBC9) in a similar 
manner to ubiquitin (Wilkinson and Henley, 2010).  Unlike ubiquitin however, 
conjugation via an E3 is not essential as UBC9 is sufficient to conjugate to lysines 
within a ΨKXE/D consensus motif, where Ψ is a large hydrophobic residue (Desterro et 
al., 1998; Rodriguez et al., 2001; Sampson et al., 2001; Sternsdorf et al., 1999).  A 
reverse consensus motif and hydrophobic cluster SUMOylation motif have also been 
observed (Matic et al., 2010).  SUMO2 and SUMO3 also contain a consensus motif at 
K11 permitting the formation of mixed SUMO2/3 chains.  SUMO1 does not share the 
ability to form chains due to the absence of a consensus motif and prohibits further 
extension of SUMO chains in vivo (Matic et al., 2008). SUMO1 chains have however 
been observed in vitro (Cooper et al., 2005; Pedrioli et al., 2006).  
 
 
SUMO1     MSDQEAKPSTEDLGDKKE-GEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGG 
SUMO2     MADEKPKE-----GVKTENNDHINLKVAGQDGSVVQFKIKRHTPLSKLMKAYCERQGLSMRQIRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGG 
SUMO3     MSEEKPKE-----GVKTE-NDHINLKVAGQDGSVVQFKIKRHTPLSKLMKAYCERQGLSMRQIRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGG 
ubiquitin M----------------------QIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG 
          *                      :: *    .. : ::::    :.::     :::*:.  . *: * *: : :  *  :  ::.*..:.:  .  ** 
 
Figure 1.3 Sequence alignment between human SUMO paralogues and 
ubiquitin 
Human SUMO2 and SUMO3 are almost identical (~97% identity) but differ 
significantly from SUMO1 (~50% identity).  All SUMO proteins have very low 
similarity to ubiquitin (~20%).  Multiple sequence alignment performed with 
CLUSTAL W. 
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Figure 1.4 Ubiquitin and SUMO2 share the β-grasp fold structure 
Structural alignment between ubiquitin (PDB 2GBN, orange) and SUMO2 (PDB 
D207, blue) shows a very similar structure despite very low sequence similarity (~20% 
identity).  Structures aligned using MacPyMOL 
 
Many SUMO target proteins do not contains consensus motifs and require an 
additional level of specificity to be mediated by SUMO E3 ligases.  Deletion of yeast 
SUMO E3 ligases, Siz1 and Siz2, significantly reduces protein modification by the 
yeast SUMO orthologue, Smt3 (Johnson and Gupta, 2001) indicating that E3-
independent SUMOylation plays only a small role in yeast. SUMO E3 enzymes have 
been demonstrated to mediate non-consensus SUMOylation (Chiou et al., 2014) and 
enhance consensus site SUMOylation (Fuhs and Insel, 2011).  Most SUMO E3s are 
thought to act to bring together UBC9 and substrates in a similar fashion to ubiquitin 
RING E3 ligases (Wilkinson and Henley, 2010).  Although the SUMO modification is 
not a signal for proteasomal degradation, SUMOylation can indirectly induce protein 
degradation.  The ubiquitin E3 ligase RNF4 recognises SUMO chains through multiple 
SUMO interaction motifs (SIMs) (Prudden et al., 2007; Sun et al., 2007; Uzunova et al., 
2007; Xie et al., 2007).  This results in substrate ubiquitylation and degradation of poly-
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SUMOylated substrates (Tatham et al., 2008), thus demonstrating another example of 
interplay between UBL modifications. 
 
1.1.4 URM1 
Ubiquitin-related modifier-1 (URM1) was discovered in yeast and was observed 
conjugated to high molecular weight species in a UBA4 dependant fashion (Furukawa 
et al., 2000).  Although the E2 and E3 enzymes remain undiscovered, the resemblances 
of Uba4p to ubiquitin’s E1 and Urm1p to ubiquitin’s β-grasp-fold structure place URM1 
as member of the UBL family.  Urm1p conjugates to alkyl hydroperoxide reductase 
(Ahp1p) (Goehring et al., 2003) and to members of its own pathway (Van der Veen et 
al., 2011) under oxidative stress.  However, protein urmylation has yet to be confirmed 
as a specific cellular mechanism as E2, E3, and deurmylating enzymes have not been 
identified. 
 
Urm1p has also been recognised for its similarity to the bacterial thiamine synthesis 
pathway, in which a ThiF/ThiS acyldisulphide conjugate is required for thiazole moiety 
synthesis (Xi et al., 2001).  Unlike the ubiquitin system, Urm1p was found to resemble 
the ThiF/ThiS conjugate by also forming an acyldisulphide intermediate with its E1, 
Uba4.  Although Urm1p is not involved in thiamine synthesis, it acts as a sulphur carrier 
in the thiolation of tRNA (Figure 1.5).  Urm1p therefore represents a unique member of 
the ubiquitin family in that it functions both as a sulphur carrier and a classic UBL and 
suggests an evolutionary link between the ubiquitin system and bacterial sulphur 
carriers. 
 
 8 
 
Figure 1.5 URM1 pathway resembles the bacterial thiamine synthesis pathway 
The ubiquitin (A), ThiS (B), and Urm1 (A) pathways share only the first UBL 
adenylation of the carboxy terminus.  The URM1 pathway subsequently resembles the 
initial steps of the bacterial thiamine synthesis pathway by formation of the 
acyldisulphide intermediate.  Figure reproduced from (Pedrioli et al., 2008). 
 
URM1’s role as a sulphur carrier is essential for the thiolation of uridine-34 on 
tRNAs encoding for lysine, glutamine, and glutamic acid.  The modified tRNA position 
34 complements the third codon position of the three AAA, CAA , and GAA codons.  
Because tRNAs can ‘wobble’ at the third codon position (Crick, 1966), tRNA thiolation 
has the potential to alter the specificity of recognition.  This can influence the extent of 
wobble to restrict recognition to the cognate codon or enhance recognition of near 
cognate codons (Agris, 2004). 
 
The uridine-34 thiolation (s2) is also accompanied by an additional 5-methoxy-
carbonyl-methyl (mcm5) modification (Figure 1.6) which is mediated by the Elongator 
protein complex (ELP) and each modification appears to affect formation of the other 
(Pedrioli et al., 2008).  Deletion of URM1 results in hypothiolation of tRNAs and lower 
tolerance to stress conditions such as starvation, oxidative stress, and temperature shifts 
(Goehring et al., 2003).  Additionally, deletion of URM1 results in translation defects 
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specifically for AAA, CAA, and GAA codons which results in a wide-spread impact on 
the proteome for genes rich in these three codons (Rezgui et al., 2013).   
 
 
Figure 1.6 Chemical structures of uridine and mcm5s2-uridine 
The uridine-34 of tRNAs recognising K, Q, and E codons are modified by both 
mcm5 and s2.  Reproduced from (Pedrioli et al., 2008). 
 
1.1.5 Other ubiquitin like proteins 
Other members of the ubiquitin family exist including ISG15 (interferon stimulated 
gene 15kDa protein), FAT10 (human leukocyte antigen F-associated transcript 10), 
UFM1 (ubiquitin fold modifier 1), and ATG12 (autophagy-related protein 12), which 
conjugate to protein in a ubiquitin like manner.  Other non-canonical members of the 
family include Hub1 (homologous to Ub), which lacks C-terminal glycine and is 
unlikely to conjugate to proteins.  ATG8 (autophagy-related protein 8) is also most 
unusual in that it modifies lipids via a covalent bond to phosphatidylethanolamine (Van 
der Veen and Ploegh, 2012). 
 
1.2 Introduction to mass spectrometry and proteomics 
1.2.1 Mass spectrometry for proteomics 
Bottom-up proteomics (also known as shotgun proteomics for complex samples) is 
currently the most conventional approach to protein identification (Figure 1.7).  Proteins 
are first digested to generate a set of short peptides, typically using a high specificity 
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enzyme like trypsin.  Tryptic peptides are separated by C18 chromatography for online 
analysis by mass spectrometry.  As ‘bottom-up’ implies, the individual peptide 
identification need to be reassembled into their respective protein identities in silico.  
This workflow can also be conducted in combination with other offline fractionation 
techniques, including 1D and 2D SDS-PAGE, isoelectric focusing, or strong cation 
exchange. 
 
 
Figure 1.7 A typical bottom-up proteomics workflow 
Protein samples are digested into peptides. Peptides are analysed by liquid 
chromatography, directly coupled to a mass spectrometer via electrospray ionisation.  
MS data is interpreted to assign peptide and protein identifications. 
 
Soft ionisation techniques like electrospray ionisation (ESI) (Fenn et al., 1989) and 
matrix assisted laser desorption/ionization (MALDI) (Karas and Hillenkamp, 1988) 
enabled delivery of fragile biomolecules like proteins into the gas phase.  Early MALDI 
techniques collected spectra on single protein digests and assignment of protein identity 
was conducted using only peptide masses by peptide mass fingerprinting (PMF) (Pappin 
et al., 1993).  ESI permitted C18 reverse phase chromatographic separation of peptides 
to be coupled directly to a mass spectrometer.  Mass spectrometers also gained the 
ability to isolate and fragment individual species, such as MALDI post-source decay 
and ion trap collision induced dissociation (CID).  In combination with the ability to 
interpret peptide fragmentation spectra (MS/MS or MS2), LC-MS/MS made the 
analysis of more complex samples possible.  Advancements in mass spectrometry 
sensitivity, speed, and resolution, has made mass spectrometry an indispensable tool for 
the analysis of complex proteomic samples (Clauser et al., 1999; Hebert et al., 2014). 
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While most mass spectrometry principles discussed are generally applicable to any 
high resolution mass spectrometer, specific applications refer to the Thermo Velos 
Orbitrap mass spectrometer (Figure 1.8) which was the instrument used during this 
research.  The Velos Orbitrap mass spectrometer is a hybrid instrument, meaning that it 
is comprised of two mass analysers, an ion trap and an orbitrap.  The ion trap is a low 
mass resolution analyser, but it is relatively fast and sensitive.  The ion trap performs 
ion isolation and fragmentation (MS2), and can pass ions forward to the orbitrap 
analyser.  The ion trap is also unique in that it can perform multiple rounds of isolation 
to further fragment an MS2 fragment (MS3).  The Orbitrap mass analyser is an 
electrostatic trap which detects ion oscillations and converts them to mass spectra using 
Fourier transform (Makarov, 2000).  The orbitrap resolution is proportional to transient 
time and although it can record very high resolution mass spectra it is slow compared to 
the ion trap.  Hybrid instruments also have the unique ability to operate both analysers 
simultaneously enabling rapid collection of ion trap spectra in parallel during an 
orbitrap scan. 
 
 
Figure 1.8 Schematic of the hybrid Velos Orbitrap mass spectrometer 
The main features of this hybrid mass spectrometer are the inclusion of two 
independent mass analysers, the ion trap and the orbitrap.  A high-energy collisional 
dissociation (HCD) cell is also available for an alternative peptide fragmentation 
technique. 
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1.2.2 LCMS data structure and modes of acquisition 
LCMS data can be considered as regular samplings over a continuous 
multidimensional domain (Figure 1.9).  As peptides elute from C18 chromatography, 
they are observed with isotopic resolution over the m/z domain, with an intensity, and 
elution time range.  This data is often reduced to represent a feature as a discrete triple 
of m/z, intensity, and elution time.  Peptide fragmentation data is also an additional 
discontinuous level of information associated with peptide features (Figure 1.10).  
Typically, a ‘high-low’ strategy is taken where MS1 is collected at high resolution and 
the acquisition cycle is completed with one or more MS2 data acquisitions at low 
resolution.   This strategy ensures high quality precursor mass accuracy and rapid MS2 
acquisition. 
 
 
Figure 1.9 A peptide is observed as a ‘feature’ in 3-dimensional LCMS data 
landscape 
A peptide feature is observed as multiple isotope peaks over the m/z, intensity, and 
time domains.  A feature can be deconvoluted from continuous 3D data to discrete m/z, 
intensity, and elution time of its monoisotopic peak (indicated with arrow).  A feature 
may also have associated MS2 spectra. 
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Figure 1.10 A depiction of LC-MS/MS data-dependent acquisition sequence 
During LC separation of peptides, MS1 scans survey the eluting peptides.  One or 
more ions are selected for fragmentation to generate MS2 scans before repeating the 
cycle for the duration of the LC gradient.  Note that an additional MS3 event (not 
shown) is possible using ion traps but is not routinely done in proteomics. 
 
The MS1-level feature landscape of a sample can be analysed by continuously 
collecting MS1 scans.  In contrast, the addition fragmentation data must be acquired 
with some decision logic.  For the analysis of samples with unknown composition, the 
duty cycle is usually directed by data-dependent acquisition (DDA).  In DDA, the 
decision on what precursor ions to select for fragmentation is determined by the 
observed ions in the preceding MS1 scan (usually the most abundant n peaks).  Hybrid 
instrument can operate two detectors for MS1 and MS2 acquisition simultaneously, but 
to do so the decision logic must come from quick average-resolution ‘preview’ scan 
(Figure 1.11).  For a more targeted data acquisition, an inclusion list containing 
precursor m/z and time can be used to guide selection of ions to fragment.  A targeted 
analysis can still be a DDA analysis, in which case precursors on the list will be 
acquired if observed in the MS1 scan.  In data independent acquisition (DIA), MS2 
spectra are acquired without any consideration for observed MS1 signals and therefore 
relies heavily on scheduling MS2 event times.  
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Figure 1.11 Illustration of alternative MS2 data acquisition methods 
Hybrid orbitap instruments normally acquire a ‘preview’ survey scan to enable data-
dependent acquisition (DDA) of MS2 spectra to proceed simultaneously to a high 
resolution MS1.   In non-hybrid instruments, or where preview is not used, the high 
resolution MS1 scan acts as a survey which delays DDA decision logic.  An inclusion 
list can guide precursor selection in DDA analysis or schedule MS2 events in data 
independent analyses (DIA). 
 
1.2.3 Computational proteomics 
Identification of peptides and proteins is relatively straightforward for sequenced 
genomes.  A protein database can be digested in silico to generate peptides and their 
theoretical spectra.  Candidate precursor ion identities can be determined through 
accurate mass matches to theoretical peptide masses.  In simple mixtures and high mass 
precision, peptide mass fingerprinting (PMF) is sufficient to identify proteins (Pappin et 
al., 1993), although MS2 spectral comparison in the normal approach with MS2 capable 
mass spectrometers.  The theoretical and experimental spectra can be compared to 
generate a similarity scores.  Higher precision on both precursor and fragment ions will 
minimise search space and improve specificity.  Many software platforms are capable of 
such searches including SEQUEST (Eng et al., 1994), Mascot (Perkins et al., 1999), and 
XTandem (Craig and Beavis, 2004).  Concatenating forward and reverse databases can 
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help determine true identifications from false positives using statistical models, such as 
PeptideProphet in the Trans-Proteomic Pipeline (TPP) (Keller et al., 2002). 
  
1.2.4 Quantitative proteomics 
Comparing proteomes for quantitative differences can give insight into molecular 
cause and consequence of different biological states.  Mass spectrometry allows us to 
both identify and quantify peptides simultaneously and numerous methods for 
quantitative comparison have been developed including label-free, iTRAQ, spectral 
counting, and stable isotope labelling with amino acids in cell culture (SILAC) 
(Wasinger et al., 2013).  When isotope labelling during cell growth is a possible 
experimental approach (Figure 1.12), SILAC offers favourable quantitative precision 
(Oppermann et al., 2013).  Lysine and arginine auxotrophic cells are grown in light 
media or media containing isotopically heavy arginine and lysine.  Mixing cells before 
sample processing minimises handling variation and digestion with trypsin ensures that 
most peptides contain an isotopic label.  Ratios between light and heavy isotope labels 
for identified peptides can be assembled into protein ratios using many supporting 
software solutions including XPRESS (Han et al., 2001). 
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Figure 1.12 Overview of SILAC labelling 
Cell cultures are grown in light or heavy stable isotope labelled arginine and lysine. 
Cells are mixed prior to samples processing including tryptic digestions, followed by 
LCMS analysis.  Computation analysis derived relative quantitation on identified 
peptides and proteins. 
 
1.3 Mass spectrometry of ubiquitin-like modifiers 
The proteomics field faces numerous challenges in characterising UBL 
modifications.  One of these challenges is overcoming the low abundance of UBL 
modified proteins.  Lessons from other PTMs, such as phosphorylation, has taught us 
that peptide-level enrichment techniques are critical to enable efficient PTM analysis by 
mass spectrometry.  Enrichment techniques like IMAC and TiO2 have enabled global 
proteome analysis of phosphopeptides, however, their differing enrichment specificities 
highlight the need for multiple enrichment strategies (Bodenmiller et al., 2007).  
Ubiquitin has recently received much attention in global proteome experiments due the 
development of two K-GG specific antibodies.  They too have overlapping but non-
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identical substrates suggesting that further enrichment strategies could also benefit 
ubiquitin studies (Wagner et al., 2012).   
 
Other members of the ubiquitin family have yet to receive a similar level of 
attention, partly due to a lack of peptide level enrichment strategies.  Even in samples 
where enrichment is not necessary, mass spectrometry analysis of UBL conjugation 
sites is further challenged by the complex nature of the modification.  Unlike small 
modification like phosphorylation and acetylation, UBLs leave a peptide remnant on 
modified lysines complicating their analysis (Jeram et al., 2009). 
 
While many of the challenges are specific to detection of UBL modification sites, 
the effect UBLs have on the proteome as a whole should not be overlooked.  
Quantitative analysis of the entire proteome can reveal potential UBL substrates by 
perturbing members of ubiquitin degradation pathways (Chen et al., 2012).  
Furthermore, global proteome analyses can also reveal UBL-dependent dynamic 
changes in signalling networks (Bennett et al., 2010).  Achieving a wide proteome 
coverage with sensitive quantitation in whole proteomes is still a developing field 
(Colaert et al., 2011). 
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1.4 Thesis roadmap 
Each of the three results chapters present research addressing some of the main 
challenges in UBL analysis.  Each chapter is a semi-independent body of work and 
approaches UBL research from the bench, at the mass spectrometer, and in silico.   
 
Chapter II, “Sortase Mediated Biotinylation for Isopeptide Enrichment (SoMBIE)”, 
addresses the low abundance challenge and presents a novel method for the enrichment 
of ubiquitin isopeptides. 
 
Chapter III, “Isotope Coded Isopeptide Detection (ICID)”, addresses the challenges 
in confident identification of isopeptides.  In this chapter, techniques are presented for 
the detection and identification of isopeptides in LCMS analyses, with a focus on UBLs 
with long tryptic remnants. 
 
Chapter IV, “HyperProphet”, presents a new workflow and software to improve 
coverage and accuracy in quantitative SILAC analyses of unfractionated proteomes. 
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Chapter II 
Sortase Mediated Biotinylation for 
Isopeptide Enrichment (SoMBIE) 
 
2.1 Introduction 
 
2.1.1 Ubiquitylation substrate identification 
The identification of ubiquitylated substrates is important for understanding 
biological systems and their points of regulation.  This is often achieved by perturbation 
of the ubiquitin system, such as mutating or deleting members of the ubiquitylation 
machinery.  In such cases, targets for ubiquitin dependent degradation can be indirectly 
inferred.  Upon deletion of an E3 ligase, up regulated proteins are revealed as a potential 
substrate for the E3 due to their accumulation.  For example, a label-free quantitative 
proteomics approach has successfully identified filamin A and filamin B as substrates of 
ASB2, which is a subunit responsible for substrate recruitment to the cullin-RING E3 
ligase complex (Burande et al., 2009).  While this is a straightforward approach for the 
discovery of candidate ubiquitin substrates, this approach is limited to degraded 
substrates rather than non-degredatory roles of ubiquitylation.  Furthermore, many 
candidates could be observed due to indirect effects.  Proteomic investigations into the 
role of the ubiquitin system responses to disease states or exogenous stimuli requires a 
more direct focus on ubiquitylated substrates to distinguish between ubiquitin 
dependent responses and other indirect proteome changes.  It is therefore important to 
focus specifically on the ubiquitylated subset of the proteome.  This can be achieved by 
enriching for ubiquitylated substrates prior to proteomic analysis. 
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2.1.2 Protein-level enrichment of ubiquitylated substrates 
A major limitation in the identification of ubiquitin substrates is the low abundance 
within the proteome.  While most proteins will be ubiquitylated at some point in their 
life cycle, the pool of ubiquitylated substrates in the proteome is small due to rapid 
degradation once modified.  Only a small portion of a protein may be modified or only 
modified during specific cell stages.  Enrichment of ubiquitin, and with it the conjugate 
substrates, is a common approach to dealing with the dynamic range challenge.  In 
genetically tractable systems, N-terminal fusions between affinity tags and ubiquitin 
offer a powerful way to enrich for ubiquitin.  Note that C-terminal tags are not possible 
due to the requirement for the free C-terminal carboxyl group involved in conjugation.  
 
A range of tags have proven successful, commonly 6HIS for its tolerance to 
denaturing conditions (Peng et al., 2003; Tsirigotis et al., 2001), but also more complex 
double affinity tags such as 6HIS–Myc (Hitchcock et al., 2003) and Strep-HA 
(Danielsen et al., 2011). For cells where genetic manipulation is impractical, ubiquitin 
purification can be achieved using the FK2 antibody (Matsumoto et al., 2005).  
Ubiquitin binding domains are also available for ubiquitin affinity purification, such as 
ubiquitin-associated (UBA) domain-containing proteins Rad23 and Dsk2 (Mayor et al., 
2005).  Construction of a tandem-repeated ubiquitin-binding entities (TUBEs), based on 
UBA domains of ubiquilin 1, increases affinity for polyubiquitin to enhance enrichment 
of polyubiquitylated substrates (Hjerpe et al., 2009; Shi et al., 2011a). 
 
2.1.3 Ubiquitylation substrate lysine identification 
Enrichment for ubiquitylated substrates increases the specificity for assigning 
ubiquitin substrate candidates. However, non-specific binding to affinity media or co-
precipitation of interactors increases false assignments.  Identifying the specific lysine 
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to which ubiquitin is conjugated is an important step in validating substrates as genuine 
targets.  Knowledge of the conjugated lysine also enables downstream investigation into 
the biological significance of target lysines through mutagenesis.  When dealing with 
individual substrates, mutagenesis can be used as an initial approach but is often 
impractical due to the number of lysines, and the modified lysine is not necessarily 
specific within a protein zone of modification (Mattiroli and Sixma, 2014).  
Alternatively, determining the specific lysine that is modified can be achieved by mass 
spectrometry based isopeptide identification. 
 
As for a typical proteomics workflow, the most common approach for identifying 
ubiquitin isopeptides is by tryptic digestion followed by mass spectrometry.  As the C-
terminal sequence of ubiquitin (…RLRGG) contains tryptic sites near the C-terminal 
carboxyl conjugation site, the tryptic remnant of ubiquitin is a very short GG 
modification, or sometimes a short LRGG missed cleavage.  Figure 2.1 compares the 
fragmentation of a linear peptide to an equivalent ubiquitin isopetpides.  Because the 
tryptic remnant is a small modification, fragmentation within this group does not 
contribute significantly to the overall spectrum. 
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Figure 2.1 A comparison of peptide spectra with ubiquitin tryptic remnants 
Spectrum identifications for ubiquitin peptides encompassing the K6 lysine for the 
missed cleaved unmodified (A), GG modified (B) and LRGG modified (C) peptides.  A 
shift in the modified lysine residue mass is observed allowing confident identified but 
without interference from the ubiquitin tryptic remnant fragment ions.  Data was 
acquired from a tryptic digest of K6 ubiquitin dimer. 
 23 
 
From an in silico standpoint, the modified K-GG residue can be considered as a 
single entity with a +114.04292 Da mass, thus resembling simple modifications like an 
acetylation or methylation.  An LRGG remnant giving a +383.22809 Da modification 
can also occur due to tryptic missed cleavage of the ubiquitin side chain and should be 
accounted for during database searches.  Over-alkylation with iodoacetamide may cause 
lysine double alkylation resulting in a modification of identical atomic composition to a 
diglycine modification (Nielsen et al., 2008).  Care should be taken to avoid this by 
using alternative alkylating reagents with differing modification mass or less reactive 
reagents such as chloroacetamide.  Addition tryptic missed cleavages should be 
permitted because the modified residue is no longer efficiently cleaved by trypsin, 
although cleavage of the modified K-GG residue has been reported (Denis et al., 2007).  
Validation of results should also attempt to distinguish between a modification with GG 
and semitryptic cleavage after asparagine (N) which has a near identical mass of 
114.04293 Da, although this will only occur with semi-tryptic database searches 
permitting.  Management of false positive modified peptides should be considered 
carefully as global target-decoy results do not necessarily hold true for the modified 
subset of a search result, particularly when combining results from multiple search 
engines (Shi et al., 2011b).  But on the whole, if isopeptide spectra can be acquired, 
assignment of ubiquitylated peptides identities to the spectra is not a limiting factor. 
 
Even in sample enriched for ubiquitylated proteins, there are typically many 
candidate proteins identified that do not have isopeptides assigned.  Note that 
identifying a protein may be straight forward as only one of the multiple available 
tryptic peptide are required to be identified.  In contrast, identifying an individual 
peptide or isopeptide of interest may be more challenging due to low signal intensity or 
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poor fragmentation.  For direct purification of substrate proteins (as opposed to 
ubiquitin enrichments) and in vitro reactions, modification stoichiometry can be low 
making isopeptide identification difficult. 
 
2.1.4 Peptide-level enrichment of ubiquitylated substrates 
Overcoming isopeptide detection challenges can be achieved by direct purification 
of the isopeptides.  Unlike protein level purifications, these methods focus on the unique 
structure of isopeptides that differentiate them from typical peptides.  Upon tryptic 
cleavage, ubiquitin modified peptides acquire two N-termini; the native peptide N-
termini and a second N-termini derived from the ubiquitin remnant.  This unique feature 
enables isopeptides to be targeted for enrichment using amine reactive fluorous affinity 
tags (Brittain et al., 2005).  In this approach, lysine reactivity was blocked by 
guanidination of peptides with O-methylisourea and N-terminal amines were derivatised 
with an N-hydroxysuccinimide ester of 1H,1H,2H,2H- perfluorohexanoic acid.  
Peptides with two flourous tags bind more stringently to fluorous-functionalised silica 
allowing singly modified peptide to wash away in moderate solvent washes.  While this 
is an intriguing approach, it has been demonstrated only on digests of polyubiquitin but 
has not been shown to be effective in more challenging samples.  Furthermore, 
isopeptide amines remain blocked with the uncharged perfluorohexanoate modification.  
These peptides were effectively analyses by MALDI, but the modification is likely to be 
detrimental to analysis by ESI. 
 
Another unique feature of ubiquitin isopeptides is the unique epitope generated by 
the K-GG tryptic remnant.  This epitope was exploited by generating an antibody with 
specificity to the internal K-GG and without cross reactivity to N-terminal diglycine 
(Xu et al., 2010).  While initial results were modest, subsequent optimised usage 
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(Wagner et al., 2011), and development of a second antibody (Kim et al., 2011) has 
resulted in purification of ubiquitin isopeptides from whole cell digests with impressive 
identification rates being reported.  Each antibody has an overlapping but non-identical 
sequence preference around the modified lysine suggesting a sequence bias for one or 
both antibodies (Wagner et al., 2012).  This suggests there may be a class of isopeptides 
that are poorly enriched using these antibodies.  This technique has now become the 
dominant approach for the enrichment of ubiquitin isopeptides for analysis by mass 
spectrometry. 
 
The available methods for enrichment of ubiquitin isopeptides are limited.  By 
nature of the methods, having specificity towards internal KGG epitope, or requiring 
two N-termini, neither method permits enrichment of N-terminal ubiquitylation.  The 
method presented in this chapter is a novel approach to enrichment of ubiquitin 
isopeptides which also permits targeting N-terminal diglycine modifications.  In this 
approach, a method is developed to take advantage of the polyglycine specificity of the 
enzyme Sortase A. 
 
2.1.5 Sortase A anchors virulence factors on gram positive bacterial 
cell wall 
Staphylococcus aureus is major cause of human infection and as a major health 
concern, the study of S. aureus virulence is an active area of research.  The virulence 
factor Protein A is well known for its immunoglobulin binding properties, and its 
expression on the cell surface contribute to S. aureus pathogenicity (Patel et al., 1987).  
A host of cell surface proteins are presented on the surface of S. aureus and other gram 
positive bacteria that containing an LPXTG motif (Marraffini et al., 2006; Navarre and 
Schneewind, 1999).  In a screen for cell wall sorting mutants, sortase A (henceforth just 
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referred to as sortase) was identified as a potential mechanism for sorting these cell wall 
proteins (Mazmanian et al., 1999).   S. aureus Sortase A is the type specimen for a large 
collection of sortase enzymes that have been discovered throughout gram positive 
bacteria, some of which have differing sequence specificities (Dramsi et al., 2005).  
Further characterisation confirmed that sortase was indeed the enzyme responsible and 
that cysteine-184 was necessary for enzymatic activity suggesting a transpeptidation 
was occurring (Ton-That et al., 1999).  Sortase recognises the LPXTG sorting signal 
motif and proteolytically cleaves at the threonyl-glycyl amide bond to form a thioester 
intermediate.  In a second transpeptidation step, the substrate is transferred to the N-
terminus of pentaglycine of the cell wall peptidoglycan (Figure 2.2).  The discovery and 
characterisation of sortase has lead to the introduction of new enzyme in the toolkit for 
biotechnological applications. 
 
 
 
Figure 2.2 Sortase conjugates bacterial cell surface proteins to peptidoglycan 
Sortase recognises the LPXTG cell sorting motif, then via a thioester intermediate, 
conjugates the C-terminal threonine to the N-terminus of pentaglycine within the outer 
cell wall peptidoglycan. 
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2.1.6 Current use of Sortase A in biotechnology 
Sortase has been used in biotechnological applications for its transpeptidase activity.  
More importantly, the specificity in which it recognises its substrates can be exploited 
to direct sortase to conjugate two approriately labelled biomolecules (Figure 2.3).  
Fusion of two proteins can be achieved by incorporating the LPXTG motif near the C-
terminus of one protein, and polyglycine at the N-terminus of another.  This application 
of sortase is a useful tool for in vitro ligation between protein domains where gene 
fusions fail (Levary et al., 2011).  Conjugation reactions have also been demonstrated 
for creating cyclic polypeptides and glycopeptides (Wu et al., 2011) and cyclic 
cytokines (Popp et al., 2011).  Application of sortase also extend to conjugations to 
other organic molecules where polyglycine is modified with a wide range of molecules 
such as fatty acids, fluorescent probes, biotin, nucleic acids, sugars, and antibiotics 
(Proft, 2010).  
 
 
 
Figure 2.3 Sortase can be exploited to mediate conjugation between 
biomolecules 
By incorporation the LPXTG motif near the C-terminus of protein X and 
polyglycine at the N-terminus of protein Y, a conjugated X-Y product can be generated.  
Proteins can be substituted for alternative reagents and solid supports as long as the 
LPXTG and polyglycine are accessible to sortase. 
 
2.1.7 Sortase A specificity 
The utility of sortase lies largely in its specificity.  Extended reaction times with 
variant peptide substrates have revealed a small tolerance for individual amino acid 
substitutions for the LPXTG motif, with only the glycine being absolutely specific 
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(Kruger et al., 2004).  However, this tolerance was only observed in the absence of the 
preferred substrate.  Non-specific reactivity has otherwise not been reported and sortase 
is considered specific for the LPXTG motif.  Other sortase variants from S. aureus, and 
sortases from other species have different specificities, but should not be confused with 
S. aureus Sortase A.   
 
Although sortase recognises pentaglycine as the second substrate in its native 
scenario, sortase has been confirmed as more tolerant to shorter glycine nucleophilic 
substrates.  In vitro kinetic analysis revealed that the length of the polyglycine is only 
required to be a diglycine and extending to three or more glycines only slightly 
improves reactivity (Huang et al., 2003).  No reactivity was detected against a single 
glycine and GV and GA dipeptides were found to be possible substrates for sortase but 
with much higher Km values.  Huang et al. (2003) concluded that the nucleophile 
binding site of sortase is specific for diglycine.  Diglycine was also reported as favoured 
substrate for peptide-peptide conjugations (Pritz et al., 2007) and for attachment to solid 
supports (Chan et al., 2007) but with reduced recognition of substrates where the second 
glycine was substituted for other amino acids. 
 
2.1.8 Objectives of research 
Limited peptide level purifications options are available for ubiquitin isopeptides.  
Also, no option available is applicable towards linear ubiquitin linear peptides.  Sortase 
mediated conjugation has been identified as a potential mechanism for targeting 
digycine motifs in tryptic peptides and, although sortase has been used in a wide range 
of applications, the applicability towards ubiquitin isopeptide enrichment has not been 
investigated to date.  Because isopeptides posses an unusual conformation there is a 
possible hindrance to recognition between sortase and the ubiquitin tryptic glygly 
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remnants giving uncertainty to this application.  The degree to which non-specific 
reactivity would interfere was also uncertain as there are reports of GX reactivity at low 
level relative to the preferred GG substrate.  The objectives of this research was to 
determine the feasibility of using sortase, and if feasible, develop a methodology 
whereby peptides containing a diglycine ubiquitin tryptic remnant are enriched for mass 
spectrometry analysis.  Although this chapter has focused on purification of ubiquitin 
isopeptides, the same principles apply to all glygly modifications, including those from 
NEDD8 and ISG15, which also have a glygly tryptic remnant. 
 
This chapter presents work that is predominantly a methods development project 
which has gone through a number of modifications since its conception.  The initial 
experimental design will be presented along with key adaptations made during the 
development of this method, followed by example applications of Sortase Mediated 
Biotinylation for Isopeptide Enrichment (SoMBIE). 
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2.2 Materials and Methods 
 
2.2.1 Peptides  
All were custom syntheses at >90% purity, except GG which was available at 
>99.5%): 
GG (Sigma) 
LIFAGK(GG)GLEDGR (JPT Peptide Technologies GmbH) 
biotin-VELPRTGEE (Pepceuticals Ltd, UK) 
biotin-VELPKTGEE (Generon Ltd, UK) 
biotin-AGGGGG-VELPKTGEE (JPT Peptide Technologies GmbH) 
biotin-Ttds-VELPKTGEE (JPT Peptide Technologies GmbH) 
biotin-Ttds-SGGSGGSGGGGGVELPKTGEE (JPT Peptide Technologies GmbH) 
biotin-SGGSGGSGGGGGVELPKTGEE  (JPT Peptide Technologies GmbH) 
biotin-SGGSGGSGGGGGVELPKTGEEHHHHHH (JPT Peptide Technologies 
GmbH) 
biotin-SGGSGGSGGGGGVELPETGEEHHHHHH (Thermo Fisher Scientific 
GmbH) 
 
2.2.2 Protein reagents 
Protein for in vitro ubiquitylation were as published (Kazlauskaite et al., 2014)): 
Flag-ubiquitin (Boston Biochem), MDYKDDDDKGG precedes ubiquitin M1 
Human recombinant Ube1, purified from Sf21 insect cell line 
Human His-SUMO-Parkin, expressed in E. coli, tag cleaved off by His-SENP1 
MBP-TcPINK1 expressed in E. coli, (and a kinase-inactive version, D359A) 
Human recombinant UbcH7, expressed in E. coli. 
6His-Sumo-Miro1, expressed in E. coli. 
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6HIS-HALO-TUBEs (Tandem-repeated Ubiquitin-Binding Entities), expressed in 
E. Coli.  Sequence based on Genebank Q9UMX0, expressed in pET28a vector 
(pET28a-6HIS-TEV-HALO-4xUbiquilin) 
 
Sortase (wt and variants): Sortase 60-206 protein sequences are preceded by 6HIS 
and an S-tag (underlined), followed immediately by sortase A Q60 
Sortase A, wt (MRC-PPU cloning Ref: SC20983) 
MGSSHHHHHHSSGLVPRGSHMKETAAAKFERQHMDSQAKPQIPKDKSKVA
GYIEIPDADIKEPVYPGPATPEQLNRGVSFAEENESLDDQNISIAGHTFIDRPNYQ
FTNLKAAKKGSMVYFKVGNETRKYKMTSIRDVKPTDVEVLDEQKGKDKQLTL
ITCDDYNEKTGVWEKRKIFVATEVK 
Sortase A, 3x point mutant, Tag deletion ∆G2, D160N K190E K196T (MRC-PPU 
cloning Ref: DU22269) 
MSSHHHHHHSSGLVPRGSHMKETAAAKFERQHMDSQAKPQIPKDKSKVAG
YIEIPDADIKEPVYPGPATPEQLNRGVSFAEENESLDDQNISIAGHTFIDRPNYQF
TNLKAAKKGSMVYFKVGNETRKYKMTSIRNVKPTDVEVLDEQKGKDKQLTLI
TCDDYNEETGVWETRKIFVATEVK 
Sortase A, 5x point mutant, Tag deletion ∆G2, P94R D160N D165A K190E K196T 
(MRC-PPU cloning Ref: DU22272) 
MSSHHHHHHSSGLVPRGSHMKETAAAKFERQHMDSQAKPQIPKDKSKVAG
YIEIPDADIKEPVYPGPATREQLNRGVSFAEENESLDDQNISIAGHTFIDRPNYQF
TNLKAAKKGSMVYFKVGNETRKYKMTSIRNVKPTAVEVLDEQKGKDKQLTLI
TCDDYNEETGVWETRKIFVATEVK 
 
2.2.3 Sortase cloning and expression  
All coning was performed by the cloning services team (Dundee MRC-PPU).  
Expression of Sortase A was performed by the Protein Production and Assay 
Development  (Dundee MRC-PPU).  The sortase A (gene ID ADC38675) was cloned 
from Staphylococcus aureus genomic DNA.  The sequence corresponding to amino 
acids 60-206 was inserted into a pET28a plasmid including a HIS6 and S-tag.  pET28a-
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HIS6-S-tag-SrtA60-206 was transformed and expressed in Escherichia coli BL21 cells. 
Cells were grown in LB medium containing 50 µg/mL kanamycin (Sigma) at 37 °C to 
an OD600 of 0.8. 250 µM isopropyl 1-thio-β-D-galactopyranoside (Sigma) was added 
to induce expression and cell were harvested by centrifugation  at 3,000 x g for 5 min 
after 16 hr growth at 15 °C. Cells were lysed by sonication in 25 mM HEPES/NaOH pH 
7.5, 150 mM NaCl, 0.1 mM EGTA, 0.1 mM EDTA, 1 mM Leupeptin (Sigma), 5 mM 
imidazole. Lysate was clarified by centrifugation  at 17,000 x g for 5 min and applied to 
Ni Sepharose Fast Flow (GE Healthcare) and eluted in 25 mM HEPES/NaOH pH 7.5, 
100 mM NaCl, 0.1 mM EGTA, 0.03% Brij-35, 400 mM imidazole, 10% glycerol and 
buffer exchanged into 50 mM HEPES pH 7.5, 10% glycerol, 150 mM NaCl, 1 mM 
Dithiothreitol (DTT)(Formedium).  Sortase point mutants were derived from the above 
plasmid and were expressed as outlined above. 
 
2.2.4 Re-purification of sortase 
Additional purification of the Sortase 3x point mutant was conducted by size 
exclusion on a HiLoad 16/600 Superdex 75 column (GE Healthcare) in 50 mM Tris pH 
7.5, 150 mM NaCl, with protein signal detection at 280 nm.  5 mg of protein was 
fractionated and the most abundant fraction was re-concentrated on NiNTA agarose 
(Qiagen), eluted in 50 mM Tris pH 7.5, 150 mM NaCl, 400 mM imidazole, then 
dialysed overnight against 50 mM Tris pH 7.5, 150 mM NaCl using a 1 kDa dialysis 
unit (Amersham). 
 
2.2.5 SDS-PAGE and western blotting 
A fixed proportion of 1/1000 of the sample was collected during purification and 
analysed by 15% SDS-PAGE with coomassie staining.  A duplicate gel was transferred 
to Hybond-C Extra Nitrocellulose membrane (Amersham) and blocked in 4% 
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BSA/TBS/0.1% Tween 20 overnight.  Incubation with 1/1000 FK2 anti-ubiquitin 
antibody (Millipore) was followed by 1/3000 Goat Anti-Mouse IgG (H + L)-HRP 
Conjugate in 1% BSA/TBS/0.1% Tween 20 for 1 hr.  Incubations were separated and 
followed by five 15 min washed in TBS/Tween 20 and developed using the Immun-Star 
HRP Chemiluminescent Substrate Kit (Bio-Rad). 
 
2.2.6 Yeast protein extract preparation  
For whole yeast proteome digest, wild-type SILAC yeast strain 
(BY4741  lys1∆::KAN, lys2∆::KAN, arg4∆::KAN) was inoculated into SD (6.7 mg/mL 
yeast nitrogen base without amino acids and (NH4)2SO4 (Becton Dickinson), 0.68 
mg/mL Triple Dropout CSM Mix -K, -R, -A (Formedium), 2% (wt/vol) glucose, 0.01% 
(wt/vol) Adenine, 0.2 mg/mL Pro, 0.02 mg/mL arginine, 0.03 mg/mL lysine).  Pre-
cultures were grown overnight from a single colony then diluted to OD600 ~0.05 and 
grown to OD600 ~0.8.  Cells were collected by centrifugation at 3,000 x g for 5 min. 
Cells were lysed with 2 M NaOH, 1 M β-mercaptoethanol (Sigma) for 5 min on ice, 
then proteins were precipitated with 50% TCA on ice for 10 min.  Proteins are 
precipitated by centrifugation at 3,000 x g for 5 min and washed twice with cold 
acetone. Pellets were dried and resuspended in 8 M urea, 0.5% RapiGest (synthesised 
in-house), 100 mM Tris pH 7.5. Protein content was determined by diluting samples 
20x in water, 25 µl of which was mixed with 1 mL Bicinchoninic acid (Pierce), 0.08% 
CuSO4 (Sigma) and incubated for 1 hr at 37 °C before measuring OD562.  
Concentrations were interpolated from a standard curve of BSA. 
 
Protein preparation for poly-ubiquitylated substrate purification, a 600 mL yeast 
culture was grown as above but to OD600 of 1.2.  Cells were harvested by 
centrifugation  at 3,000 x g for 5 min and resuspended in an equal volume PBS pH 7.5 
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and droplets of cell suspension were frozen in liquid nitrogen.  Cell were lysed in a pre-
cooled Spex SamplePrep 6870 freezer mill (7 cycles for 2 min at 15 cps followed by 3 
min cooling). Freezer milled yeast powder was resuspended on ice in cold TBS/1% 
Triton X-100, 2 µg/mL Pepstatin (Sigma), 10 µg/mL Leupeptin (Sigma), 0.5 mM PMSF 
(Roche), 4% Roche Protease Inhibitor (made at 1 tab/mL), 15 mM IAA.  Protein was 
clarified by two centrifugations at 17,000 x g for 5 min followed by ultracentrifuation at 
50,000 x g at 4 °C for 1 hr. 
 
2.2.7 Tandem-repeated Ubiquitin-Binding Entities (TUBEs) affinity 
purification of poly-ubiquitylated proteins 
2 mL (500 µL packed bead volume) of HaloLink Sepharose Resin (Promega) was 
pre-washed twice in TBS pH 7.5/0.05% Triton X-100 and incubated at 4 °C overnight 
with 4 mg NiNTA enriched 6HIS-HALO-TUBE protein in TBS pH7.5.  Unbound 
TUBEs were removed with five washes in TBS/0.05% Triton X-100. Freezer-milled 
ultracentrifuged yeast extract was applied to TUBEs beads and incubated at 4 °C for 4 
hr.  Beads were then washed five times in TBS/0.1% Triton X-100.  Beads were further 
washed 5 times in TBS without detergent and eppendorf tube changed twice during 
washing to remove plastic bound proteins and detergent.  Proteins were eluted in 1% 
RapiGest/25 mM Tris 7.5 at 50 °C for 5 min and pooled with a wash with water.  
Elution was repeated with Laemlli buffer to check for elution efficiency. 
 
2.2.8 Digestion of yeast proteins and TUBEs eluate 
50 µg yeast protein extract, or entire TUBEs eluate, was reduced in 5 mM tris(2-
carboxyethyl)phosphine (TCEP) for 1 hr, alkylated with 5 mM chloroacetamide 
(ClAA)(Sigma) for 30 min, and the remaining ClAA was quenched with 2 mM DTT.  
The sample was diluted 10-fold and digested with 1:100 trypsin (or 5 µg for TUBEs 
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eluate) at 37 °C overnight.  Trypsin activity was blocked with 5 mM PMSF for 2 hr at 
37 °C before acidification with trifluoracetic acid (TFA) (Thermo Scientific), 
precipitation of rapiGest by centrifugation at 17,000 x g for 15 min , and purification of 
peptides on a C18 MicroSpin column (The Nest Group) and dried. 
 
2.2.9 In vitro ubiquitylation of Miro1 
The in vitro reaction was performed by Agne Kazlauskaite (Alessi lab, MRC, 
Dundee University) and was carried out as published in (Kazlauskaite et al., 2014).  2 
µg Parkin was phosphorylated by incubating with 1 µg of PINK1 at 30 °C for 1 hr in 25 
µL of 50 mM Tris – HCl ( pH 7.5), 0.1 mM EGTA, 10 mM magnesium acetate, 1% β-
mercaptoethanol and 0.1 mM ATP.  For Miro1 ubiquitylation, the reaction was diluted 
to 50 µL of 50 mM Tris – HCl  pH 7.5, 0.05 mM EGTA, 10 mM MgCl2, 0.5% β2-
mercaptoethanol, 0.12 µM E1, 1 µM UbcH7 and 2 µg 6xHis-Sumo-Miro1, 0.05 mM 
Flag-ubiquitin, and 2 mM ATP, and incubated 30 °C for 60 min.  There reaction was 
terminated with 1% rapiGest at 95 °C for 5 min and reduced in 5 mM (TCEP) at 50 °C 
for 30 min. Additional Tris–HCl was added to 100 mM to ensure buffering at pH 7.5 
followed by cysteine alkylation in 10 mM ClAA at 20 °C in the dark for 30 min. 
Samples were diluted to 0.1% RapiGest and digested with 1 : 50 w/w trypsin overnight 
at 37 °C. Trypsin activity was blocked with 5 mM PMSF for 2 hr at 37 °C before 
acidification with 1% TFA and incubated at 37 °C for 1 hr before precipitating acid-
cleaved RapiGest by centrifugation at 17 000 x g for 15 min. Peptides were purified on 
C18 MicroSpin columns and dried. 
 
2.2.10 Sortase mediated biotinylation and enrichment of biotinylated 
peptides 
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2.2.10.1 Sortase mediated biotinylation and enrichment of biotinylated peptides 
from Yeast 
50 µg dried tryptic yeast peptides were resuspended in 20 µL sortase reaction buffer 
(50 mM Tris pH 7.5, 150 mM NaCl, 5mM CaCl2, 2 mM DTT) including 200 µM 
biotin-SGGSGGSGGGGVELPKTGEEHHHHHH bait peptide and equilibrated to 20 
°C.  5 µM sortase (3x point mutant) was added and incubated for 45 min before 
stopping reaction with 1% RapiGest and heating to 95 °C for 5min.  Sample was diluted 
10x in 2xTBS and excess bait peptide depleted on 45 µL NiNTA agarose (Quagen) for 
45 min before collecting the flow through and pooling with 2 washes of 
2xTBS/0.1%RapiGest.  Peptides in NiNTA flow-through were bound to 25 µL M-270 
magnetic streptavidin Dynabead solution (Invitrogen) for 45 min, washed with 
2xTBS/0.1% RapiGest 5 times.  Peptides were tryptically released from the beads with 
125 ng trypsin in TBS at 30 °C for 15 hr.  Eluate was pooled with a wash of TBS/0.1% 
RapiGest and peptides were purified by C18 Microspin columns. 
 
2.2.10.2 Sortase mediated biotinylation and enrichment of biotinylated peptides 
from polyubiquitin enriched yeast 
Dried peptides derived from polyubiquitin enriched yeast proteins were processed as 
for yeast but with the following exceptions.  Streptavidin beads were washed in 
TBS/0.1% Triton X-100 followed by 6 washed in 2xTBS/0.1%RapiGest.  Elution from 
streptavidin was performed by bait hydrolysis in sortase reaction buffer with 0.005%Rg 
and 5 µM sortase (re-purified sortase 3x mutant). 
 
2.2.10.3 Sortase mediated biotinylation and enrichment of biotinylated peptides 
from a Miro1 in vitro reaction 
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30 µL (of 50 µL reaction) dried peptides was processed as for yeast but with the 
following exceptions.  Sortase reaction was for only 30 min and using the biotin-
SGGSGGSGGGGGVELPETGEEHHHHHH bait petpide.  Bait was not depleted over 
NiNTA, instead, peptides were bound directly to 200 µL of streptavidin bead solution, 
and washed.  Elution from streptavidin was performed by sortase reaction buffer 
containing 0.01% RapiGest, 2 µM sortase (re-purified sortase 3x mutant) and G 
dipeptide as 500 µM. Eluate was pooled with an additional 500 mM NaCl wash. 
 
 
2.2.11 Mass Spectrometry Data acquisition 
Peptides were injected onto a self packed 75 µm inner diameter PicoTip Emitter 
(New Objective), packed with Magic C18AQ 3 µm 200 Å beads (Michrom 
Bioresources) which was heated to 45 °C.  A Proxeon EASY-nLC or a Dionex 
Ulitimate 3000 HPLC delivered a 250 nL/min gradient using buffers A (0.1% formic 
acid, 2% acetonitrile) and B (0.1% formic acid, 90% acetonitrile) for peptide analyses.  
Complex samples also included the addition of 3% DMSO.  Gradients were run from 1-
40% B over 25 min (synthetic peptide reactions), 60 min (in vitro ubiquitylations) or 90 
min (complex yeast samples) followed by a high solvent wash and equilibration.  Data 
were acquired on a Velos Orbitrap mass spectrometer (Thermo Fisher Scientific), at 60k 
Orbitrap resolution, and with a preview scan triggering data dependent acquisition 
(DDA) of the top 15 precursors above a 500 precursor intensity threshold, or 30k 
resolution top 1 MSn for rapid peptide analyses.  Peptides were isolated within a 2 m/z 
window for fragmentation by rapid scan ion trap CID.   
 
2.2.12 Data analysis 
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LCMS raw data files were converted to mzXML format using ReAdW.exe.  For 
assays on synthetic peptides, in-house developed software was used to extract 
chromatographic peak areas for manually validated monoisotopic precursor m/z, ppm 
tolerance, and retention time ranges.  MS2 spectra were assigned to peptide 
identifications by searching against a S. cerevisiae protein database (version 2011-02-03 
from SGD http://www.yeastgenome.org/) or a composite database containing protein 
reagent sequences and common contaminants appended to an E. coli database.  Search 
engine used was either Mascot (Matrix Science) or Comet (Eng et al., 2013).  Search 
parameters included +57.02146 Da for carbamidomethylcysteine and variable 
modifications+15.994915 Da for methionine oxidation, +114.0429 Da for GG, and 
+383.2281 Da for LRGG.  Where a tryptic threonine remnant was expect, +215.0906 
Da for TGG and 101.0477 Da for N-terminal theonine was also permitted as a variable 
modification.  Peptide precursor tolerance was set to 25 ppm (or 10 ppm for Mascot) 
and 0.4 Da for MS2 spectra, and semi-tryptic peptides were permitted up to 3 missed 
cleavages.  Mascot search results were filtered at a peptide score of 25.  Comet search 
results were validated using the Trans-Proteomic Pipeline (TPP) v4.6 with peptide and 
protein assignments being validated at 1% FDR using PeptideProphet and 
ProteinProphet. 
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2.3 Results and Discussion 
 
2.3.1 Conceptual design 
In contrast to previous biotechnological applications, the conjugation event in this 
strategy aims to specifically target the polyglycine motif that exists on ubiquitin 
isopeptides after tryptic digest.  In this strategy, which is outlined in Figure 2.4, the 
LPXTG sorting signal motif is embedded within a synthetic biotinylated peptide which 
is used as bait to fish ubiquitin isopeptides.  In addition to the N-terminal biotin and 
sorting signal sequence, the bait peptide also possesses an arginine in the non-specific X 
position to enable the isopeptides to be released from streptavidin using trypsin.  The 
consequence of proteolytic cleavage within the motif is that a threonine residue remains 
attached resulting in a TGG isopeptide remnant.  The TGG remnant offers a useful 
marker to distinguish between affinity tagged and native isopeptides without 
interference from the bait peptide, which is a valuable utility for methods development. 
 
 
Figure 2.4 Strategy overview for the Sortase Mediated Biotinylation for 
Isopeptide Enrichment 
Sortase two-step reaction includes proteolytic cleavage of the LPXTG motif and 
formation of a threonyl-thioester intermediate (A) and transpeptidation of the threonly 
intermediate to the diglycine nucleophile (B).  Conjugated isopeptides are then enriched 
on streptavidin (C), then tryptically released (D) followed by LCMS analysis (E). 
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2.3.2 Proof of principal 
Although there is evidence that sortase can conjugate to polyglycine stretches 
shorter than its native pentaglycine (Huang et al., 2003), there is no evidence to indicate 
that a branched diglycine isopeptide is a suitable substrate.  To demonstrate that 
viability of the proposed strategy, sortase was incubated with the biotinylated bait 
peptide, biotin-VELPRTGEE, and a synthetic isopeptide, LIFAGK(GG)GLEDGR.  
Figure 2.5 demonstrates the formation of a peptide corresponding to the expected mass 
of the conjugated peptide.  This confirmed the feasibility of biotinylating isopeptides 
using sortase, however, a poor conversion efficiency resulted under the initial 
conditions used. 
 
Figure 2.5 The diglycine remnant of a tryptic ubiquitin branched isopeptide is a 
valid sortase substrate in vitro 
40 µM biotinVELPRTGEE (628.303 m/z, 2+), and 30 µM LIFAGK(GG)GLEDGR 
(463.921 m/z, 3+) isopeptide were incubated with samplings for LCMS analysis at 0 
(A) and 12 (B) hours.  Extracted ion chromatograms reveal the formation of the 
anticipated peptide conjugate, LIFAGK(biotinVELPRTGG)GLEDGR (771.080 m/z, 
3+), after a 12hr incubation. 
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2.3.3 An excess of bait peptide is required for efficient isopeptide 
biotinylation 
For the isopeptide enrichment strategy to be successful, a much higher conversion 
efficiency is required.  It was noticed that the conjugated isopeptide product also 
contained the LPXTG motif.  It is probable that this product is also a valid substrate for 
sortase, therefore the conjugation reaction is an equilibrium between the thioester bait 
intermediate and conjugated isopeptide (Figure 2.6).  It was reasoned that increasing the 
bait peptide might promote formation of the thioester intermediate, as this is a rate 
limiting step (Race et al., 2009).  In turn, an increased amount of thioester intermediate 
would drive the transpeptidation reaction in favour of biotinylating the isopeptide 
diglycine side chain.  
!
 
Figure 2.6 Sortase mediated isopeptide biotinylation is an equilibrium reaction. 
In this overview of the sortase 2-step reaction, note that formation of the thioester 
intermediate occurs by recognition and cleavage of the LPXTG motif present in both 
the bait peptide and the biotinylated isopeptide product.  The bait peptide thioester 
hydrolysis is non-reversible. 
 
To assess the effect of increasing bait concentration, the sortase reaction was 
assayed from 0-400 µM bait with a static 50 µM isopeptide.  At high concentrations of 
bait peptide, a hydrolysed form of the bait peptide became evident, which partially co-
eluted with the intact bait peptide (Figure 2.7A).  This species no longer contains a 
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recognisable LPXTG motif and will therefore be a non-reversible product and will 
accumulate as the reaction proceeds.  Each sample was analysed by LCMS to monitor 
peptide peak areas of peptide substrates and products (Figure 2.7B).  Increasing the bait 
peptide concentration resulted in more efficient isopeptide biotinylation as indicated by 
both increasing biotinylated isopeptide product formation and decreasing unconjugated 
isopeptide concentration.  The substrate formation curve plateau suggests that the 
system is approaching substrate saturation.  Addition of even higher bait concentrations 
would not result in a significant increase in isopeptide biotinylation.  An increase of the 
hydrolysed bait also occurs with increasing bait peptide, which appears to be a non-
linear increase.  A hydrolysis rate increase would be expected as the relative availability 
of diglycine substrate decreases.  If a nucleophilic substrate is unavailable, a prolonged 
unstable thioester intermediate would result in increase hydrolysis from water. 
 
It is clear that a many-fold excess of bait is necessary to achieve an optimal bait 
conversion.  A large excess of the biotinylated bait peptide will also increase the scale 
of the downstream purification.  A balance between reaction efficiency and excessive 
biotin reagents must be met.  Under the conditions used, a 4-fold excess of bait over 
isopeptide was considered a suitable compromise, which corresponds to a conversion of 
approximately 50% (as judged by the reduced isopeptide signal in Figure 2.7). 
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Figure 2.7 Excess bait peptide drives formation of biotinylated isopeptide 
Sortase reactions were conducted for 20 hours against synthetic isopeptide with 
increasing amounts of bait peptide.  An LCMS chromatogram of with a high bait 
concentration (200 µM) indicates the presence of the hydrolysed bait peptide (A).  
Peptide peak areas for reaction substrates and products are plotted with increasing bait 
peptide concentration (B).  Note that the GEE C-terminal end of the cleaved bait peptide 
is not detectable by reverse phase chromatography due to its hydrophilicity. 
 
2.3.4 Purification of biotinylated isopeptide 
The biotinylated bait peptide allows for isopeptide recovery on streptavidin beads.  
Note that the total biotin in the reaction is determined by the amount of bait peptide 
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used, therefore the amount of streptavidin required is not determined by the isopeptide 
biotinylation efficiency or bait peptide hydrolysis.  Figure 2.8 presents initial attempts 
to purify biotinylated isopeptides on streptavidin followed by release with trypsin.  To 
quantitatively assess the recovery of isopeptides, a tryptic digest of the reaction products 
was compared to the tryptic elution from streptavidin by LCMS.  The eluted peptide 
corresponded to only 8% of the expected isopeptide signal.  While this is a positive 
validation that tryptic elution from streptavidin is a feasible means of purifying 
biotinylated peptides, recovery was poor.  A significant improvement in efficiency was 
required to make this approach a practical solution to purifying ubiquitin isopeptides.   
 
Figure 2.8 Biotinylated isopeptide can be purified and recovered with streptavidin 
and trypsin 
Two equal portions of a sortase reaction (A) were either tryptically digested or 
applied to streptavidin and tryptically eluted.  Comparing extracted ion chromatograms 
for tryptic isopeptides without streptavidin purification (B) and after streptavidin 
purification (C) indicated that only ~8% of the isopeptide is recovered from 
streptavidin. Absolute intensities are indicated to the right of each chromatogram. 
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The choice of straptavidin beads was also a critical factor.  To maintain 
compatibility with LCMS analysis, beads pre-blocked in BSA or detergent had to be 
avoided due to a significant contamination of tryptic BSA or polymers.  Complete 
removal of excess blocking agents from pre-blocked beads was not possible, therefore 
using unblocked streptavidin beads was essential.  The presence of streptavidin tryptic 
peptides were also visible, which is an inevitable consequence of the elution procedure. 
 
2.3.5 Optimisation of bait Peptide design 
Because the recovery of isopeptides from streptavidin was a significant limiting 
factor, this was an initial focus for improvement.  Given the short peptide sequence 
used, it was likely that the exposure of the tryptic cleavage site away form the 
streptavidin bead surface was insufficient for full access to trypsin.  To improve 
exposure of the peptide, the bait peptide was redesigned to include a linker region 
between the biotin and the LPXTG motif.  A selection of linkers were tested, including 
poly-glycine and SGG repeats which have previously been used as flexible linker 
between protein domains (Reddy Chichili et al., 2013).  A Ttds-Linker (N-(3-{2-[2-(3-
Amino-propoxy)-ethoxy]-ethoxy}-propyl)-succinamic acid) was also used as a non-
amino acid alternative (Figure 2.9).  Note that the arginine tryptic site was also changed 
to a lysine.  This was to allow for testing endoprotease lysC as an eluting enzyme with 
dimethylation of streptavidin to protect the beads from digestion by lysC.  
Unfortunately, lysC was found to be inefficient at eluting isopeptides compared to 
trypsin. 
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A comparison between bait peptide designs was conducted to assess the impact on 
both isopeptide biotinylation and recovery from streptavidin (Figure 2.10).  All bait 
peptides offered similar sortase reactivities.  Tryptic release from streptavidin was 
significantly improved for all baits with extended linkers.  The fact that the TtdsSGG3 
linker did not result in further improvement over Ttds or SGG3 alone suggests that the 
shortest linker extension is sufficient to expose the tryptic site away from the bead 
surface.  Only two thirds of the isopeptide was recovered with the longer bait peptides.  
The incomplete recovery is presumably non-specific losses due to additional exposure 
plasticware and streptavidin beads.  The intermediate length SGG3 linker was selected 
for further use. 
 
Figure 2.9 Ttds linker structure 
Ttds: N-(3-{2-[2-(3-Amino-propoxy)-ethoxy]-ethoxy}-propyl)-succinamic acid, 
C14H28N2O6 (MW: 320.4) 
 
 
Figure 2.10  An extended bait peptide linker enables efficient isopeptide 
recovery from streptavidin 
50 µM synthetic isopeptide was Sortase reacted for 30 hours with 200 µM of 6 
different bait peptides.  The conversion efficiency was determined as the TGG tryptic 
isopeptide signal as a percentage of total (GG + TGG) isopeptide signal in a tryptic 
digest of the reaction (A).  The final TGG tryptic elution product was quantified as the 
percentage of the TGG signal in a digested portion of the sortase reaction (B). 
Bait peptide key: 
-    Biotin-VELPKTGEE 
AG5  Biotin-AGGGGG-VELPKTGEE 
Ttds  Biotin-Ttds-VELPKTGEE 
SGG3  Biotin-SGGSGGSGGGGGVELPKTGEE 
TtdsSGG3  Biotin-Ttds-SGGSGGSGGGGGVELPKTGEE 
SGG3-H6  Biotin-SGGSGGSGGGGGVELPKTGEEHHHHHH 
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2.3.6 Depletion of excess bait with a C-terminal HIS6 affinity tag 
Recall that efficient biotinylation of isopeptides requires an excess of bait peptide to 
drive the equilibrium.  This excess also increases the amount of streptavidin beads 
required during the downstream affinity purification step.  Streptavidin has a low level 
trypsin sensitivity and an excessive use of streptavidin results in dominating streptavidin 
peptides.  Also included in Figure 2.10 was the SGG3-H6 bait peptide containing a C-
terminal hexahistidine affinity tag.  The hexahistidine modified bait offers a way of 
depleting unreacted bait peptide.  Note than the affinity tag is released during formation 
of the bait-sortase thioester intermediate but remains attached to any unreacted bait.  
The excess GEEHHHHHH C-terminally cleaved peptide does not interfere with LCMS 
analyses because, like the former GEE peptide, it is hydrophilic and washes off C18 at 
very low solvent concentration.  The bait hydrolysis will also cleave off the 
hexahistidine tag but without conjugating to an isopeptide, so depletion of all non-
conjugated bait is not possible.  Although this depletion step is optional, it permits 
increased amounts of bait peptide to be used, or scaling up a purification, while 
minimising the amount of streptavidin required in the final purification step. 
 
Excess bait can be depleted on NiNTA, and only the flow-through is required for 
further processing therefore NiNTA elution can be omitted.  NiNTA agarose was 
determined to have the capacity of approximately 2.5 µg bait peptide peptide/100 µL 
NiNTA agarose bead solution (Qiagen).  Excess bait depletion was also explored by 
C18 reverse phase cutoff.  C18 offers an attractive option due to its fractionation 
efficiency and low non-specific sample losses.  This option became available only due 
to the hydrophilicity of the hexahistidine tag which was predicted to have very low 
affinity for C18 (Krokhin and Spicer, 2009).  Note that in Figure 2.11A, the intact bait 
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peptide is an early eluting species, in contrast to the bait without a hexahistidine tag 
(Figure 2.8A) but still eluted later than predicted.  The elution of the bait was effective 
at 12% acetonitrile, whereas isopeptide and conjugated isopeptide were retained (Figure 
2.11B-D).  Biotinylated isopeptides will have an increased retention time preventing 
loss of most peptides, although very hydrophilic isopeptides will still likely be lost 
during this procedure. 
 
Figure 2.11 Excess bait peptide can be depleted by C18 fractionation 
A sequential elution of a sortase isopeptide reaction (A) from C18 indicates that the 
unconjugated hexahistidine tagged bait peptide (706.82 m/z, 4+) can be depleted from 
C18 reverse phase media at 12% acetonitrile/0.1% formic acid (B) while retaining 
unconjugated (463.92 m/z, 2+) and conjugated isopeptide (1019.84 m/z, 2+), which can 
be eluted for further analysis (C-D). 
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2.3.7 Improved biotinylation efficiency using Sortase mutants with 
increased catalytic activity 
It was observed that reactions were very slow and benefited from extended reaction 
times.  Given that the reaction is an equilibrium, a complete isopeptide biotinylation is 
not achievable.  However, improved isopeptide biotinylation may be achieved by 
ensuring that the optimal reaction time point is reached.  For the current protocol, this 
was expected to be an impractical reaction time of more than 24 hours.  Overcoming 
this limitation was investigated by characterising the performance of sortase reactions 
over time, for both wt sortase and for sortase mutants.  Sortase mutants with increased 
bait binding affinity and catalysis were published in a screen that used sortase to 
exemplify a directed evolution methodology (Chen et al., 2011b).  Two of the reported 
mutants were selected for expression and purification.  A triple-point mutant 
(D160N/K190E/K196T) and a five-point mutant 
(P94R/D160N/D165A/K190E/K196T), both of which were reported to have an 
increased catalytic activity and decreased Km for the LPXTG motif.  Assays for wt and 
both mutants were conducted with time points subjected to LCMS analysis to quantify 
product formation (Figure 2.12).  
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Figure 2.12 Mutant sortase enzymes enhance the rate of isopeptide 
biotinylation 
LCMS analysis of time course reaction between 200 µM bait peptide and 50 µM 
isopeptide for three sortase variants follows (A) the biotinylated isopeptide product 
(1019.84 m/z, 2+) and (B) the hydrolysed bait peptide (843.89 m/z, 2+).  
Chromatographic features are indicated in Figure 2.11. 
 
 
Both mutant enzyme have vastly superior reactions rates relative to wt, which is 
consistent with published sortase catalytic activities (Chen et al., 2011b).  The wt 
sortase does not reach optimal product formation even after 24 hours, whereas the point 
mutants enabled the reaction to be completed in 1-2 hours.  The expected optimal time 
for the wt sortase can be extrapolated to approximately 35 hours, assuming the same 
amount of product is produced for all enzymes.  For the sortase mutant reactions, the 
isopeptide product decays after prolonged reaction times.  This can be explained by the 
eventual hydrolysis of the bait peptide (Figure 2.12B), which lacks a complete LPXTG 
motif.  As the LPXTG motif substrate availability falls below the concentration of 
isopeptide, the equilibrium will shift in favour of deconjugating the biotinylated 
isopeptide. The triple-point mutant was selected for further use in the SoMBIE method, 
although either sortase mutant would be suitable for accelerated substrate biotinylation. 
 
2.3.8 Optimisation of isopeptide elution 
In Figure 2.12, it was observed that the enhanced sortase enzymes will hydrolyse the 
bait peptide given extended reaction times.  By manipulating the reaction conditions, 
the equilibrium can be shifted in favour of releasing isopeptides from the bait peptide.  
Although this is an undesirable reaction when biotinylating isopeptides, it does 
highlight the fact that sortase can be used as a protease with specificity for the LPXTG 
motif.  Because the hydrolysis reaction is slow compared to the transpeptidation 
reaction, eluting isopeptides with a competing peptide may prove to be more efficient 
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than hydrolysis.  A short glycyl-glycine dipeptide was tested for its ability to conjugate 
to the bait peptide.  Figure 2.13 shows formation of an abundant glygly-conjugated bait 
peptide indicating that the dipeptide is an effective substrate and can be used to aid 
elution of isopeptide.   The dipeptide is sufficiently hydrophilic to be depleted during 
C18 cleanup and an excess of this peptide will not interfere with downstream LCMS 
analysis. 
 
 
Figure 2.13.  A glycyl-glycine dipeptide is a sufficient sortase substrate for 
competitive elution of isopeptides 
Extracted ion chromatogram for reaction products after a 1 hour sortase reaction 
between 200 µM bait peptide and 1 mM glycyl-glycine dipeptide (not detected).  An 
abundant diglycine-conjugated peptide confirms that a short GG dipeptide is an 
effective sortase substrate. 
 
 
In the new elution scheme (Figure 2.14), sortase releases isopeptides by forming a 
thioester intermediate with the streptavidin bound bait peptide.  Reforming the 
isopeptide-bait conjugation is discouraged by shifting the equilibrium towards both 
hydrolysis and conjugation to excess diglycine.  The proteolytic specificity means that 
other protein contaminants such as keratin or proteins used to block beads from non-
specific losses (eg BSA) will also remain undigested.  Contaminating proteins will be 
depleted during peptide C18 clean-up as large proteins tend to bind very strongly to 
C18.  Streptavidin will also remain undigested making the elution much cleaner than 
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with trypsin.  Because streptavidin peptides will no longer dominate a sample, this 
makes the NiNTA or C18 bait peptide depletion step less important unless the reaction 
is scaled up to large volumes.  As cleavage now occurs after the threonine, isopeptides 
can also be recovered with their original GG tryptic remnant. 
 
 
Figure 2.14 A revised strategy overview for elution of isopeptides from 
streptavidin using sortase as a protease. 
The streptavidin bound biotinylated isopeptide (left) can be eluted with sortase.  To 
discourage the reverse reaction, which is equivalent to the original biotinylation 
reaction, excess GG dipeptide is added to drive the reaction towards original product 
back to deconjugated form. 
 
Now that trypsin is no longer required for isopeptide elution, the tryptic site in the 
non-specific position in the LPXTG motif is not necessary.  This point is of importance 
as the bait peptide tryptic site is extremely sensitive to cleavage from residual tryptic 
activity.  Although this is not a concern for synthetic peptide experiments, tryptic 
digests require PMSF treatment and C18 cleanup to deplete all tryptic activity.  Failure 
to completely deplete residual tryptic activity results in cleavage of the bait prior to 
conjugation and cleavage of biotinylated isopeptides, which was observed as TGG-
isopeptides prior to streptavidin enrichment and in streptavidin flow-through.  Although 
the tryptic TGG-isopeptide method is useful for methods development, changing the 
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motif from LPKTG to LPETG for routine samples streamlines sample processing and 
improves robustness of the method.  A new bait peptide was resynthesised without the 
tryptic site; biotin-SGGSGGSGGGGGVELPETGEEHHHHHH (SGG3-E-H6). 
 
Isopeptide elution is the last step and is immediately followed by LCMS analysis.  
Unlike trypsin, the sortase enzyme was found to be incompatible with LCMS analysis.  
An LCMS analysis of the initial sortase preparation revealed significant interference 
from peptides and detergents (Figure 2.15).  These contaminants are inconsequential for 
the first biotinylation step as these contaminants are washed prior to elution from biotin.  
To make an LCMS grade sortase preparation, additional size exclusion 
chromatography, NiNTA enrichment, and dialysis was required to obtain sufficient 
enzyme purity.  NiNTA enrichment and dialysis alone was not sufficient to remove 
contaminating peptides. 
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Figure 2.15 Purification of Sortase to LCMS grade quality for use as a protease 
LCMS analysis of initial sortase preparations revealed contaminating detergent 
polymers and peptides.  Re-purification was attempted with NiNTA and dialysis, and 
size exclusion chromatography. Base peak chromatograms of ~1 ug sortase C18 eluates 
(A-C) indicate initial contaminant signals (A), and effective removal of late eluting 
detergent polymers but insufficient depletion of early eluting peptide contaminants by 
NiNTA/dialysis (B).  Both detergent polymers and peptide contamination were 
significantly reduced after size exclusion chromatography (C).  Purification was 
conducted by selecting the most abundant fraction detected at 280nm during size 
exclusion chromatography (D) which was confirmed by SDS-PAGE (E, * indicated 
selected fraction). 
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2.3.9 Sensitivity improvements for low concentration substrates 
Most of the previous validation experiments were conducted using 50 µM synthetic 
isopeptide.  A more challenging sample could have a much lower isopeptide 
concentration due to limited sample amounts or low ubiquitylation stoichiometry.  To 
determine conditions suitable for enrichment of low abundance substrates, time course 
reactions were conducted using an isopeptide concentration reduced to 1 µM (Figure 
2.16).  The bait peptide was monitored over two orders of magnitude corresponding to a 
5-500 molar excess over isopeptide.  Contrary to results observed in Figure 2.7, 
biotinylation occurred more rapidly and the decay of the biotinylated isopeptide was not 
observed after extended reaction times.  A greater proportion of the isopeptide was also 
biotinlyated using less bait peptide than previously observed.  These observations are 
explainable by the low isopeptide concentrations because the reverse reaction in the 
equilibrium is not favoured until the bait peptide concentration approaches that of the 
biotinylated isopeptide.  The effect of reduced isopeptide concentration can be 
considered analogous to the excess bait peptide requirment for efficient isopeptide 
biotinylation (Figure 2.7) as the reaction is driven by a preferential ratio of bait to 
isopeptide.  It is fortunate that isopeptide biotinyation becomes more efficient and less 
susceptible to over-reaction as the sample concentration decreases.  This makes the 
existing protocol tolerant to reduced substrate concentration and suitable for low 
abundance isopeptides.   
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Figure 2.16 Biotinylation of isopeptide is efficient for low concentration 
isopeptide 
A time course sortase reaction following the conversion of synthetic isopeptide 
(1µM) to conjugated-isopeptide using 5, 50, and 500 µM bait peptide  (SGG3-E-H6).  
Percent conversion is measured by the loss of non-conjugated isopeptide signal and is 
relative to signal at time zero. 
 
2.3.10 Application: unfractionated yeast proteome 
A sortase enrichment of isopeptides from a whole yeast proteome digest was 
attempted.  Note that this experiment pre-dates the advent of the sortase elution 
protocol.  Biotinylation was conducted using the SGG3-H6 bait peptide, with excess 
bait depletion over NiNTA, and with tryptic release of peptides from streptavidin.  In 
this experiment, a tryptic threonine remnant remains on the diglycines which permits 
confident differentiation between peptide carry over and enriched peptides.  The most 
abundant isopeptides expected from the yeast proteome are the K48, K63, and K11 
ubiquitin chain linkages (Peng et al., 2003).  Search results for the unfractionated 
proteome (Mascot, peptide score >25) did not result in isopeptide identifications, which 
is an expected result from a highly complex non-enriched sample.  In the sortase 
enriched sample, the reduction in sample complexity enabled confident identification of 
K48 and K63 isopeptides.  No further isopeptides to ubiquitin or other substrates were 
identified.  Figure 2.17 displays the pre- and post- purification LCMS analyses and 
extracted ion chromatograms for the identified K48 ubiquitin isopeptide. 
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Figure 2.17 Enrichment of isopeptides from a whole yeast proteome 
LCMS analyses are presented before (A-B) and after (C-D) isopeptide enrichment 
from unfractionated yeast.  Base peak chromatogram for the enriched sample (C) 
indicates depletion of dominating ions observed in A.  The base peak ion in C (603.312 
m/z at ~55mins) belongs to digested streptavidin.  Extracted ion chromatogram for the 
K48 ubiquitin tryptic GG-isopeptide (B) and the sortase enriched TGG-isopeptide (D) 
demonstrates that isopeptides are preserved during the enrichment. 
 
One contributing factor to the poor results in this experiment is the level of 
streptavidin peptide contaminants.  The most abundant peptide observed (Figure 2.17C) 
is a streptavidin peptide and this limits the amount of material that can be analysed.  
This highlights the importance of using sortase to elute peptides, which prevents tryptic 
peptides from contaminating proteins from dominating a sample.  The most significant 
factor limiting the performance was revealed to be enrichment of peptides other than the 
target isopeptides.  Search parameters permitted an N-terminal threonine because 
diglycine may also occur on peptide N-termini as well as on isopeptides.  N-terminal 
diglycine may occur due to N-terminal ubiquitylation, most notably from linear 
ubiquitin chains, but also due to pre-existing KGG or RGG tryptic sites in protein 
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sequences.  Reactivity is expected for the predicted 769 N-terminal diglycine peptides 
arising from 102 yeast proteins in the yeast proteome (out of 6795 predicted open 
reading frames).  However, an overwhelming majority of peptides beginning with a 
single N-terminal glycine were also present indicating that there is significant reactivity 
towards mono-glycine peptides. 
 
To gain a numerical overview, spectral counting was used for all peptides identified 
(Mascot peptide score >25).  Peptides were binned into target diglycine peptides (linear 
and isopeptides), side reactive mono-glycine linear peptides, and non-target linear 
peptide without N-terminal glycine. Figure 2.18 gives a graphical overview of these 
peptide before and after sortase mediated enrichment of peptides.  Non-target peptides 
are effectively depleted.  Only a small number of non-target peptides remain due to 
carry over and also potentially tryptic peptides cleaved from enriched missed-cleaved 
peptides.  An order of magnitude more side reactive peptides were identified than the 
diglycine peptides. 
 
Figure 2.18 A spectral counting comparison between pre-enriched and 
enriched yeast proteome. 
Peptide counts are compared for a pre-enrichment tryptic yeast control analysis 
(grey bars) and for enriched peptides (black bars).  Peptide categories included sortase 
reactive diglycine peptides (linear and isopeptide), side-reactive N-terminal glycine 
linear peptides, and non-target linear peptide.  Enriched peptides are identified by the 
threonine residue remaining after tryptic release from streptavidin beads. 
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 These results indicate that sortase does not have the high degree of specificity 
towards diglycine indicated in the literature.  The yeast proteome data was interrogated 
to determine the sequence specificity towards N-terminal amine nucleophiles.  All 
peptides identified with an N-terminal threonine modification (indicating that the N-
terminal nucleophilic amine was recognised by sortase) were subjected to a sequence 
analysis to determine if any positional amino acid biases exist (Figure 2.19).  The 
results show that there is a very high degree of specificity towards an N-terminal 
glycine.  In contrast, there is no preference for any particular amino acid in positions 2 
or beyond, not even towards glycine. 
 
 
 
Figure 2.19 A single N-terminal glycine is necessary and sufficient for sortase 
recognition. 
Sequence conservation analysis of purified linear peptides (n=1687) from the yeast 
proteome using Seq2Logo (www.cbs.dtu.dk/biotools/Seq2Logo/ (Thomsen and Nielsen, 
2012)) indicates that sortase can modify peptides with a single glycine at the N-terminus 
(A) but has no bias towards any amino acid in subsequent amino acid positions (B). 
 
Given the unexpected breadth of reactivity, conjugation to other amines was 
investigated.  Analysis of in vitro reactions did not indicate reactivity towards Tris 
buffer (expected modification of +103.0633 on the bait peptide).  A re-analyses of the 
data permitting threonine modifications on the lysine side chain revealed 118 peptides 
with lysine reactivity.  This corresponds to ~6.5% lysine reactivity relative to single N-
terminal glycine peptides.  This fits well with theoretical nucleophilicity of the amines 
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based on the pKa of glycine (9.58) and lysine (10.67), as only the deprotonated amine is 
nucleophilic.  Lysine reactivity could be prevented by blocking lysines prior to 
digesting sample, for example by dimethylation or acetylation.  However, the number of 
peptides enriched via lysine reactivity was less than diglycine peptides, and given the 
extent of interfering single glycine peptides, lysine reactivity is not a limiting factor in 
this experiment.  It is however an interesting insight into the activity of sortase.  It 
would seem that an unbranched primary amine molecule is a sufficient nucleophile in 
this experimental context with peptides.  The observed lysine reactivity is contradictory 
to previously published findings (Ton-That et al., 1998).  Lysine reactivity has been 
reported for the sortase A orthologue in Corynebacterium diphtheriae during pilin 
assembly but onto a conserved lysine containing motif, WxxxVxVYPK (Ton-That and 
Schneewind, 2003).  In the native context for sortase, substrate presentation or 
accessibility on the bacterial cell wall may play a more significant role in sortase 
specificity than the nucleophilic substrate preference. 
 
2.3.11 Application: Poly-ubiquitin affinity purified yeast proteome 
using Tandem-repeated Ubiquitin-Binding Entities (TUBEs) 
Although the SoMBIE methodology suffers from interfering side reactions in highly 
complex samples, potential applications may still include proteome samples pre-
enriched for ubiquitylated substrates.  To asses this potential, a yeast extract was 
enriched for poly-ubiquitin using Tandem Ubiquitin-Binding Entities (TUBEs).  6HIS-
Halo-TUBEs were coupled to HaloLink Sepharose Resin before affinity purification.  
Western blotting for ubiquitin indicates a successful enrichment for ubiquitin and 
ubiquitylated substrates (Figure 2.20).  Tryptic peptides from the affinity purified poly-
ubiquitylated substrates were biotinylated with the SGG3-H6 bait peptide, excess bait 
was depleted over NiNTA, and streptavidin purified.  This experiment differs from the 
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prior unfractionated yeast experiment in that peptides were release from streptavidin by 
bait hydrolysis using the re-purified sortase.  This elution method will result in 
restoration of the original peptides and isopeptides without a threonine modification. 
 
 
Figure 2.20 Affinity purification of yeast poly-ubiquitylated substrates 
Poly-ubiquitin was affinity purified from freezer-milled yeast extract using Tandem 
Ubiquitin-Binding Entities (TUBEs).  NiNTA purified 6His-Halo-TUBEs was coupled 
to chloroalkane beads.  Efficient coupling is indicated by depletion from solution (A).  
By coomassie stained SDS-PAGE (B), a smear of protein is detected after elution in 
RapiGest.  A western blot (FK2 anti-ubiquitin) indicates polyubiquitylated substrate 
enrichment and complete elution in the first eluate (C). 
 
LCMS analyses of the TUBEs affinity purified yeast confirmed a significant 
enrichment for poly-ubiquitin by the identification of ubiquitin chain isopeptide 
linkages K6, K11, K27, K29, K48 and K63.  A total of 63 diglycine isopeptides were 
identified over 1153 putative ubiquitin substrates (at 1% FDR).  In the sortase mediated 
peptide purification, a similar coverage of isopeptides was observed, with a total of 67 
isopeptides over 741 proteins.  A spectral count analysis of peptide categories (Figure 
2.21) is remarkably similar to the equivalent analysis for unfractionated yeast (Figure 
2.18).  Although the samples differs from the unfractionated yeast proteome, the poly-
ubiquitin enriched sample is still of very high complexity, as indicated by the total 
proteins and total spectra identified.  The spectral counting analysis indicate that the 
methodology still suffers from dominating mono-glycine peptides even in samples pre-
enriched for poly-ubiquitylated substrates. 
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Figure 2.21 A spectral counting comparison between TUBEs poly-ubiquitin 
enriched and double purified TUBEs/sortase yeast proteome. 
Peptide counts are compared for an LCMS analysis of poly-ubiquitin enriched yeast 
using TUBEs (grey bars) and for an additional peptide-level sortase purification of 
isopeptides (black bars).  Peptide categories included sortase reactive diglycine peptides 
(linear and isopeptide), side-reactive N-terminal glycine linear peptides, and non-target 
linear peptide. 
 
An analysis of the LCMS chromatograms (Figure 2.22) does reveal a more 
promising improvement in the method though.  The streptavidin eluate is no longer 
dominated by streptavidin peptides as a result of the improved elution protocol.  The 
enriched K48 ubiquitin isopeptide is now a major signal which indicates that the method 
can improve the relative isopeptide signal.  Note that the base beak intensity of the 
sortase enriched sample was lower than in the pre-sortase sample.  An increase in 
sample load may improve the signal to noise of low abundance peptides where substrate 
isopeptides would be detected.  However, this would not improve the sample 
complexity which is currently the major limitation of the method.  The SoMBIE 
methodology would therefore be better suited to improving the signal of isopeptides in 
samples of lower complexity. 
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Figure 2.22 Enrichment of isopeptides from TUBEs poly-ubiquitin enriched 
yeast proteome 
LCMS analyses are presented for a TUBEs affinity purification of poly-ubiquitin 
from yeast before (A-B) and after (C-D) an additional sortase mediated isopeptide 
enrichment.  Base peak chromatogram for the enriched sample (C) indicates depletion 
of dominating ions observed in A.  Extracted ion chromatograms for the K48 ubiquitin 
tryptic GG-isopeptide (B) indicates an enrichment of ~20x relative to unfractionated 
yeast (Figure 2.17B), and that the K48 isopeptide is a dominant signal in the sortase 
enriched sample (D).  The other dominant peak in C is the hydrolysed bait peptide 
(843.894 m/z).  
 
 
2.3.12 Application: in vitro ubiquitylation of Miro1 by PINK-activated 
Parkin 
Mutations in both PINK1 (PTEN-induced kinase 1) and Parkin (RING-IBR-RING 
ubiquitin E3 ligase) are associated with early onset Parkinson’s disease.  PINK has been 
found to phosphorylate Parkin at serine-65 in the UBL domain which leads to activation 
of Parkin, which in turn mediates ubiquitylation of substrate proteins (Kondapalli et al., 
2012).  In collaborative work with Kazlauskaite et al. (2014), phosphorylated Parkin 
was used to ubiquitylate its putative substrate Miro1 (Mitochondrial Rho GTPase 1).  
Identification of Miro1 ubiquitylation sites proved to be very difficult for in-solution 
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digests and presented an excellent case study for using sortase to enrich for isopeptides.  
In vitro ubiquitylation was conducted as published (Kazlauskaite et al., 2014).  
Enrichment of isopeptide from this digest was conducted using non-tryptic bait peptide 
(biotin-[SGG3]-E-H6) and elution from streptavidin with re-purified sortase.  The 
depletion step to remove excess bait was omitted. 
 
The input to the isopeptide enrichment is presented by SDS-PAGE (Figure 2.23A).  
At the protein level, multiple Miro1 ubiquitylations are clearly visible, although it is 
unclear whether this is multi-mono ubiquitylation or ubiquitin chains attached to Miro1.  
The ubiquitylation does not occur in the absence of active PINK, in which case Parkin 
E3 ligase is not activated by phosphorylation.  The PINK-WT sample was processed 
and a standard tryptic digest was used as a pre-sortase control.  At the peptide level, the 
LCMS analysis of the in vitro reaction before isopeptide enrichment is dominated by 
ubiquitin peptides (Figure 2.23B).  The first obvious difference in the enriched sample 
(Figure 2.23C) is the depletion of dominant peptides.  Also note that the base peak 
intensity in each analysis is of similar base peak intensity (1x108-2x108) and are both 
near the maximum sensible load for an LCMS analysis.  Spectral counting was used to 
determine a quantitative measure of the impact of the purification (Figure 2.24).  Of the 
6 proteins in the in vitro reaction, only isopeptides belonging to ubiquitin and UbcH7 
were identified in the initial tryptic sample.  After enrichment, isopeptides were 
identified for all proteins in the in vitro reaction and the spectral count was also 
increased for ubiquitin and UbcH7.   
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Figure 2.23 Enrichment of isopeptides from in vitro ubiquitylated Miro1 
SDS-PAGE of Miro1 ubiquitylation reaction using WT PINK1 and kinase dead 
PINK1 (negative control) demonstrates multiple forms of ubiquitylated Miro1 (A).  A 
comparison between LCMS analyses before (B) and after (C) isopeptide enrichment 
clearly show a depletion of the dominant peptides present in B. 
 
Figure 2.24 A spectral counting comparison between pre-enriched and 
enriched Miro1 ubiquitylation reaction. 
All spectra identified at 1% FDR were counted for each protein in the sample for 
LCMS analyses before (grey bars) and after (black bars) isopeptide enrichment.  
Isopeptide spectra are presented relative to total spectra assigned to a protein (A) and as 
total counts (B).  Spectra over the entire sample are also presented in groups of target 
GG/isopeptides (includes linear peptides with two N-terminal glycines), G/linear (single 
N-terminal glycine side-reactive peptides), and linear peptides (non-specific linear 
peptides without N-terminal glycine) for analyses before (grey bars) and after (black 
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bars) isopeptide enrichment (C).  The data in C also includes E. coli peptide 
contaminants. 
 
To gain a quantitative indication of the level enrichment obtained by looking at 
individual peptides, precursor ion chromatograms were extracted for the Miro1 lysine 
modifications observed.  The most abundant signal was derived from a 38 amino acid 
peptide encompassing a modification on K572 (Figure 2.25).  This lysine has been 
confirmed as the major ubiquitylated lysine by site mutagenesis (Kazlauskaite et al., 
2014).  This peptide contained a missed cleavage in addition to the expected K572 
missed cleavage, making this an unusually challenging peptide to identify due to its 
length, high charge state and apparent low intensity.  The fully tryptic cleaved peptide 
was not observed and is not necessarily expected to be abundant due to an aspartic acid 
adjacent to the lysine which is known to inhibit proteolytic cleavage by trypsin 
(Rodriguez et al., 2008).  The signal for the identified charge state was not observed in 
the non-enriched sample explaining why a positive identification was not achieved.  
Signal for a higher charge state was detected slightly above the noise, but the higher 
charge state peptide did not result in an identification in either sample.  The enrichment 
obtained for the peptide was greater than 100-fold.  Additional Miro1 ubiquitylation 
sites were identified, including K153 and K406, and extracted ion chromatograms 
revealed that their precursors were not clearly detectable without enrichment (Appendix 
A).  Additional isopeptides were assigned to Miro1 but were actually on the N-terminal 
SUMO1 fusion and corresponds to SUMO1 K23 and K25.  There is no reason to 
assume that modifications to N-terminal fusion proteins have any relevance in vivo, 
which highlights the need for caution in assigning biological relevance from in vitro 
reactions. 
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Figure 2.25 The SoMBIE methodology effectively enriches substrate 
isopeptides in in vitro reactions 
Extracted ion chromatograms are indicated (*) for Miro1 K572 isopeptide 
MPPPQAFTCNTADAPSKDIFVK(GG)LTTMAMYPHVTQADLK (1088.29 m/z, 4+) 
before (A) and after (B) isopeptide enrichment along with the precursor spectra 
identified in the isopeptide enriched sample (C).  Extracted ion chromatograms for the 
more abundant 5+ ion (870.83 m/z) was detectable before (D-E) and after (F-G) and 
enrichment but was not identified.  The isopeptide enrichment was greater than 100x, 
which enabled confident identification of the K572 isopeptide (H). 
 
The presence of linear peptides with single glycines at the N-terminus was also 
observed in search results for the enriched sample.  In Figure 2.24C, spectral counting 
for this class of peptide was presented along with GG-peptides and non-target linear 
peptides over the entire Miro1 ubiquitylation dataset.  A marked reduction of linear 
peptides is observed indicating a successful depletion of non-target peptides.  N-
terminal glycine peptides were also retained, but unlike previous experiments on 
complex samples, they do not heavily dominate the sample.  The majority of these 
peptides are in fact spread over almost 100 E. Coli proteins which are impurities 
remaining from E. coli expressed enzyme preparations.  On determining the identity of 
the major ions, a small number of the N-terminal glycine peptides from Miro1 and Ube1 
were observed to be dominating the sample.  Extracted ion chromatograms for these 
peptides reveal that they are not high intensity signals in the original sample, and that 
their dominance in the enriched sample is a result of enrichment rather than carry-over 
(Figure 2.26).  Note that these ions correspond to dominant ions in Figure 2.23C.  These 
peptides are also enriched approximately 100-fold indicating that the SoMBIE method 
results in similar levels of enrichment for ubiquitin GG-isopeptides and single glycine 
N-terminal containing peptides.  Importantly, the cross reactivity towards single 
glycines did not completely counter the benefits of the procedure.  This validates the use 
of the SoMBIE procedure for improving isopeptide detection in samples of low 
complexity. 
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Figure 2.26 SoMBIE also enriches linear peptides with N-terminal glycine and 
N-terminal ubiquitin diglycine 
Comparison of the four most abundant N-terminal glycine containing peptides 
(belonging to Miro1 and Ube1) before (A) and after (B) enrichment.  Note that peptides 
in A are at ~1% of the signal intensity in the pre-enriched sample (refer to fig2.23A) 
and that the peptides in B correspond to abundant peaks in Figure 2.23B. Diglycine 
linear peptide corresponding to N-terminally ubiquitylated peptides are also enriched 
(C-D). 
 
 
A class of linear peptides of importance is the N-terminal diglycine modification 
derived from N-terminal ubiquitylation.  Purification of the N-terminal ubiquitin peptide 
carrying a diglycine (GGMQIFVK) was also enriched ~100x (Figure 2.26C-D).  The 
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enrichment of N-terminal glygly is an important distinction between this method and 
those that are strictly specific for isopeptides.  Note that this peptide exemplifies the 
capability of the purification but is not biologically relevant in this experimental context 
because it is actually an artefact of the N-terminal FLAG-tag on ubiquitin. 
 
2.3.13 Future method improvements 
Because the mono-glycine side reaction limits the methods effectiveness, 
improvements to this method must focus on improving the specificity of sortase towards 
diglycine.  One approach could be to find alternative sortase variants with altered 
specificity.  In the directed evolution strategy that discovered the sortase mutants (Chen 
et al., 2011b), randomly mutated sortase was expressed along with cell surface 
immobilised triglycine nucleophile.  Biotinylated peptide containing the LPETG sorting 
signal motif was added to enable sortase mediated biotinylation of cells and FACS 
sorting was used to enrich for cells with efficient labelling.  By using limiting amounts 
of LPETG peptide, sortase mutants with lower Km for the LPETG motif were 
discovered.  The same procedure could potentially be repeated to obtain a diglycine 
specific sortase variant by expressing a cell surface immobilised LPETG peptide.  The 
conjugation could then evolve towards recognition of biotinylated GG-isopeptide with 
negative screening against a biotinylated linear GX peptides. (Theile et al., 2013) points 
out that the sorting signal also requires an additional amino acid directly after the motif 
for efficient binding; the sorting signal motif is really therefore LPXTGX.  The GX 
binding position is likely to be at or near the same binding site for the recipient 
nucleophile.  Also, sortase is non-reactive towards a single glycine amino acid (Huang 
et al., 2003).  Taken together, this suggests that the enzyme-substrate binding at the 
second amino acid residue of the nucleophilic peptide is important for substrate 
recognition which gives hope that the specificity of this binding may be manipulated.  
Also note that the evolution of sortase towards a stronger preference for a GG 
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nucleophile may further restrict the sorting signal motif to LPXTGG, in which case the 
bait peptide will need to be modified accordingly. 
 
It is possible that the work with sortase mutants has been overly focused on the rate 
of reaction.  A range of sortase mutants were reported by (Chen et al., 2011b) with 
increased catalytic rates.  However, the increased Kcat and decreased Km(LPXTG) 
were also approximately proportional to an increased Km(GGG). (Chen et al., 2011b) 
reported that the mutant sortase enzymes did not have compromised specificity towards 
substrates of 3-5 glycines despite differences in Km(GGG).  However, shorter glycine 
stretches were not tested and the increased Km(GGG) may translate to an increased 
tolerance for GX peptides.  Should this be the case, very long reaction times with the wt 
sortase may provide improved diglycine selectivity.  100% specificity with wt sortase is 
not possible given reports that GA and GV peptides have some reactivity, albeit with a 
much higher Km values (Huang et al., 2003). 
 
Although a strong preference for diglycine was reported (Huang et al., 2003), a 
lower catalytic rate for mono-glycine peptides can be overcome by having a high 
concentration of GX peptides, as is expected to be the case in complex proteome 
samples.  The high degree of observed GX reactivity may be a result of reacting for a 
maximum yield of biotinylated isopeptide which may also be nearing a maximal 
reaction point for GX peptides.  Re-optimising on GG/GX peptide biotinylation ratio 
may offer improved isopeptide recover relative to undesirable linear peptides.  
However, this reduced reaction time will result in reduced total recovery of isopeptides 
and will diminish the sensitivity of the method.  This would also require a much tighter 
control of the reaction times and would need to revert to a slower sortase variant.  
Although some improvement may be achieved by taking advantage of differential 
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GG/GX kinetics, alternative sortase enzymes with higher specificity would be 
preferable. 
 
The reactivity to single glycine peptides also highlights the reversibility of the initial 
thioester formation.  The cleaved C-terminal portion of the bait peptide can be 
reconjugated to reform the initial bait peptide (refer to first step in Figure 2.6) and this 
equilibrium plays a part in the requirement for excess bait peptide.  An alternative bait 
could be synthesised where the -LPXT*G- motif is made as a depsipeptide (where * is 
an ester bond rather than an amide).  Depsipeptides are reactive in the initial protease 
step to form the thioester intermediate, but the resulting hydroxy-glycine peptide is not 
reactive in the transpeptidation step due to lacking the amine nucleophile (Williamson 
et al., 2012; 2014).  Although this will not improve reaction specificity, it will improve 
the reaction efficiency thus minimising the amount of bait peptide and affinity media 
required.  The bait peptide could also be pre-bound to streptavidin or alternatively a 
non-biotinylated bait could be coupled directly to NHS activated bead.  Direct coupling 
was initially avoided as it does not allow for characterising the reaction by LCMS.  Re-
optimising for this approach would generate a more time efficient and simpler protocol 
reminiscent of a kit-based approach for ubiquitin isopeptide enrichment. 
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Chapter III 
Isotope Coded Isopeptide Detection 
(ICID) 
 
3.1 Introduction 
 
Ubiquitin is well placed as the type specimen of the UBLs.  Not only was it the first 
UBL discovered (Goldstein et al., 1975), it is the most well studied UBL and has the 
most extensive collection of know substrates.  But progress in ubiquitin analysis by 
mass spectrometry was not achieved solely for its early discovery.  Ubiquitin, as well as 
NEDD8 and ISG15 tryptic isopeptides retain a simple diglycine modification and are 
identified with relative ease.  The challenge of detecting low abundance isopeptides was 
also well addressed with the advent of anti-diglycine antibodies.  Although ubiquitin 
isopeptide analysis is still not as straightforward as proteomic analysis of non-modified 
proteins, it is in a far more advanced state than that of the other members of the 
ubiquitin like family. 
 
An interest in the functional significance of the entire UBL family is also growing.  
In a recent study using protein arrays and application of mitotic cell extracts, more than 
1500 proteins were found to be putative substrates of a range of UBLs including 
ubiquitin, SUMO2/3, NEDD8, FAT10, SUMO1, UFM1, and ISG15 (Merbl et al., 
2013).  This research revealed that each UBL has a distinct network of substrate 
proteins and the role of each UBL is not fully appreciated.  As current research 
broadens its focus to the wider group of UBLs, there is an increasing requirement for 
mature MS-based techniques for studying each member of the ubiquitin family.  One of 
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the major hurdles in the analysis of UBLs is the identification of isopeptides, 
particularly those with long tryptic remnants. 
 
In the previous chapter, the enrichment of isopeptides was addressed in an attempt 
to deal with the dynamic range and sensitivity challenge of UBL analyses.  In this 
chapter, research is presented that approaches the study of UBLs from the perspective 
of determining confident isopeptide identifications.  A particular focus is given to UBLs 
with long tryptic remnants that require non-standard proteomic techniques for analysis. 
 
3.1.1 Enrichment of UBLs. 
UBL modified proteins represent a small fraction of the proteome and, like 
ubiquitylated substrates, require enrichment and purification to achieve detection by 
mass spectrometry.  Of the non-ubiquitin UBLs, SUMO has received the most attention.  
PolySUMOylated proteins can be enriched with a SUMO interacting domain from 
RNF4, which contains four SUMO interacting motifs (SIMs).  Although this domain 
binds only weakly to mono-SUMO, it has been successfully applied to identification of 
more than 300 putative polySUMO conjugates from HeLa cells (Bruderer et al., 2011).  
Mono-SUMOylated substrates can also be enriched with monoclonal antibodies raised 
against C-terminal peptides derived from SUMO1 and SUMO2.  This approach has 
yielded 584 endogenous SUMO modified proteins from HeLa cells (Becker et al., 
2013).  In genetically tractable systems, expression of HIS6-tagged SUMO (Vertegaal 
et al., 2006) or TAP-tagged SUMO (Golebiowski et al., 2010) enables a purification 
along with its modified substrates .  The high stringency purification of TAP-tagged 
SUMO2 has enabled detection of 766 heat shock induced changes in HeLa cells 
(Golebiowski et al., 2009). 
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In an earlier study in yeast, 251 candidates for SUMOylation were identified by 
mass spectrometry following a His6-FLAG-SUMO purification, six of which were 
confirmed through identification of SUMO isopeptides (Denison et al., 2005).  Denison 
et al. (2005) were able to achieve these isopeptide identifications because the yeast 
SUMO orthologue, Smt3, has a short tryptic remnant of EQIGG.  The mammalian 
scenario is contrasted to yeast in that mammalian SUMO has a very long tryptic 
remnant.  In recent enrichments of SUMO in mammalian systems using polySUMO 
interacting domains, anti-SUMO antibody and HIS6/TAP-tagged SUMO, SUMO 
isopeptides were not identified.  In these studies, identified proteins were presumed 
substrates because they co-purified with the modifying UBL.  A technique for 
collapsing poly-SUMOylated proteins into one molecular weight even aims to remove 
the UBL modifier by treating with SUMO specific proteases making conjugation site 
identification impossible (Blomster et al., 2009).  Although enrichment strategies are 
improving significantly, identifying conjugation sites to confirm putative substrates has 
largely been neglected - and with good reason as the analysis of UBLs with long tryptic 
remnants remains extremely challenging. 
 
3.1.2 Spectral complexities of long UBL tryptic remnants 
When dealing with most members of the ubiquitin like family, a tryptic digest does 
not result in an inconsequential remnant like the diglycine from ubiquitin, NEDD8, and 
ISG15 (Figure 3.1).  A range of longer remnants occur, from a relatively short EQIGG 
from Smt3 (S. cerevisiae SUMO orgtholog) to the extreme case of human SUMO2 
which gives rise to a tryptic remnant of 32 amino acids.  Unmodified peptides and 
peptides with simple modifications are assigned identities by correlating the spectral 
pattern to their theoretical fragment ions.  Simple modifications are accounted for 
simply by a mass shift in the ion series.  Spectral interpretation of long UBL modified 
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peptides is complicated, not just because of the size of the modification, but because the 
modification itself is proteinaceous and prone to fragmentation (Figure 3.2).  For large 
SUMO2 peptides, the modifier is longer than a typical tryptic peptide and resulting 
fragments often dominate over the substrate fragment ions. 
 
 
Ubiquitin: QQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG 
ISG15:  LFWLTFEGKPLEDQLPLGEYGLKPLSTVFMNLRLRGG 
NEDD8:  QQRLIYSGKQMNDEKTAADYKILGGSVLHLVLALRGG 
FAT10:  TQIVTCNGKRLEDGKMMADYGIRKGNLLFLACYCIGG 
SUMO1:  SLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGG 
SUMO2/3: QIRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGG 
Smt3_sc:  SLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGG 
Ufm1:  SAIITNDGIGINPAQTAGNVFLKHGSELRIIPRDRVG 
 
Figure 3.1 C-terminal sequences from a selection of Ubiquitin like modifiers. 
UBLs present a variety of C-terminal sequences resulting in a diverse range of 
tryptic remnants.  Digestion with trypsin cleaves after arginine or lysine to leave a C-
terminal portion on the lysine of a substrate tryptic peptides (underlined).  
 
 
 
 
Figure 3.2 Fragmentation of peptides and modified peptides 
A depiction of fragmentation for a peptide with no modification (A), a ubiquitin 
tryptic remnant (B), and a long UBL tryptic remnant (C).  The long UBL modified 
peptide has altered fragmentation and is mixed with a series of b and y ions overlapping 
with the substrate ion series, and in many cases dominate over fragment ions from the 
substrate peptide. 
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3.1.3 Alternative proteolytic enzymes: 
The use of alternative proteolytic enzymes is an useful strategy to improve protein 
coverage in regions where tryptic sites are rare or overly abundant.  This approach is 
also useful for the analysis of isopeptides with long tryptic UBL remnants because the 
generation of short remnants are amenable to analysis using standard standard 
proteomic software.  The combination of trypsin, Glu-C, Asp-N, and pepsin was used to 
improve coverage of SAE2 to identify auto-SUMOylation sites (Truong et al., 2012).  
Chymotrypsin has proven useful for detecting a shorter QQQTGG SUMO1 remnant 
(Dumont et al., 2011).  Similarly, elastase produces a range of remnants including GG 
for SUMO1 and also QTGG and TGG for SUMO2 (Chicooree et al., 2013c).  Acid 
hydrolysis at aspartic acid also produces a relatively short VFQQQTGG for SUMO1 
(Osula et al., 2012).  The effect these alternative enzymes also have on the substrate 
peptide should not be ignored.  Although Smt3 already has a short tryptic remnant, 
identifying lysine conjugation sites on UBC9 still requires the use of GluC to identify 
isopeptides (Klug et al., 2013). 
 
Many of the alternative enzymes, such as chymotrypsin, elastase, and pepsin, have a 
broader specificity than trypsin.  This results in a more complex sample due to miss-
cleavage of the UBL remnant or substrate peptides creating multiple peptide species.  
Trypsin has high specificity and maintains a C-terminal lysine/arginine charge making it 
particularly desirable for complex samples.  The use of alternative enzymes for 
analysing SUMO isopeptides has almost exclusively been for relatively simple in vitro 
reactions. 
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3.1.4 Sequence manipulations for improved analytic capabilities: 
The use of SUMO mutants is becoming a popular approach to study SUMO 
isopeptides.  By inserting a tryptic site near the C-terminus, the length of the remnant 
can be shortened enabling analysis using standard proteomic search engines while 
maintaining a tryptic sample processing.  A variety of mutants have been created, such 
as RGG to generate a ubiquitin-like di-glycine remnant (Knuesel et al., 2005; 
Wohlschlegel et al., 2006).  A particularly effective strategy includes a series of mutants 
in each of the SUMO variants that allows each to be distinguished by their unique short 
tryptic remnants (Figure 3.3).  Sequence modification has also been taken to a further 
extreme by creating a lysine-deficient SUMO2 in addition to Q87R and T90R 
mutations.  This creates a lysC resistant SUMO resulting in digestion of all proteins 
except SUMO and its conjugated peptide.  Subsequent SUMO enrichment and tryptic 
digest enables substrate peptides to be analysed with reduced sample complexity.  This 
strategy enabled detection of 103 substrate isopeptides (Matic et al., 2010). 
 
SUMO has also been altered for isopeptide purification purposes.  By introducing 
cysteines into the C-terminal peptide of SUMO between lysC and tryptic sites, lysC 
generated isopeptides can be purified on thiopropyl beads and then release of diglycine 
isopeptides with trypsin (Blomster et al., 2010).  This method has the benefit of both a 
short remnant and a means of purifying isopeptides.  Although this required alteration 
of six amino acids in the SUMO sequence, conjugation to a substrate protein PARP-1 
was shown to be viable in vivo.  Manipulation of SUMO to generate a diglycine 
remnant is not just useful for shortening the isopeptide remnant for bioinformatic 
simplicity.  The ubiquitin-like diglycine remnant has proven most successful in 
combination with the ubiquitin anti-diglycine antibody (Tammsalu et al., 2014).  This 
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strategy enabled identification of more than 1000 sumoylated lysines from HEK293 
cells stably expressing 6His-SUMO2-T90K. 
 
The manipulation of SUMO sequences has significantly enhanced analytical power 
for cells that are genetically tractable.  However, when we consider UBLs in light of 
human disease, we are faced with significant constraints.  Tissues from human patients 
will contain wild-type UBL sequences and genetic manipulation and transfection of 
biologically relevant primary cell lines is difficult (Gresch and Altrogge, 2012).  To 
study the entire UBL family in medically relevant scenarios, it is essential that we 
develop the ability to study UBLs with their long tryptic remnants intact.  
 
SUMO1:  …FEGQRIADNHTPKELGMEEEDVIEVYREQTGG 
SUMO2:  …FDGQPINETDTPAQLEMEDEDTIDVFRQQTGG 
SUMO3:  …FDGQPINETDTPAQLEMEDEDTIDVFRNQTGG 
 
Figure 3.3 C-terminal arginine mutants enable effective MS analysis of SUMO 
isopeptides. 
Strategy for creating mutants of SUMO1, SUMO2, and SUMO3 demonstrate ability 
to produce short tryptic remnants and differentiate between SUMO variants (Galisson et 
al., 2011; Lamoliatte et al., 2013) .  Mutated amino acids are bold/underlined and were 
formally all Q. 
 
 
3.1.5 Methods for improved UBL isopeptide detection 
The UBL remnant presents a constant feature across this class of peptide.  As a 
result, Lamoliatte et al. (2013) observed that the remnants of SUMO C-terminal 
arginine mutants had characteristic fragment ions that could be used for identification 
and confirmatory purposes.  By repeatedly cycling through consecutive 100-m/z 
precursor isolation windows, detection of diagnostic ions from the NQTGG remnant 
allowed for a targeted re-acquisition of SUMOylated peptides from HEK293 cells 
expressing the SUMO3 C-terminal arginine mutant.  The detection of UBL isopeptides 
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through diagnostic remnant ions can also be enhanced by chemical modification.  
Reductive methylation of peptide N-termini enhances small a- and b-ions making even 
the short ubiquitin GG remnant ions detectable in MS2 spectra (Chicooree et al., 2013a; 
2013b).  These methods improve identification of isopeptides with short remnants, 
however, they have not been demonstrated for more complex isopeptides like native 
SUMO isopeptides. 
 
A method has also been developed for distinguishing isopeptides from linear 
peptides by guanidinating lysines with O-methyl isourea and sulfonating N-termini with 
amine reactive 4-sulfophenyl isothiocyanate (Wang and Cotter, 2005; Wang et al., 
2005).  MS2 spectra display dominant ions for the loss of the tag and ubiquitin 
isopeptides have a characteristic loss of two tags, one from each N-termini.  On 
recognising the isopeptide signature in MALDI spectra, spectra could be re-acquired at 
increased scan quality to detect lower intensity b- and y- ions to identify the peptide. 
 
These methods introduce the concept of distinguishing linear peptide from 
isopeptides and the potential for chemical modifications to improve isopeptide 
detection.  However, the power of these methods are limited to interpretation of MS2 
spectra.  As yet, there is no method for distinguishing isopeptides at the MS1 level. 
 
3.1.6 Software solutions for identifying UBL isopeptides 
Typical proteomic search engines are capable of dealing with simple modifications 
by creating an in silico mass shift for modified amino acids.  However, they are not able 
to deal with composite spectra derived from fragmentation of the modifier itself.  
Software support for analysis of complex isopeptide fragmentation is limited.  Although 
expected fragmentation ions can easily be calculated for predicted isopeptides, without 
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specialised software laborious manual interpretation of spectra is required.  This limited 
throughput approach has been successful for sumo E3 RanBP2 autoSUMOylation 
sites(Cooper et al., 2005) and SUMO polymerization sites (Matic et al., 2008). 
 
To aid manual interpretation, Matic et al. (2008) introduce the concept of a virtual 
modification.  Because the SUMO remnant is typically longer than the substrate, 
isopeptides can be conceptually rotated about the isopeptide bond to make the UBL part 
of the main peptide (Figure 3.4).  The majority of the fragment ions can therefore be 
accounted for by fragmenting the ‘main’ peptide whereas the smaller C-terminal part of 
the substrate peptide becomes a mass-shift without considering fragment ions. 
 
Figure 3.4 Isopeptide ‘virtual’ modification simplifies isopeptide spectral 
interpretation 
An isopeptide sequence can be conceptually rotated about the isopeptide bond to 
make the UBL remnant part of the main peptide, and the C-terminal portion of the 
substrate the ‘virtual’ modification. 
 
The ChopNSpice tool was developed to make composite SUMO-substrate peptide 
databases (Hsiao et al., 2009). This program takes the C-terminal UBL peptide remnant 
and all possible substrate peptides and creates linearised UBL-substrate peptide 
sequences.  The tool was demonstrated to identify SUMO2 isopeptides in vitro and in 
vivo and has also been used to also identify isopeptides from FAT10 (Leng et al., 2013).  
In a similar strategy was used by Tammsalu et al. (2014), but using only substrates 
detecting using a shortened SUMO KGG mutant.  Their virtual branched peptide 
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databases was used to identify SUMO isopeptides in existing datasets of wild-type 
SUMO purifications.  A significant benefit of this tool is that the resulting databases can 
be searched by standard proteomic search engines thus making SUMO isopeptide 
analysis achievable without a high degree of manual interpretation.  However, there can 
be significant loss of spectral assignment as a result of peptide linearisation.  Figure 3.5 
outlines how fragment ions derived from the C-terminal part of the substrate peptide can 
no longer be assigned.  This results in diminished confirmation of the substrate peptide 
assignment, which is of concern when large UBL modifiers like SUMO2 already often 
dominate over substrate fragmentation. 
 
Figure 3.5 The ChopNSpice strategy results in loss of spectral assignment 
True fragment ions from the C-terminal part of the substrate peptide (A) no longer 
correlate with predicted fragment ions after creation of the linearised peptide (B).  The 
substrate C-terminal b- and y-ions (examples indicated) increase or decrease by the 
mass of the UBL, respeciviely.  Ions derived from the N-terminal part of the substrate 
peptide and the UBL can be assigned correctly however. 
 
 
The SUMmOn pattern recognition software was developed specifically to address 
the complex fragmentation derived from long SUMO tryptic remnants (Pedrioli et al., 
2006).  Because SUMO isopeptides result in fragmentation series from both the target 
and modifying peptides, SUMmOn performs two independent scorings for the SUMO 
modification and the target peptide.  SUMmOn can therefore match all fragment ions 
from both UBL modifier and substrate peptide, unlike proteomic database searches 
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using chopNSpice databases.  SUMmOn can also recognise and score SUMO ions in 
spectra for which there is no candidate substrate peptide.  SUMmOn has been used to 
identify unexpected SUMO1 sites (Pedrioli et al., 2006), and in conjunction with a lysC 
digestion, NEDD8 polymerisation sites (Jeram et al., 2010). 
 
3.1.7 Objectives of research 
UBL modifications should be considered in the context of the entire proteome rather 
than in isolation.  Global proteome analysis, and analyses of many modifications 
including UBLs, will ultimately become common practice when characterising biologic 
systems.  UBL research should therefore be heading towards isopeptide analyses with 
integration into standard proteomic workflows.  Genetic manipulations are generally not 
feasible requiring analysis of long remnants.  A sample processing with an enzyme of 
high specificity is essential for complex samples, thus creating a very short remnant will 
not always be practical for all UBLs.  Current success in the analysis of UBL 
isopeptides with long remnants is limited, even for in vitro UBL modifications.  
Expanding our ability to study UBLs in a broader range of biological scenarios would 
have significant benefits, especially for medical applications. 
 
This research focuses on improving analytic techniques for long UBL remnants.  To 
address the specific challenges involved, no attempts will be made to shorten isopeptide 
remnants.  UBLs will be maintained as native sequences and trypsin will be the 
preferred proteolytic enzyme.  Isopeptide identification will be approached from the 
bench, at the mass spectrometer, and bioinformatically, in an attempt to create a 
straightforward approach to tackling this complex domain of research.  Attention is 
given mainly to SUMO, as the tryptic remnants from SUMO1/SUMO2 are the longest 
and most difficult to analyse. 
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3.2 Materials and Methods 
 
3.2.1 Plasmids 
Plasmids were constructed by the Dundee MRC-PPU cloning facility. 
Plasmid pET156P-6HIS-SUMO1 (MRC-PPU cloning Ref: DU32080) genebank 
NP_003343.  Protein sequence (13.6 kDa): 
MGSSHHHHHHSSGLEVLFQGPGSMSDQEAKPSTEDLGDKKEGEYIKLKVIG
QDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELG
MEEEDVIEVYQEQTGG 
Plasmid pET156P-6HIS-SUMO2 (MRC-PPU cloning Ref: DU32081) genebank 
AK311837.1.  Protein sequence (13.1 kDa): 
MGSSHHHHHHSSGLEVLFQGPGSMADEKPKEGVKTENNDHINLKVAGQDG
SVVQFKIKRHTPLSKLMKAYCERQGLSMRQIRFRFDGQPINETDTPAQLEMEDE
DTIDVFQQQTGG 
 
3.2.2 Proteins reagents 
Ubiquitin and K11, K48, K63 ubiquitin dimers were produced by the Dundee MRC 
Protein Production unit.  Recombinant RanGAP1(481-587), E1-SAE1/2 and Ubc9 
proteins were kindly supplied by the R. Hay’s lab, University of Dundee.  Recombinant 
RNMT (human isoform 1) was kindly provided by V. Cowling’s lab, University of 
Dundee. 
 
3.2.3 Media 
M9 minimal media (1L): 200 mL of M9 salts (1 L stock 64 g Na2HPO4-7H2O, 15 g 
KH2PO4, 2.5 g NaCl, 5 g NH4Cl), 2 mL of 1 M MgSO4, 20 mL 20% glucose, 100 µL 
1M CaCl2 
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Defined auto-induction media, final concentrations: 25 mM (NH4)2SO4, 50 mM 
KH2PO4, 50 mM Na2HPO4, 0.8% (v/v) glycerol, 0.015% (w/v) glucose, 0.5% (w/v) 
lactose, 2 mM MgSO4, 20 µM CaCl2, 10 µM MnCl2, 10 µM ZnSO4, 2 µM each of 
CoCl2, CuCl2, NiCl2, Na2MoO4, Na2SeO3, and H3BO3, 0.2 µM each of nicotinic acid, 
pryridoxine, thiamine, p-aminobenzoic acid, folic acid, riboflavin, vitamin B12.  0.2 g/L 
of each of the 20 standard amino acids except F/W/Y/C. 
 
3.2.4 Bacteria Transformation (E. coli DH5-alpha and BL21) 
  Approximately 50 ng plasmid was mixed with 100 uL of BL21 competent cells 
for 30 min on ice.  Cells were heat shocked for 45 sec at 42 °C and then incubated on 
ice for 2 min.  After addition of 0.9 mL of LB, cells were incubated for 1 hr at 37 °C 
before collecting cells by centrifugation at 3,000 x g for 5 min and plating on LB-amp 
or LB-kan plates. 
 
3.2.5 Expression of SUMO1 and SUMO2 in M9 minimal media 
BL21 cells transfected with SUMO2 plasmid were grown as precultures in M9 
media with 50 µg/mL carbenicillin (Sigma)at 37 °C.  Pre-cultures were diluted to an 
OD600 of 0.05 and grown to approximately OD600 of 0.6.  Cultures were sampled 
(pre-induction control) then split into two cultures.  For SUMO1, either tyrosine 
(Formedium) or 13C915N-tyrosine (Cambridge Isotopes) to 0.2 mg/ml (from solid).  For 
SUMO2, either phenylalanine (Formedium) or 13C6-phenylalanine (Cambridge 
Isotopes) was added to 0.2 g/L (from a 100x stock).  An additional 50 µg/mL 
carbenicillin was added, the temperature was dropped to 20 °C, and cells were induced 
with 1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG; Sigma).  Cells were grown 
for 19 hr (to OD600 ~2.0) before collecting cells by centrifugation at 3,000 x g for 5 
min.  Cell pellets were resuspended in cold buffer (200 mM phosphate pH 7.5, 250 mM 
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NaCl, 0.1% triton, 0.5 mM EGTA, 1 mM EDTA, 10 µg/mL leupeptin (Sigma), 1 mM 
Phenylmethylsulfonyl fluoride (PMSF, Roche), 1 mM Tris(2-carboxyethyl)phosphine 
(TCEP, Thermo Scientific)).  Cells were ruptured using a probe sonicator (Branson) on 
ice for 30 sec at 30% amplitude.  Sonications were repeated 3 times with 1 min rests on 
ice between each. Debris was pelleted by centrifugation at 3000 x g for 15 min.  The 
supernatant was applied to NiNTA agarose (Quagen), detergent was removed with 
thorough washes in PBS and beads were changed to a clean eppendorf before elution.  
His-SUMO1/2 was eluted in PBS/400 mM imidazole and dialysed for 16 hr at 4 °C 
against PBS, 0.5 mM TCEP in a 1 kDa dialysis unit (Amersham).  Note that His-tag and 
precission cleavage site (LEVLFQGP) remain intact on the N-terminus of proteins. 
 
3.2.6 Expression of SUMO1 in DIAM 
SUMO1 was expressed as described for M9 media expression except for the 
following amendments.  Cells were grown in DAIM-CYWF media and was 
supplemented with F, W, and either light Y or heavy 13C915N-Y to 0.2 mg/ml.  Cells 
were still induced with IPTG even though the media is can auto-induce. 
 
 
 
3.2.7 Expression of N15 SUMO2 
Expression was conducted as above but with the following amendments.  Cells were 
grown in ISOGRO 15N Growth Medium (Sigma) at 98% 15N isotope purity.  Cells were 
induced with 100 µM IPTG and the temperature was dropped to 15 ºC for overnight 
growth.  Cells were lysed in 50 mM Tris/HCl pH 7.5, 250 mM NaCl, 1% Triton, 1mM 
EDTA, 1mM EGTA, 1mM DTT.  Cells were eluted from NiNTA in 50 mM HEPES pH 
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7.5, 150 mM NaCl, 0.03% Brij-35, 0.5 M imidazole.  Eluted protein was buffer 
exchanged into waster using PD-10 Desalting Columns (GE healthcare). 
 
3.2.8 In vitro SUMOylation reactions 
5 µg RanGAP1 was SUMOylated with 0.5 µg E1 (SAE1/2), 1.5 µg E2 (UBC9), and 
3 µg 1:1 mix SUMO2/13C6-phenylalanine heavy SUMO2 in 20 µL 50 mM Tris (pH 
7.5), 5 mM MgCl2, 2 mM ATP, and 5 mM DTT for 2 hr at 37 °C.  
 
SUMOylated RNMT was kindly provided by Thomas Gonatopoulos Pournatzis 
(Cowling lab, MRC, Dundee University) but using SUMO reagents synthesised as 
above.  In a total final volume of 10 µl, 3 µg recombinant RNMT were incubated with 
0.1 µg E1-SAE enzyme, 0.75 µg Ubc9 and 3 µg 1:1 mix SUMO2/13C6-phenylalanine 
heavy SUMO2 in the presence of 50 mM Tris (pH 7.5), 5 mM MgCl2, 5 mM ATP. The 
samples were incubated at 37 °C for 5 hr. 
 
SUMO reactions were terminated at 95 °C for 5 min.  Protein was reduced in 0.5% 
RapiGest and 10 mM DTT at 37 °C for 40 min, then cysteines were alkylated with 25 
mM chloroacetamide (Sigma) for 30 min.  The sample was diluted 10x with 100 mM 
ammonium bicarbonate and digested with trypsin at 1:40 wt/wt.  RapiGest was 
precipitated with acidification with trifluoracetic acid and centrifugation at 17,000 x g 
for 15 min, and peptides were purified on a C18 MicroSpin column (The Nest Group) 
and dried. 
  
3.2.9 Isotope labelling ubiquitin isopeptides. 
30 µg mixture of K11/K48/K63 ubiquitin dimers (Protein Production group, College 
of Life Sciences, University of Dundee) were amine blocked by four additions of either 
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50 mM nicotinic NHS ester (synthesised as previously described (Münchbach et al., 
2000)) from a 1 M stock in dimethylformamide at 1 hr intervals at 37 °C with a final 
incubation time of 8 hr followed by tryptic digest and peptide clean-up on C18.  
Peptides were isotope labelled in 125 mM TEAB 70% (v/v) isopropanol with 1U 
mTRAQ Δ0 or Δ4 (Applied Biosystems). Serine, threonine, and tyrosine esters were 
deblocked with 5% (w/v) hydroxylamine (Sigma) for 1 hr at 37 °C followed by an 
additional C18 cleanup.  
 
3.2.10 LCMS data acquisition 
Peptides were injected onto a self packed 75 µm inner diameter PicoTip Emitter 
(New Objective), packed with Magic C18AQ 3 µm 200 Å beads (Michrom 
Bioresources) which was heated to 45 °C.  A Proxeon EASY-nLC or a Dionex 
Ulitimate 3000 HPLC delivered a 300 nL/min gradient using buffers A (0.1% formic 
acid, 2% acetonitrile) and B (0.1% formic acid, 90% acetonitrile) for peptide analyses.  
Gradients were run from 1-40% B over 60 min (in vitro RanGAP1 SUMOylation) or 
120 min (RNMT SUMOylation) followed by a high solvent wash and equilibration.  
Data were acquired on a Velos Orbitrap mass spectrometer (Thermo Fisher Scientific), 
at 100k Orbitrap resolution, and with a preview scan triggering data dependent 
acquisition (DDA) of the top 12 precursors above a 500 precursor intensity threshold. 
Peptides were isolated within a 2 m/z window for fragmentation by rapid scan ion trap 
CID.   
 
3.2.11 Targeted LCMS data acquisition 
Targeted LCMS analysis were conducted as for RanGAP1 analysis method but with 
method variations including; monoisotopic precursor selection on/off, charge state 
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screening on/off, dynamic exclusion on for 30 sec after 1 repeat or off, MSn trigger 
threshold at 500 or 5000 counts. 
 
3.2.12 Infusion MS data acquisition of tyrosine AAs 
50 µM solution of tyrosine or 13C915N-tyrosine was prepared in 30% methanol, 0.1% 
formic acid.  The solution was infused by Hamilton syringe at 4 uL/min to an 
electrospray source.  MS acquisition was acquired at 100k resolution 
 
3.2.13 Data analysis 
LCMS raw data files were converted to mzXML format using ReAdW.exe.  
Assignment of SUMO isopeptide spectra was done using SUMmOn (Pedrioli et al., 
2006) using precursor monoisotopic masses with 3 Da tolerance, fragment average 
masses at unit tolerance, charges states 3-9, and permitting oxidised methionine.  Each 
analysis was repeated for 8 combinations of SUMO2 fully-cleaved/miss-cleaved, 
oxidised methionine/non-oxidised methionine, light/heavy phenylalanine. 
 
Detection and assignment of isopeptides, and compilation of SUMmOn results, was 
conducted using in-house software.  See Results and Discussion for details, and 
Appendix E for details on usage and parameters.  External feature detection algorithms 
also used included using Progenesis (www.nonlinear.com), Maxquant (Cox and Mann, 
2008), OpenMS (Kohlbacher et al., 2007), msInspect (May et al., 2009), and superHirn 
(Mueller et al., 2007).  Viewing ICID and SUMmOn/ICID compiled data (tab delimited 
format) was viewed in Microsoft Excel.  Manual validation of spectra was conducted in 
Xcalibur 2.2 Qual Browser (Thermo Scientific) 
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For targeted analysis in tryptic yeast, MS2 spectra were assigned to peptide 
identifications by searching against a S. cerevisiae protein database (version 2011-02-03 
from SGD http://www.yeastgenome.org/) using X!!Tandem release 10-12-01-1 (MPI 
parallelised version of X!Tandem, http://wiki.thegpm.org/wiki/X!!Tandem).  Search 
results were validated using the Trans-Proteomic Pipeline (TPP) v4.6 running on Linux.  
Peptide assignments were validated using PeptideProphet and accepted above 1% FDR. 
 
3.2.14 Software development 
All software was developled in Eclipse 4.3 (Kepler) using Java 1.6 on Mac OSX 
and run on both Mac OSX and CentOS linux platforms.  External JAR libraries used 
include jopt-simple-4.3.jar (http://pholser.github.io/jopt-simple/) and 
jrap_StAX_v5.2.jar (http://sourceforge.net/projects/sashimi/). 
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3.3 Results and Discussion 
 
3.3.1 Strategy for detecting isopeptides by isotope coding 
Isotope labelling for quantitative proteomics is commonplace, such as SILAC and 
chemical labelling with heavy formaldehyde.  For peptides that are confidently 
identified, isotope labelled peptide pairs can be interrogated to derive quantitative 
information.  The strategy presented here applies the use of isotope labelling to the 
reverse of this concept.  Instead of extracting isotopic information from identified 
peptides, detection of isotope labelled peptide pairs can be used as a method of 
identifying peptides.  Specifically, peptide isotope labelling is used to uniquely 
distinguish UBL modified isopeptides from unmodified linear peptides. 
 
To target UBL modified peptides, their unique features need to be exploited to 
distinguish them from unmodified peptides.  The labelling strategy, outlined in Figure 
3.6, uses an equal mixture of light and heavy stable isotope labelled UBL for in vitro 
reactions.  The use of isotopes enables detection of isopeptides as distinctive isotopic 
pairs in high resolution MS1 scans.  An important feature of this strategy is the unique 
ability to predetermine UBL isopeptide features within a dataset without the use of MS2 
fragmentation data.  This approach is therefore of particular benefit for the analysis of 
isopeptides with very complex fragmentation where MS2 spectral identification is 
difficult, most notably SUMO2 isopeptides with a 32 amino acid tryptic remnant. 
 
The predetermination of UBL isopeptide features enables alternative strategies to be 
undertaken to determine the identity of the UBL conjugation site.  In the simplest case, 
assignment of a peptide identification can be made by accurate precursor mass alone.  
The detection of isopeptide precursors can also complement existing isopeptide 
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identification strategies by adding confidence to MS2 interpretations.  Having a list of 
candidate isopeptide features also enables a targeted MS analysis to acquire additional 
MSn spectra.   
 
 
Figure 3.6 Conceptual overview of the isotope coded isopeptide detection 
(ICID) strategy 
A) Light and heavy isotope coded UBLs are used in equal proportions for in vitro 
substrate modification.  The reaction is digested to generate peptides and isopeptides 
prior to mass spectrometry analysis.  Bioinformatic analysis is performed to detect 
diagnostic isotope pairs to support identification of isopeptides.  B) A depiction of a 
spectrum containing unmodified peptides and isotope labelled isopeptides (*) which are 
observed as pairs of features at diagnostic mass intervals. 
 
In this strategy, the in vitro reaction, sample processing and initial MS acquisition 
are straightforward and do not require deviation from existing experimental procedures.  
The novel aspects of this workflow lie in the generation of isotope labelled UBL and the 
bioinformatic interpretation of the data.  A more detailed diagram of the workflow is 
presented in Figure 3.7.  Both generation of isotope labelled UBL and development of 
bioinformatic workflows will be major focuses of this chapter. 
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Figure 3.7 Illustration of the ICID sample processing and bioinformatic 
workflow 
Individual steps in the ICID workflow are presented and a can be categorised into 
UBL expression, sample processing, MS data acquisition, and bioinformatic analysis 
(essential elements indicated *).  Novel aspects of this work included expression of 
isotope coded UBL and bioinformatic interpretation of MS data. 
 
 
3.3.2 Synthesis of isotope labelled UBLs 
Chemical labelling of UBLs is not practical because they must remain functional for 
in vitro reactions.  UBLs must therefore be isotope labelled during expression in E. coli.  
To make an effective isotope labelled UBL, expression protocols must be modified to 
include isotopes within the C-terminal region of the UBL.  The isotopes must remain 
within the proteolytic remnant after digestion so that the isotopes remain associated 
with the substrate peptide.  This could potentially be achieved by atomic-level labelling 
with nitrogen or carbon.  Alternatively, a SILAC approach could be taken to incorporate 
heavy amino acids.  Ideally, isotopes should not alter chromatographic elution time, so 
deuteriated amino acids should be avoided if possible.  However, no single amino acid 
would necessarily be suitable because UBLs do not all share a high degree of sequence 
similarity.  Both atomic-level and amino acid level labelling were explored.   
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3.3.2.1 15N labelling 
As a general strategy for labelling UBLs, heavy nitrogen salts could be used to label 
every amino acid ensuring that the C-terminal peptide is labelled for all UBLs.  SUMO2 
was expressed in E. coli using media containing 98%-purity 15N ammonium salts as a 
sole source of nitrogen.  The SUMO2 product was digested with trypsin and the 
resulting digest analysed by LCMS.  It was observed that using 98% 15N produces 
heavy peptide isotopic distributions with only ~50% of the signal falling on the desired 
heavy monoisotope (Figure 3.8).  The 32-amino acid long C-terminal tryptic peptide 
includes 38 independent nitrogen incorporations resulting in an accumulation of 
impurity.  Note that a 2% 14N impurity may be tolerable for SILAC where multiple 
isotopes are incorporated as a single amino acid.  The methodology presented in this 
chapter will rely heavily on detection of light/heavy isotope intervals.  Without a clear 
monoisotopic signal, detection of isotope pairs will be difficult and will result in 
missing isopeptide discoveries.  With only ~1.5 nitrogens per amino acid, this approach 
might be feasible for UBLs that generate shorter tryptic remnants.  However, the high 
isotopic purity required makes it impractical for UBLs that generate long remnants. 
 
 
Figure 3.8 98% 15N isotope labelling generates poorly defined isotope clusters. 
The large SUMO2 C-terminal tryptic peptide 
FDGQPINETDTPAQLEMoxEDEDTIDVFQQQTGG generates a light isotope cluster 
with a clear monoisotopic peak (A) whereas the 98% 15N heavy peptide does not have a 
well defined monoisotope (B).  Expected monoisotopic signals are indicated (*). 
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3.3.2.2 SILAC labelling  
Due to restrictions on isotope purity for long peptides, a SILAC approach is 
necessary to label UBLs.  The caveat of this approach is that expression of each UBL 
will need to be tailored to the UBL sequence.  SILAC with heavy arginine and lysine is 
an intuitive approach and an arginine/lysine auxotrophic E. coli has been used to 
express heavy SUMO2 (Matic et al., 2011).  For the purpose of this research, an 
arginine and/or lysine labelled UBL is of limited use because tryptic digestion will 
cleave after both arginine and lysine leaving the C-terminal peptide without a heavy 
amino acid.  It would however be feasible if using enzymes other than trypsin, such as 
glu-C, but only if an arginine or lysine remains on the C-terminal remnant.  This would 
lengthen the remnant making identification even more difficult, but it would serve to 
generate isopeptides that would distinguish between ubiquitin, NEDD8, and ISG15.  
This may also be of use when substrate proteins are not suited to analysis with trypsin 
due to a lack of or an abundance of tryptic sites.  Since isopeptides derived from 
ubiquitin, NEDD8, and ISG15 are not difficult to identify under most circumstance, 
attention was given to more challenging UBLs such as SUMO. 
 
Labelling with heavy amino acids without generating additional auxotrophs was 
preferred so that the methods might be extrapolated to a general method for expressing 
heavy UBLs.  The aromatic amino acids were selected for the option to inhibit their 
synthesis by blocking the shikimate pathway with glyphosate (N-
(phosphonomethyl)glycine, a herbicide), which has been applied to incorporation of 
unnatural aromatic amino acids (Neerathilingam and Markley, 2010).  Isotope coding 
was implemented using 13C915N-tyrosine and 13C6-phenylalanine for SUMO1 and 
SUMO2, respectively.  This would result in a single tyrosine incorporation into the C-
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terminal SUMO1 peptide and 2 phenylalanines in the C-terminal SUMO2 peptide.  In 
the case of a missed-cleavage, the SUMO2 peptide will include 3 phenylalanine 
residues (refer to Figure 3.1 for sequences).  Note that light SUMO1 and SUMO2 also 
need to be mixed at 1:1 after expression.  Mixing the isotopes at 1:1 during expression 
can only be done if there is exactly one amino acid being incorporated, otherwise a 
distribution of isotopes will be incorporated.   
 
3.3.2.3 SILAC labelling SUMO1 and SUMO2 in minimal media 
Using the prototrophic BL21 E. coli strain, SUMO proteins were expressed in 
minimal media with tyrosine or phenylalanine supplementation, but without glyphosate 
treatment  (Figure 3.9).  In-gel tryptic digestion and LCMS analysis of 13C6-
phenylalanine SUMO2 identified the expected heavy peptide and no light peptide was 
observed (Figure 3.10).  The phenylalanine in the media was therefore the sole source 
of phenylalanine indicating that feedback inhibition of phenylalanine synthesis must 
have occurred.  This observation is consistent with expected inhibition of pheA (Nelms 
et al., 1992).  No heavy isotopes were detected above natural isotope distributions in 
any other amino acids indicating that phenylalanine isotopes were not being recycled 
into other amino acids. 
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Figure 3.9 Expression of heavy SUMO1 and SUMO2 in minimal media 
SUMO proteins were expressed using in minimal media (without amino acids).  
Expression cultures were supplemented with either light or heavy tyrosine for SUMO1 
or light or heavy phenylalanine for SUMO2.  A comparison between non-induced and 
induced cultures indicate a high level of expression of both SUMO1 and SUMO2 
(~17kDa) under these growth conditions. 
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Figure 3.10  Heavy phenylalanine incorporation into SUMO2 is complete in 
phenylalanine supplemented minimal media 
MS spectra of the C-terminal peptide 
FRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGG from the light (A) and 13C6-
phenylalanine heavy (B) 6HIS-SUMO2 gel bands from Figure 3.9.  The expected 
monoisotopic m/z from light and heavy SUMO2 are indicated (*) and correspond to an 
interval of 18.0604 Da (three 13C6-phenylalanine amino acids are expected in this 
peptide).  No light isotope is observed in the heavy expressed SUMO2 confirming 
isotope labelling.  The isotopic clusters to the right belong to an unrelated peptide. 
 
In contrast to the successful results observed from SUMO2 expression, the SUMO1 
C-terminal peptide did not result in a clean incorporation of tyrosine (Figure 3.11).  The 
isotopes were shifted to a wider mass distribution than the light peptide, which would 
not be expected from just a single heavy tyrosine.  This indicates that not only are cells 
degrading tyrosine, but the tyrosine breakdown products are also being incorporated 
into other amino acids.  It is noteworthy that no light tyrosine peptide was observed 
indicating that feedback inhibition of tyrosine synthesis was still effective. 
 
 
Figure 3.11  Tyrosine isotopes are recycled in minimal media 
SUMO1 labelling is complete in tyrosine supplemented minimal media as indicated 
by the absence of light peptide.  The isotope distribution of the labelled peptide is 
shifted to a higher mass distribution than the light peptide indicating that 13C915N-
Tyrosine isotopes are recycled into other amino acids.  Asterisks indicate expected 
monoisotopic peaks from the light (upper panel) and heavy (lower panel) C-terminal 
SUMO1 peptide, ELGMEEEDVIEVYQEQTGG. 
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3.3.2.4 SILAC labelling SUMO1 in defined media 
SUMO1 was expressed in defined media including amino acids in an attempt to 
inhibit the synthesis of all amino acids that might incorporate recycled tyrosine isotopes.  
In this media, heavy tyrosine containing peptides did not display an isotope distribution 
shifted to a higher mass range (Figure 3.12).  Unexpectedly, the apparent mono-isotope 
was one neutron lighter than the calculated mono-isotope.  MS analysis of the tyrosine 
used in the media confirms that the amino acid product is correctly isotope coded 
(Figure 3.13).  The specific recycling of 15N and/or 13C can be explained by 
metabolism occurring in the pathway after the point of feedback inhibition occurring on 
tyrA (Bongaerts et al., 2001).  The inhibition occurs prior to the synthesis of the 
tyrosine precursor, hydroxyphenylpyruvate, which can be made from prephenate or by 
deamination of tyrosine (Figure 3.14).  Re-amination of heavy hydroxyphenylpyruvate 
with light nitrogen can produce the lighter isotope of tyrosine that is observed.  The 
degradation products can obviously be utilised in general amino acid synthesis, as was 
observed when attempting to express SUMO1 in minimal media.  Phenylalanine is 
regulated in an analogous fashion to tyrosine but isotopes were not incorporated 
elsewhere.  This suggests that it is the 15N that is being recycled rather than the 
hydroxyphenylpyruvate because the phenylalanine used to label SUMO2 did not 
include and 15N.  The observed monoisotope in the current SUMO1 expression product 
is approximately equivalent to 13C9-tyrosine incorporation.  SUMO1 should in future be 
expressed with 13C9-tyrosine to prevent isotope recycling through 
deamination/amination of tyrosine and to maintain a normal isotopic cluster. 
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Figure 3.12 Tyrosine deamination causes loss of 15N in defined media 
MS spectra of the C-terminal SUMO1 peptide expressed in defined media 
containing light tyrosine (A) or heavy 13C915N-Tyrosine (B) shows that there is a loss of 
an isotope from the heavy amino acid.  Additional isotope incorporation appears to be 
inhibited by including a full supplement of amino acids (comparing to Figure 3.10B).  
Asterisks indicate expected monoisotopic peaks from light (upper panel) and heavy 
(lower panel) SUMO1 C-terminal peptide, ELGMEEEDVIEVYQEQTGG. 
 
 
 
Figure 3.13 Analysis of light and heavy 13C915N-Tyrosine amino acid confirms 
expected isotope composition and purity 
Infusion MS analysis of (A) light tyrosine (Formedium) and (B) 13C915N-Tyrosine 
(Cambridge Isotopes) used in media preparation verifies a mass difference of 10.0270 
which is very close to the expected 10.0272 (~1.1 ppm error).  This confirms that the 
unexpected light peptides observed in E. coli expressed proteins are a consequence of 
tyrosine metabolism. 
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Figure 3.14 Key pathway events in tyrosine metabolism permitting isotope 
recycling 
Recycling of the tyrosine amine group in E. coli can occur despite feedback 
inhibition of tyrosine synthesis.  The amination/deamination cycle results in removal of 
heavy nitrogen for potential use in other amino acids and also modifies heavy tyrosine 
with a light nitrogen. 
 
 
3.3.2.5 General labelling strategies for UBLs 
Inhibition of aromatic amino acid synthesis with glyphosate turned out to be 
unnecessary as isotopes of natural amino acids, unlike unnatural analogues, can cause 
the feedback inhibition required for labelling proteins in prototrophic E. coli.  Labelling 
in media with a full amino acid complement and selective replacement with heavy 
amino acids without α-amino isototopes appears to be an ideal general strategy for the 
aromatic amino acids phenylalaninine and tyrosine.  Alternative strategies are apparent 
allowing for most UBLs to be labelled in a similar manner.  In addition to the SUMO 
proteins, labelling with phenylalanine can also isotopically label the FAT10 tryptic 
remnant.  Atomic labelling would work for short remnants only, such as 15N labelling 
for Smt3 and nitrogen plus carbon for very the very short remnants from ubiquitin, 
ISG15, NEDD8, and Ufm1.  Additional strategies are available if using proteolytic 
enzymes other than trypsin.  Other amino acids have been reported to effectively 
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incorporate without needing auxotrophic cells, including histidine, lysine, methionine 
and alanine (O'Grady et al., 2012).  A wide range of BL21 auxotrophs have also been 
published offering an alternative approach where a specific UBL and proteolytic 
enzyme required them (Lin et al., 2011; Matic et al., 2011; Mehlhorn et al., 2013). 
 
3.3.3 ICID bioinformatic analysis 
Bioinformatic analysis includes multiple steps for data processing and identification 
of isopeptides (refer to Figure 3.7 for a diagrammatic overview of the process).  The 
essential steps required are only data format conversion to mzXML and execution of the 
ICID software, although manual validation of the results is also recommended.  The 
ICID software is the primary focus of the bioinformatic interpretation as this is the core 
detection of isotope coded UBLs.  Optional elements are also available, including 
incorporation of the SUMmOn search engine to complement this workflow. 
 
3.3.3.1 MS acquisition and data pre-processing 
A typical data dependent MS acquisition is a suitable dataset for ICID analysis.  The 
ICID software relies on high mass accuracy thus limiting the supported MS platforms to 
high resolution instruments, such as Orbitraps.  MS2 data are not utilised for detection 
of isotope coded peptide pairs therefore only high resolution MS1 spectra are required.  
MS method design will however impact the use of SUMmOn or any other software that 
interprets MS2 spectra.  Alternative MS2 data acquisition methods such as targeted MS 
analyses are equally suitable for ICID analysis as long as high resolution MS1 scans are 
included in the analysis. 
All data is first converted to mzXML format, which is a generic format for 
representing MS data (Pedrioli et al., 2004), and enables the workflow to be MS 
platform independent.  Both the ICID software and the SUMmOn search engine 
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(Pedrioli et al., 2006) utilise mzXML format.  Given the high dependency on MS1 data 
for feature detection, a well calibrated analysis with accurate precursor masses will 
benefit the analysis.  Checking the mass accuracy of the analysis and, if necessary, 
performing post acquisition mass calibration is recommended.  Post acquisition LCMS 
calibration software has also been developed (see HyperProphet chapter). 
 
3.3.3.2 ICID software overview 
The ICID software was developed in the Java language and has a simple usage 
requiring a single call on the terminal.  A diagrammatic overview of the user interaction 
is presented in Figure 3.15.  User defined parameters influence isotope coded isopeptide 
detection, assignment of peptide identifications, and inclusion list generation.  Details 
on code usage and help on input parameters can be found in Appendix B.  The ICID 
process includes the detection of isotope coded feature pairs, assignment of peptide 
identifications to the detected features, and output of results for further analysis. 
 
 
Figure 3.15 User interaction overview for the ICID software 
An LCMS analysis (in mzXML format) and a protein database (in fasta format) are 
used as input to detect isotope coded isopeptides and assign peptide identifications 
under the direction of user defined parameters.  The detected candidate isopeptides are 
output to an inclusion list (for optional targeted MS analysis) and with full supporting 
information for further analysis. 
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3.3.3.3 ICID Isotope Peak Picking algorithm 
The most critical aspect of this workflow is to be able to detect isotope pairs within 
MS data.  Initially, the feature detection algorithm from Progenesis 
(www.nonlinear.com) was used to detect all features in a run.  Feature detection 
deconvoluted each peptide feature to a discrete monoisotopic m/z, with a 
chromatographic elution time and peak intensity.  This feature set was then imported as 
input to determine co-eluting feature pairs at the diagnostic isotope mass interval.  
While this successfully detected many isotope coded peptide pairs, a limitation in 
isopeptide detection was observed due to errors in the initial detection of features, 
which were frequently missing or incorrectly assigned to the wrong isotope (Figure 
3.16). 
 
Figure 3.16 Example of erroneous feature detection in third party feature 
detection software 
Image captures from Progenesis graphical interface displays an example of a 
correctly detected peptide feature of a light (L) and heavy (H) Δ4Da isotope labelled 
pair (A) and a feature detection error where the second isotope has been incorrectly 
identified as the monoisotope (the correct monoisotope is indicated with an arrow). 
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In an attempt to find an improved algorithm, five popular commercial and free 
feature detection software packages were tested, including Progenesis, Maxquant (Cox 
and Mann, 2008), OpenMS (Kohlbacher et al., 2007), msInspect (May et al., 2009), and 
superHirn (Mueller et al., 2007).  A test sample was generated by mTRAQ labelling 
tryptic ubiquitin dimer and spiking into tryptic whole yeast lysate.  Ten manually 
validated low abundance features, belonging to 5 pairs of isotopically labelled peptides, 
were used as positive controls.  Of the software tested, none could successfully detect 
all manually validated features.  As the bioinformatic process is heavily reliant on 
correct detection of isotope coded features pairs, code was developed to gain more 
control over feature detection sensitivity, improve detection of isotope pairs, and 
circumvent the need for third party feature detection. 
The new algorithm for detecting isotope labelled peptide pairs is not a re-
implementation of traditional feature detection.  The approach was to over-predict all 
isotope pairs in raw convoluted data and subsequently validate the quality of the 
detected features.  This relatively naive approach is practical only because the isotope 
feature pairs have a strict relationship that are not inherent to typical features.  Isotope 
feature pairs are required to be co-eluting during C18 chromatography, of similar 
intensity, and a predetermined mass interval as defined by the isotopes used during 
UBL labelling.  The in-spectrum mass accuracy, the mass error between peaks in the 
same spectra, is generally smaller than the deviation observed between spectra making 
in-spectrum isotope detection a discerning parameter.  These strict criteria permitted the 
omission of traditional feature detection and isotope pairs could be extracted directly 
from raw data.   
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The main steps in the algorithm are as follows: 
 
⁃ Import mzXML file (in centroid format) 
⁃ Find local maxima over m/z-time domains (over-prediction of chromatographic 
peaks). 
⁃ Find all mass pairs at expected isotope interval(s), restricting isotope pairs to co-
eluting features and exploiting high in-spectrum mass accuracy. 
⁃ Confirm each match feature is the monoisotope of an isotopic cluster. 
⁃ Confirm each feature pair is of the expected charge state. 
⁃ Confirm each feature pair is of approximately equal intensity. 
⁃ Merge duplicate/redundant features. 
 
The new algorithm proved to be more sensitive and successfully detected all the 
manually validated feature pairs (Table 3.1).  The validation of feature quality is more 
relaxed than traditional feature detection and retains features unless they clearly fail to 
meet the minimal criteria.  As a result of increased sensitivity, the new algorithm 
resulted in a higher number of predicted isotope features detected than most other 
algorithms.  These predicted features will also include many false positives as the test 
sample is predominantly non-isotope labelled yeast peptides.  However, the total 
number of features is still within a tolerable range for the ICID application as this is an 
achievable number for targeted MS analyses.  Fewer false positive assignments would 
be expected for in vitro samples which will be significantly less complex than whole 
cell proteome.  The algorithm was also significantly faster than the third party feature 
detection and also streamlined the process by removing requirements for external 
software.   
 
Table 3.1 A comparison between feature detection algorithms 
Five commercial and free feature detection algorithms were compared to the isotope 
feature pair detection algorithm developed for the ICID software.  A benchmark against 
10 manually validated isotope coded features indicates that the ICID software is more 
sensitive at performing this task than all other algorithms tested.  Note that not all 
detected feature pairs are necessarily correct. 
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3.3.3.4 Assignment of peptide identifications 
Detection of UBL isopeptide candidates via isotope coding allows classification of 
chromatographic features by their UBL modifying group.  If a detected peptide is in fact 
a UBL modified isopeptide then the mass of the substrate peptide can be inferred by 
subtraction of the UBL tryptic remnant.  The substrate peptide identification can, at 
least in low complexity in vitro protein mixtures, be assigned solely based on high 
precursor mass accuracy.  Mass accuracy is therefore critical during peptide assignment 
as it is based solely on MS1 precursor mass without consideration of MS2 spectral 
identification.  In this respect, identification is not unlike peptide mass fingerprinting 
(PMF) which has been a very common identification technique for MS instruments 
without MS2 capability (Pappin et al., 1993).  This approach should be contrasted to 
precursor mass identification assignment without the use of isotope coding.  If seeking a 
match in an all-by-all search space between all predicted peptides and all 
chromatographic features, then there is a high probability of finding a false positive 
match.  By reducing the search space to a smaller set of high confidence features, 
assignments can be applied with higher certainty. 
 
The ICID software accepts a fasta protein database with which to assign isopeptide 
identifications.  The fasta database should contain only proteins know to be in the in 
vitro reaction to minimise false positives.  Detection of any unexpected contaminants 
can be achieved using a conventional proteomics search engine.  Protein sequences 
should ideally be manually curated to include any sequence processing and sequence 
modifications, such as N-terminal affinity tags.  The fasta database is digested in silico 
with a custom enzyme model.  Default parameters enforce a missed cleavage around a 
lysine to allow for the UBL attachment.  The N-terminal peptide is also retained without 
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and internal lysine to allow for N-terminal UBL modification.  Additional missed 
cleavages are permitted within two residues from the N- or C- terminus without penalty 
to account for trypsin being an endo-protease.   
 
 
3.3.3.5 ICID output and manual validation 
ICID results are presented as a simple tabular format.  Key information exported 
includes; 
 
- Calculated substrate peptide MW, and the assigned peptide/protein identification 
- in-spectrum mass accuracy for the detected isotope feature pair 
- Intensity of each feature and deviation from expected 1:1 ratio 
- Feature parameters: m/z values, MW, charge, elution time, scan number 
 
Considering the inherent difficulty in isopeptide identification, the data presentation 
is relatively simple and similar to what might be exported from a conventional 
proteomic search engine.  Results are pre-filtered by the software based on user 
parameters, but data can be further viewed, sorted, and filtered using any preferred 
spreadsheet software or scripting environment such as R.  The most confident set of 
identifications can be selected by considering basic criteria, most of which are common 
to validation of standard proteomics search results.  Confidently identified peptide 
assignments should be supported by small ppm errors on both the isotope feature pair 
interval and peptide assignment.  Multiple entries covering a peptide sequence also 
gives support for identifications due to observing multiple charge states and missed 
cleavages.  Missed cleavage of the SUMO2 remnant is also frequently observed due to 
the close proximity of two arginines.  There are no MS2 spectra to manually validate, 
however, the MS1 spectra should be visually inspected to confirm the correct detection 
of light and heavy isotopic clusters.  This can be done in MS vendor data viewer (e.g.  
Xcalibur for Thermo Orbitrap instruments) and a scan number is provided with which to 
 109 
quickly find the chromatographic apices of the detected peptide features.  In the case of 
a peptide containing multiple lysine, the actual conjugation site remains ambiguous.  
Interpretation of MS2 spectra is required to clarify such cases. 
Many features detected by ICID remain unidentified.  Non-peptide substrates will 
also be expected, such as a substrate mass of 18.015 Da (water), corresponding to the 
unconjugated C-terminal peptide of the UBL, which serves as a useful positive control.  
A modified mass of 121.074 Da is also often observed as a result of modifying Tris 
buffer.  It should be stressed that detected isotope coded features without a peptide 
assignment may occur for genuine isopeptides due to incorrect prior assumptions of the 
proteins present or their sequences.  Multiple instances of a calculated substrate mass 
for various charge states and UBL missed cleavages is indicative of a potentially 
genuine isopeptide but on an unanticipated peptide.   
 
3.3.3.6 Generation of inclusion list 
Due to the unique application of isotope coding, isopeptide detection is not 
dependent on protein sequence assumptions.  Assignment of peptide identifications is 
optional and can be omitted in cases where only an inclusion list is required.  A list of 
isopeptide features can be generated quickly for immediate LCMS re-analysis.  This is 
achieved without user supervision and functions based solely only on the predetermined 
isotope specifications in the parameter file.  An inclusion list is generated with target 
mass and a time range, with overlapping entries being merged, and table output 
conforming to Orbitrap software requirements.  Masses for the light, heavy, or both 
features of an isotope pair can be selected for retargeting. 
While many spectra can be acquired during an initial DDA acquisition, a targeted 
analysis allows for additional spectral acquisition where target spectra were previously 
missing or of poor quality.  More importantly, the reduced workload of a small 
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inclusion list allows for alternative MS methods to be utilised.  With a reduced duty 
cycle, the more time consuming MS2 techniques become more feasible, such as 
increased fill volumes, increased averages, and MS2 in the Orbitrap rather than the ion 
trap.  Orbitrap spectra provide superior resolution but are much slower and less 
sensitive than ion trap CID in hybrid instruments like Orbitraps.  MS3 fragmentation is 
also an appealing option as large SUMO remnants often dominate over target peptide 
fragmentation.  An MS3 spectra may provide target peptide ions to validate the 
substrate peptide, however, this currently requires manual validation as there is no 
software support for this type of analysis. 
 
3.3.4 SUMmOn analyses and data compilation 
SUMmOn offers an alternative approach to isopeptide identification.  Although 
SUMmOn analyses are not strictly required, it is a valuable resource and a 
complementary MS2-based strategy can add further confidence to isopeptide 
identifications.  In contrast to the ICID approach, which relies on high resolution MS1 
data, SUMmOn has a strong focus on MS2 spectral analysis to identify SUMO 
isopeptides.  However, SUMmOn was developed for low resolution ion trap data and 
does not take advantage of high resolution precursor mass accuracy.  MS2 spectra for 
large high charge state isopeptides are often acquired on dominant isotopes rather than 
the monoisotopes during DDA MS acquisition.  Searches must therefore be done with a 
wide precursor error tolerance which increases false positive assignments.  Careful 
manual validation of low resolution assignments are required, particularly for the 
frequent occurrences of ambiguous target peptide assignment.  This is further 
complicated by the fact that SUMO fragmentation ions often dominate over the target 
peptide ions making manual validation difficult.  SUMmOn also presents a logistical 
limitation when analysing isotope coded SUMO2.  The SUMO2 tryptic remnant is often 
 111 
observed with a missed-cleavage and oxidised methionine.  With additional isotope 
coding there are eight observed SUMO2 remnant variants, each requiring independent 
SUMmOn analyses which must be manually validated independently. 
To further extend the capabilities for SUMO isopeptide identification, a data 
compilation tool was developed to consolidate SUMmOn analyses and ICID results into 
a single analysis (Figure 3.17).  Data compilation aims to achieve multiple tasks during 
consolidation of SUMmOn and ICID data.  High resolution precursor mass filters and 
score thresholds are applied on SUMmOn results to reduce false positive assignment, 
multiple SUMmOn analyses on each UBL variant are combined into a single analysis, 
and results are cross correlated to ICID results to ascertain whether the SUMmOn 
identification is supported by isotope coded feature pair. 
SUMmOn accepts the same mzXML file and fasta database as ICID as well as an 
additional conditions.xml file defining search parameters.  A sumo.xml file is output 
containing search results, which is used by the compilation tool, along with additional 
files enabling results to be viewed via a web browser.  Details on running SUMmOn 
can be obtained from the original publication (Pedrioli et al., 2006) and from the 
website (http://summon.sourceforge.net).  Usage details and parameters for the 
compilation tool can be found at the end of Appendix B. 
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Figure 3.17 User interaction with SUMmOn and the SUMmOn/ICID data 
compilation tool 
The mzXML and fasta input files (same as those used by the ICID analysis) are 
independently used by SUMmOn and ICID analyses.  A conditions.xml parameter file 
directs the SUMmOn search engine to assign modifier and target peptide scores which 
are written to a sumo.xml file.  Peptide assignments can be viewed through a web 
browser. 
 
Results are presented in a simple tabular format for inspection in any spreadsheet 
software.  Key information exported for each entry includes: 
 
- SUMmOn search ID (to identify which UBL variant was searched) 
- Matching ICID spectrum number for a light or heavy isotope feature (if any) 
- Embedded hyperlinks to modifier and candidate peptide spectra (SUMmOn web 
interface) 
- Precursor metrics (scan number, m/z, charge) 
- Modifier and candidate peptide scores 
- Candidate match peptide/protein 
- Candidate match metrics (MW, ppm error, which isotope matched) 
 
 
Compiled results are pre-filtered by accurate mass around the monoisotope or a 
larger isotope.  Observed precursors around the fourth isotope are not uncommon.  By 
further restricting results to those with both high SUMmOn scores and support from 
ICID, a small high quality dataset can be easily generated thus significantly reducing 
manual validation requirements.  While the ICID analysis alone can determine 
isopeptide identities, the incorporation of SUMmOn now links in MS2 spectral 
validation.  The compilation tool is SUMmOn centric and can also be run without ICID 
result making it a useful extension for SUMmOn analyses alone. 
 
3.3.5 Validation on known SUMOylation substrate: RanGAP1 
Ran GTPase-activating protein 1 (RanGAP1) was the first SUMO substrate 
identified and is known to be modified by SUMO at K524 in vivo (K526 for the mouse 
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orthologue) (Matunis et al., 1998).  RanGAP1 has a preference for SUMO1 in vivo but 
is equally modified by SUMO1 and SUMO2 in vitro (Zhu et al., 2009).  The K524 
modification occurs within the ΨKXE/D consensus motif (LKSE) and modification 
occurs through direct interaction with the E2, UBC9.  An E3 ligase is not required for 
efficient modification.  The RanGAP1 SUMOylation reaction is well characterised and 
is a common positive control for SUMOylation reactions (Flotho et al., 2012) and is an 
ideal case study to validate the use of isotope coded SUMO for identifying conjugation 
sites. 
RanGAP1 (C-terminal fragment 418-587) was SUMOylated with either SUMO2 or 
a mixture of light and isotopically heavy SUMO2.  SDS-PAGE of reaction products 
indicate that RanGAP1 was completely modified (Figure 3.18).  Both the light 
RanGAP1 and light/heavy SUMOylation reactions were subjected to in-solution 
digestion and analysed by LCMS.  The resulting LCMS files were processed through 
the ICID software using the parameter file presented in Appendix B and a fasta file 
containing proteins used in the in vitro reaction (SAE1, SAE2, UBC9, SUMO2, and 
RanGAP1).  The process was automated other than to filter the final result to only 
peptide sequences observed as multiple variants (charge state, UBL miss-cleavage, 
UBL oxidation).  The resulting analysis (Table 3.2) successfully identified the expected 
RanGAP1 SUMOylated peptide encompassing K524 (LLVHMGLLKSEDK).  An 
additional missed cleaved peptide was also identified covering the same RanGAP1 
modification site (LLVHMGLLKSEDKVK).  There are two lysines in the miss-cleaved 
peptide so the K524 modification in this peptide is presumed but not supported by the 
data.  An additional unreported RanGAP1 SUMOylation site was discovered at K452 
(LGPKSSVLIAQQTDTSDPEK).  The K11 SUMO2-SUMO2 isopeptide was also 
detected, which is a know site for SUMO2 polymerisation and also conforms to the 
consensus motif (VKTE) recognised by UBC9 (Tatham et al., 2001). 
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Figure 3.18 RanGAP1 is efficiently SUMOylated in vitro using isotopically 
coded light/heavy SUMO2 
UBC9 efficiently SUMOylates the RanGAP1 with both light (unlabelled) SUMO2 
and a 1:1 mixture of light and heavy phenylalanine labelled SUMO2.  RanGAP1 is 
completely modified, as indicated by the loss of the unmodified RanGAP1 observed at 
0 hr, and is predominantly mono-SUMOylated. 
 
 
 
Table 3.2 Table of isopeptides identified by ICID analysis in a RanGAP1 
SUMOylation reaction 
Isopeptides were identified as belonging to RanGAP1 and SUMO2 based on 
accurate mass assignment to theoretical tryptic peptides.  Note that each peptide is 
supported by either multiple charge states (z) or multiple UBL variant peptides (missed 
cleaved SUMO2 has an isotopic mass shift of 18 Da rather than 12 Da).  A total of 200 
hits were tabulated but those without peptide assignments have been truncated, except 
for the expected free SUMO2 C-terminal peptide.  The data table is essentially 
representative of the ICID output, although some columns have been omitted for 
presentation clarity. 
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To confirm that isopeptide assignments are not a result of incorrect feature 
detection, MS1 spectra were manually validated for correct assignment of monoisotopic 
peaks.  Figure 3.19 presents MS1 spectra identified as SUMO or RanGAP1 isopeptides, 
all of which were validated as correct.  The full ICID results output included a total of 
200 isotope coded features, the majority of which did not result in peptide assignments.  
A repeat ICID analysis on the RanGAP1 SUMOylation reaction with light SUMO2 
returned only 5 false positives indicating that almost all of the 200 detected features are 
a result of isotope labelling. 
 
To demonstrate incorporation with the SUMmOn search engine, SUMmOn searches 
were conducted for 8 C-terminal SUMO2 peptides (permutations of missed-cleaved, 
methionine oxidised, and heavy labelled) and compiled with ICID results into a single 
analysis.  437 SUMmOn assigned spectra passed high resolution precursor filtering 
which were then filtered to only 90 spectra with ICID support thus significantly 
minimising manual validation requirements.  Only SUMO conjugation sites with 
multiple instances were considered resulting in rapid validation of RanGAP1 and 
SUMO2 sites (Table 3.3).  However, no spectral support existed in the SUMmOn 
searches for the SUMO remnant or substrate peptide for the second RanGAP1 K452 
site.  This modification therefore remains an identification solely based on accurate 
mass assignment from isotope coding.  SUMmOn assigned spectra for the SUMO2 K11 
and RanGAP1 K524 isopeptides are presented in Figures 3.20 and 3.21, respectively. 
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Figure 3.19 Manual validation of MS1 spectra confirms correct detection of 
isotope coded features in a RanGAP1 in vitro reaction 
A selection of isotope coded peptide MS1 spectra are presented that were reported 
as being isotope coded by an automated ICID analysis of a RanGAP1 SUMOylation 
reaction.  Asterisks indicate the reported monoisotope and isotope coded mass interval, 
which have been correctly identified in all cases for the unmodified C-terminal SUMO2 
peptide (A), K11 SUMO2-SUMO2 isopeptide (B), and a selection of RanGAP1 
isopeptides (C-F).  ∆12 and ∆18 refer to the fully tryptic and missed cleaved SUMO2 
C-terminal peptide containing 12 and 18 13C carbon isotopes, respectively. 
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Table 3.3 Isopeptides identified by ICID are also independently identified by 
SUMmOn 
An independent MS2 spectral analysis of SUMO2 modified substrates by the 
SUMmOn search engine, followed by compilation of SUMmOn and ICID results, 
reveal reciprocal conformation of expected RanGAP1 and SUMO2 isopetpides.  Data is 
presented from the compilation tool which filters SUMmOn searches by accurate 
precursor mass and requiring supporting evidence from ICID analysis.  The data table is 
essentially representative of the ICID output, although some columns have been omitted 
for presentation clarity. 
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Figure 3.20 Spectral support for the SUMO2 K11 isopeptide 
Spectra assigned by SUMmOn are presented for the SUMO2-SUMO2 K11 
polymerisation site.  Fragment ions are independently assigned to the SUMO2 remnant 
(top) and the substrate peptide (bottom). 
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Figure 3.21 Spectral support for the RanGAP1 K542 isopeptide 
Spectra assigned by SUMmOn are presented for the SUMO2-RanGAP1 K542.  
Fragment ions are independently assigned to the SUMO2 remnant (top) and the 
substrate peptide (bottom). 
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Additional peptides were found that covered the RanGAP1 K542 SUMO 
conjugation site, including an oxidised methionine and an additional missed cleavage 
(Table 3.4).  A K271 SAE2 isopeptide was also discovered, which also had an oxidised 
methionine, and is a known UBC9-mediated SUMOylation site (Truong et al., 2012).  
These peptides were not originally assigned during the ICID analysis using accurate 
mass due to strict in silico digest parameters.  This exemplifies the dependence ICID 
peptide assignment has on prior sequence assumptions, however, detection of 
unassigned isotope coded features still provides an effective means of validating 
isopeptides identified by SUMmOn.  Manual validation of features for the SUMmOn 
identified isopeptides confirmed correct detection of isotope coded monoisotopes 
(Figure 3.22). 
 
 
 
Table 3.4 Isopeptides identified by SUMmOn are supported by isotope-coded 
features 
Isopeptides uniquely identified by SUMmOn include modifications and miss-
cleavages not originally assigned by the ICID analysis due to a strict search space. The 
unique peptides (or peptide modification state) are supported by detection of isotope 
coded features. 
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Figure 3.22 Manual validation of MS1 spectra corroborates SUMmOn 
isotopeptide identifications in a RanGAP1 in vitro reaction 
Isotope coded peptide MS1 spectra are presented for peptides that were not initially 
identified in the ICID analysis of a RanGAP1 SUMOylation reaction, but were 
identified by SUMmOn.  Asterisk labels indicate the monoiostope reported by the ICID 
analysis, which are correct in all cases for the K524 RanGAP1 methionine-oxidised (A) 
and doubly miss-cleaved (B) isopeptides and a methionine-oxidised SAE2 K271 
isopeptide.  ∆12 and ∆18 refer to the fully tryptic and missed cleaved SUMO2 C-
terminal peptide containing 12 and 18 13C carbon isotopes, respectively. 
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The ICID module is a valuable addition to SUMmOn for validating identifications.  
Table 3.5 presents a set of spectra that were all assigned by SUMmOn to another novel 
RanGAP1 SUMOylation site.  Spectra passed the high resolution precursor mass filter, 
however, inspection of their precursor features (figure 3.23) show that they lack isotopic 
partners. The compiled data lacked support from ICID features and was correctly 
filtered out of the dataset.  Using concordance between SUMmOn and ICID data is 
therefore an effective and convenient way to discern between true isopeptides and false 
positives with minimal interaction.  A small high quality dataset can then be given 
attention for manual validation and confirmation of UBL conjugation sites. 
 
 
 
Table 3.5 False positive SUMmOn assignments lack support from ICID 
features 
A potentially novel RanGAP1 isopeptide was assigned by SUMmOn to multiple 
peptide variants.  Precursor spectra are presented in Figure 3.23 for those in bold. 
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Figure 3.23 False positive SUMmOn assignments to a RanGAP1 isopepide lack 
isotopic partners 
Manual validation of precursors to potential RanGAP1 SUMOylation sites (bold 
entries in Table 3.5) are indicated (*) and lack isotopic partners at the expected mass 
interval (?).  This confirms that the SUMmOn assignment is a false positive and that 
lack of support from the ICID analysis has correctly contradicted the MS2 spectral 
interpretation. 
 
 
3.3.6 Application to uncharacterised substrate - RNMT 
RNA guanine-7 methyltransferase (RNMT) methylates the N-7 position during 
formation of the 5’ mRNA cap which is essential for mRNA translation (Cowling, 
2010).  RNMT also requires interaction with RNMT-Activating Mini protein (RAM) 
for efficient cap methylation (Gonatopoulos-Pournatzis et al., 2011).  In unpublished 
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work in the lab of Dr Cowling (Dundee University), HeLa cells transiently transfected 
with expression vectors encoding RNMT, RNMT was detected as a ladder suggesting 
that RNMT was modified by a UBL.  The ladder was increased by MG132 suggesting 
that the modification leads to proteasomal degradation.  Curiously, when co-transfected 
with RAM, the ladder disappeared suggesting that the RAM-RNMT interaction 
stabilised RNMT.  SUMO modification was hypothesised, although the nature of the 
modification in vivo has not been confirmed.  Investigation into in vitro SUMOylation 
revealed that RNMT also results in a modification ladder under in vitro conditions 
(Figure 3.24).  It is not clear from the gel image whether the RNMT SUMOylation 
ladder is a result of multiple mono-SUMOylations or formation of SUMO chains on 
RNMT. 
 
 
 
Figure 3.24 RNMT is SUMOylated with either SUMO1 or SUMO2 by UBC9 in 
vitro 
Recombinant monomeric RNMT was subjected to in vitro sumoylation in the 
presence of SUMO1, SUMO2 or no SUMO protein (-) for the time points indicated 
above the panels.  The reaction products were analysed by Coomassie stained SDS-
polyacrylamide gel (upper panel) or western blot to detect RNMT (lower panel).  
RNMT and sumoylated RNMT (RNMT-SUMO) are indicated.  Figure reproduced with 
permission from Thomas Gonatopoulos Pournatzis (2012) PhD thesis. 
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The RNMT (isoform 1) SUMOylation was repeated using a mixture of light and 
isotopically heavy SUMO2.  LCMS data from the tryptic digest was subjected to ICID 
analysis and SUMmOn analysis followed by SUMmOn/ICID data compilation.  Manual 
validation required multiple instances of a lysine modification site and with support 
from ICID features (exactly as done for the RanGAP1 validation experiment).  Final 
results were manually validated to confirm that precursor monoisotopes were correctly 
identified.  17 modification sites were detected (Table 3.6), although only 16 could 
reliably be assigned to RNMT.   
 
A surprisingly large selection of lysines were found to be modified indicating a very 
low degree of specificity.  Long reactions times are also required to achieve a 
significant level of modification.  This would suggest that RNMT is not a specific target 
under the current conditions and in vivo modification is mediated by an additional 
factors, if the modification observed in vivo is indeed SUMOylation.  Given the lack of 
consensus site for UBC9 mediated modification, it would seem likely that an E3 ligase 
is required to increase specificity and efficiency.  The modification area over the protein 
is large (Figure 3.25) and spans both the N-terminal domain (1-120) and the catalytic 
domain (121-476).  The non-catalytic N-terminal domain, which is required for 
recruitment to transcription initiation sites, does not bind RAM (Aregger and Cowling, 
2013).  It would seem unlikely that RAM binding would protect from SUMOylation at 
these sites suggesting that the modifications in the N-terminal domain are non-specific 
reactivity.   
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Table 3.6 Table of RNMT SUMOylation sites identified by SUMmOn with 
support from ICID analysis 
17 modification sites were identified with high mass accuracy precursors, high 
SUMmOn scores, and supported from having isotope coded UBL modifications, and 
observing multiple peptide species.  At least one species for each peptide sequences was 
manually validated to confirm accurate detection of precursor monoisotopes.  One 
SUMO isopeptide with a very short substrate peptide (KR) could be assigned to 5 
different location but could also be mapped to SAE2 and therefore cannot be reliably 
assigned to RNMT. 
 
 
 
Figure 3.25 A sequence mapping of 16 SUMO modification sites on RNMT 
16 SUMOylated lysines are mapped onto the RNMT (isoform 1) sequence 
(bold/underlined).  Amino acid numbering is according to WT human sequence 
(O43148 MCES_HUMAN isform1) but with an N-terminal extension due to an N-
terminal His-tag (the His-tag was cleaved off during purification).  Modification sites 
occur in the N-terminal domain and the catalytic domain (121-476). 
 
 
To validate if any of these sites are genuine, site directed mutagenesis could be done 
for the more abundant isopeptide signals. An analysis of lysine mutants may display a 
phenotype in vivo, or reveal reduced levels of modification by western blot if a major 
site is perturbed. Better support would come from in vivo detection without 
mutagenesis. A tandem substrate and SUMO immunoprecipitation would provide 
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strong support to RNMT being a genuine SUMO substrate. This raises the possibility of 
direct MS confirmation of in vivo isopeptides now that we have an in vitro reference. 
 
 
3.3.7 Towards in vivo isopeptide identification    
Mass spectrometry offers powerful techniques for identification and quantification 
of proteins and their modifications.  Application to in vivo systems offer the greatest 
insight into the dynamic nature of the proteome, however, application of these 
technologies to complex UBL isopeptides in vivo is extremely rare.  There are 
significant technical limitations that prohibit efficient analysis of UBL isopeptides and 
this field of research lags well behind that of simple modifications like phosphorylation 
and ubiuqitin diglycine remnants.  This section on in vivo UBL analysis presents future 
prospects for in vivo analysis of complex UBL isopeptides.  The main challenges faced 
will be discussed, and some preliminary results will be presented to support proposed 
directions for future research.  
 
 
3.3.7.1 Validation of in vitro targets 
The biological significance of in vitro reactions should always be questioned since 
the reaction is occurring outside the their natural cellular context.  Validating potential 
modification sites are often approached through mutational analysis.  Mutation of 
lysines can however result in the UBL modification jumping to neighbouring lysines 
(Klug et al., 2013).  A more direct validation on native substrates would have greater 
biological relevance.  In vitro identified isopeptides provide a valuable dataset of 
candidate isopeptides which may occur in vivo and can be used as references to target 
isopeptides in cell and tissue extracts. 
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The concept of an in vitro to in vivo strategy was proposed by Matic et al. (2008), 
where SUMO-SUMO isopeptides were identified from in vitro SUMO polymerisation 
reactions.  SUMO chains were then purified from HeLa cells and chains identified using 
the in vitro precursor ion, elution time, and fragmentation spectra as a guide.  This 
strategy was demonstrated only for SUMO polymerisation sites, and was achieved 
through manual validation against “virtual” linearised peptides.  A modified strategy 
generalised for UBL modified proteins is outlined in figure 3.26. 
 
A major limitation in this strategy is the initial identification of isopeptides which 
has been a significant challenge even in relatively simple in vitro reactions.  The 
methodologies presented in this chapter make the in vitro workflow relatively 
straightforward and the major bottleneck in the strategy has now moved from the in 
vitro to the in vivo side.  Methods for purifying UBLs like SUMO have recently made 
headway with SUMO interacting domains (Bruderer et al., 2011) and generation of anti-
SUMO antibodies (Becker et al., 2013).  Additional enrichment strategies may also be 
available via substrate specific antibodies.  UBL and/or substrate tagging is also feasible 
for many cell lines and model organisms.  Isotope labelled isopeptides from in vitro 
reactions can also be used as spike-in references to aid detection and quantification.  
The main limitations now lie in MS targeting and spectral interpretation of in vivo 
derived isopeptides.  
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Figure 3.26 Strategy for identifying in vivo UBL modification sites from in vitro 
identified UBL isopeptides 
Identification of UBL isopeptides from in vitro reactions defines spectral and 
chromatographic properties that can be used to aid in vivo detection and 
validation/invalidation of UBL conjugation sites.  Model based on the strategy proposed 
by Matic et al. (2008).  The research in this chapter primarily addresses the challenges 
for in vitro isopeptide identification. 
 
3.3.7.2 Direct detection of in vivo isopeptides 
Not all UBL modification can be produced in vitro due to substrates being difficult 
to express or the necessary E3 being unknown.  Direct detection of isopeptides without 
in vitro guidance would therefore be a valuable capability.  The previous strategy used 
isotopic UBL expressed with heavy amino acids which is only applicable to in vitro 
reactions.  An alternative isotope coding strategy for isotope labelling is presented in 
Fig 3.27.  In contrast to the previous method, isotope coding comes from chemical 
labelling of peptide N-termini.  Since isopeptides have two N-termini they will receive 
two labels.  Every peptide gains an isotopic partner but isopeptides can be distinguished 
from linear peptides by their double spacing.  To ensure isotope labelling is specific to 
N-termini, primary amines are blocked at the protein level prior to digestion.  This has 
the effect of blocking the N-terminus, therefore N-terminal UBL modifications and 
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modifications on a lysine within the first peptide will not be amenable to analysis by 
this method.  Trypsin will also no longer cleave at lysine making the digest arginine 
specific, although the method should work equally well with alternative enzymes if 
necessary.  Although the sample processing is more involved than the in vitro protocol, 
the method benefits from being applicable to UBL modified proteins from any source, 
to protein modification by any of the UBL family, and also simultaneous analysis of 
mixed UBL modifications.  Software requirements to deal with detection of isotope 
pairs have already been implemented for the in vitro protocol and is equally applicable 
here.  The ability to detect and target isopeptides without any sequence assumptions is 
particularly important in this scenario as isopeptide precursors cannot be predicted in 
complex samples. 
 
 
Figure 3.27 A strategy isotope coding isopeptides by chemical modification with 
isotopic reagents 
Amine reactivity is blocked at the protein level prior to proteolytic digestion to 
expose N-terminal peptides amines, of which there are two of on isopeptides.  Divided 
samples are labelled with light or heavy amine reactive reagents (e.g. mTRAQ) and 
recombined.  Isopeptides can be differentiated from linear peptides by their double 
isotope spacing. 
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To demonstrate the viability of the proposed isotopic labelling protocol, the 
isopeptide discovery process was applied to a mixture of K11/K48/K63 ubiquitin 
dimers.  Ubiquitin amine reactivity was blocked using nicotinic NHS ester, and 
tryptically exposed N-terminal amines were labelled with either light or +4 isotopically 
heavy mTRAQ reagents (N-methylpiperazine acetic acid NHS ester).  An inclusion list 
was generated from an initial DDA analysis using the automated ICID software and the 
sample re-acquired with a targeted DDA analysis (Figure 3.28).  In the DDA analysis, 
3040 MS2 spectra were acquired accounting for 12 isopeptide spectra.  All isopeptides 
spectra identified belonged to K48 and K63.  K11 ubiquitin isopeptides were not 
identified as a result of blocking the N-terminus and all lysines in the N-terminal half of 
ubiquitin.  During the targeted run, only 233 MS2 spectra were acquired, which 
included 27 spectra to ubiquitin isopeptides but no linear peptides were identified. 
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Figure 3.28 Isotopic chemical labelling of ubiquitin dimers enables automated 
targeted acquisition of ubiquitin isopeptides 
Ubiquitin dimers are used as a test case for isotopic chemical labelling as a strategy 
for targeting isopeptides.  Ubiquitin lysines are nicotinic acid (nic) blocked, digested 
and mTRAQ labelled.  An initial DDA analysis (A) is analysed to generate an inclusion 
list for a targeted MS analysis (B).  Shaded regions under the chromatograms indicate 
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MS2 events.  Peptide labels create a 4 Da interval for linear peptides (C) whereas 
isopeptides are detected at an 8 Da interval (D).  Spectral counting of ubiquitin linear 
peptides and isopeptides (E) show that re-targeting isopeptides resulted in an effective 
analysis isopeptides without linear peptides interfering with analysis efficiency.  This 
confirms the chemical labelling strategy to be viable option for the study of complex 
UBL isopeptides for in vivo derived samples. 
 
 
This test case demonstrated that chemical labelling with isotopic reagents can 
produce signals required for discriminating isopeptides from linear peptides.  With this 
new strategy, isopeptides can be detected and an inclusion list created in an 
unsupervised manner.  A targeted MS analysis can successfully re-acquire isopeptide 
spectra with a more efficient use of MS cycle time.  The proposed new strategy for 
isotope coding isopeptides offers exciting prospects for broadening the scope of UBL 
analysis beyond in vitro studies.  Note however that ubiquitin isopeptides were used to 
validate the procedure because their spectra are easily interpreted.  This does not 
represent the spectral complexity we would expect from SUMO isopeptides.  Nor did 
the sample offer the complexity and low abundance challenge expected from cellular 
extracts.  Efficient targeting in complex samples requires further attention to move 
forward in this area of research. 
 
3.3.7.3 MS targeting isopeptides 
For the in vitro reactions, targeting was not essential for identification of isopeptides 
as they were sufficiently intense for detection by DDA acquisition.  Initial attempts to 
collect additional spectra on the RNMT sample with targeted LCMS resulted in only a 
subset of isopeptides being re-acquired.  Given that monisotopes from isopeptides were 
manually validated as correct, this would indicate a technical limitation in the MS 
targeting method.  Targeting in vivo isopeptides will be a greater challenge and 
resolving targeting efficiency will be essential for implementation of the proposed 
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methodology.  Targeting parameters on the Orbitrap Velos software control were 
investigated for their effect on targeting efficiency.  25 manually validated tryptic 
peptides were selected from a complex whole yeast tryptic digest at an intensity of 
10,000-20,000 counts, which corresponds to ~1/5000 signal relative to base peak.  
These peptides were identified in an initial DDA analysis, they are low abundance 
features that are consistently detectable above noise, and they represent a realistic 
targeting challenge.  MS targeted data acquisition was repeated while modifying MS 
method parameters and spectra were validated at 1% FDR using XTandem and Trans-
proteomic pipeline (Figure 3.29). 
 
None of the peptides were successfully re-acquired using typical DDA settings.  For 
effective targeting, most ‘smart’ features needed to be turned off indicating that 
discovery and targeted methods are practically exclusive.  Turning off mono-isotopic 
precursor selection (MIPS) was absolutely essential suggesting that the real time peak 
detection algorithm is unable to correctly distinguish most low abundance features.  
Incorrect real-time peak detection would clearly result in a poor correspondence to a 
target list comprised of monoisotopic m/z values.  This is in keeping with the observed 
failure to detect the correct monoisotopes even during the discovery DDA 
SUMOylation analyses.  The low resolution preview scan also had a significant 
negative effect, as did poor management of the MS2 intensity trigger threshold.  Best 
results were found by data independent acquisition (DIA), where MS2 events are 
scheduled without dependence on MS1 observations.  Data independent acquisition is 
much like SRM in that it requires careful scheduling of events.  Precursor feature 
characteristics like monoisotopic m/z and charge, which are taken for granted during 
DDA analysis, will also need to be determined retrospectively.  Although DIA adds 
further bioinformatic burden to the process, these results indicate that careful data 
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management and instrument control will enable the targeting of low abundance features 
required for future application of this methodology. 
 
 
 
 
Figure 3.29 MS acquisition parameters have a drastic effect on the success of 
targeting low abundance peptides. 
25 low abundance peptides were selected from a data dependent acquisition (DDA) 
analysis for targeted analysis.  Software features including monoisotopic precursor 
selection (MIPS), preview scan, sequencing threshold, and dynamic exclusion have 
drastic effects of the ability to acquire identifiable spectra.  Superior results are found by 
data independent acquisition (DIA). 
 
 
 
3.3.7.4 Improved spectral interpretation 
Although identifying SUMO isopeptides is a challenging task in in vitro scenarios, 
using isotope coded UBL offers a straightforward approach for confident identification.  
The well defined simple composition of in vitro UBL reactions allowed us to determine 
isopeptide identities solely based on precursor mass accuracy.  This is a luxury not 
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available in complex samples.  Elution time is traditionally an important characteristic 
for feature identification through accurate mass and time (AMT) tags, but because 
isopeptides with large remnants all share a common peptide sequences, the substrate 
peptides cause only a small shift in chromatographic properties.  Figure 3.30 shows how 
isopeptides from the RNMT SUMOylation all elute within a small time range.  False 
assignment to an incorrect peptide is of greater concern for isopeptides with long 
remnants than for tryptic peptides in general.  Interpretation of fragmentation spectra is 
therefore paramount to confirming UBL substrates in complex samples. 
 
  
 
Figure 3.30 SUMOylated tryptic isopeptides have common chromatographic 
properties. 
An ICID analysis of the light/heavy SUMO2 RNMT shows that detected isopeptides 
(both fully cleaved and miss-cleaved remnant), all elute within a small percentage 
solvent off C18.  Each data point in the scatter plot represents a detected isotopic pair at 
their elution time and precursor m/z (x and y axes, respectively) and the black line 
represent the solvent gradient during the LCMS analysis (secondary y axis).  A base 
peak chromatogram above is time aligned with the scatter plot to provide a reference to 
the whole sample. 
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The additional use of MS2 spectral interpretation with SUMmOn aided 
identification confidence for in vitro isopeptides through concordance of MS1 and MS2 
based methods.  Unfortunately, interpretation of low resolution MS2 spectra with 
SUMmOn is also limited to small databases to prevent false positives (Pedrioli et al., 
2006).  Greater specificity can be achieved through high resolution MS2 spectra and 
fragmentation techniques like HCD has also been reported to give better fragmentation 
than CID for large high charge state peptides (Jeram et al., 2010).  Acquiring high 
resolution MS2 spectra is relatively slow and of low sensitivity in hybrid Orbitrap 
instruments due to a long flight path through the ion trap.  However, more recent 
Orbitrap designs like the Q Exactive and Fusion offer faster scan rates and significant 
increase in sensitivity due to the use of quadrupole ion filters. 
 
Interpretation of high resolution isopeptide spectra is unfortunately limited.  
Techniques like ChopNSpice conveniently utilise capabilities of traditional search 
engines but result in incomplete spectral coverage over substrate peptides.  To 
discriminate between UBL isopeptides, interpretation of fragmentation over the full 
substrate is essential.  Software support for high resolution MS2 could be implemented 
by updating the SUMmOn strategy, which already offers theoretically ideal spectral 
coverage.  Alternatively, in silico isopeptide fragmentation support could be 
implemented in an existing open source search engine.  An alternative strategy for 
improved isopeptide spectral interpretation is to utilise the MS3 capability of ion traps.  
The MS2 fragmentation can create isopeptide y-ions with a shortened remnant while 
subsequent MS3 can potentially validate the MS2 identification by increasing substrate 
peptide fragmentation.  MS3 has been used to manually validate SUMO isopeptides 
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(Matic et al., 2008) but here is no software support for automated MS3 isopeptide 
identification.  
 
Whether moving from in vitro to in vivo analysis, or directly targeting isopeptides in 
complex samples, sensitive and specific MSn spectral interpretation for isopeptides is 
critical for validating substrate peptides.  Bioinformatic techniques for isopeptide 
spectral interpretation is still under developed and investment in research in this area 
will be essential for successful implementation of in vivo UBL isopeptide research.  
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Chapter IV 
HyperProphet 
 
4.1 Introduction 
 
The research presented in the previous chapters was conducted with focus on 
purification and identification of UBL modifications.  The work was necessarily 
approached from the reductionist perspective to address technical challenges of 
studying small events that occur within a proteome.  In contrast, the work in this chapter 
approaches proteomics from a systems perspective - the study of the entire proteome.  
Even in the study of UBL modifications, the quantitative state of the proteome is 
important for understanding the role of the modification.  For example, putative E3 
ubiquitin ligase targets can be discovered by finding protein accumulations in E3 
mutants (Burande et al., 2009).  And while many ubiquitin substrates have been 
discovered in recent years, quantifying site occupancy, which requires the reference of a 
total proteome quantification, has yet to be achieved for the majority of ubiquitin targets 
(Carrano and Bennett, 2013).  Global proteomics studies are also necessary to 
understand the biological significance of perturbations in poorly understood pathways 
and uncharacterised gene products, such as comparing proteome-wide effects of 
deleting a panel of DUBs from the yeast genome (Poulsen et al., 2012).  The challenge 
of analysing entire proteomes is a limiting factor in proteome research and the impact 
extends beyond the analysis of UBLs and PTMs in general.  Although the research 
presented here was initiated with UBL research in mind, because it has a more 
widespread application in proteomics, its presentation has been abstracted to the study 
of unfractionated proteomes in general. 
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4.1.1 Proteome complexity limits proteome analyses 
Despite the ever increasing speed and sensitivity of mass spectrometry 
instrumentation, we are still limited in our proteome analysis capabilities. (Michalski et 
al., 2011a) points out that the mammalian proteome has 100,000 peptides that are 
detectable in a typical analysis, yet we achieve identification of only a small fraction of 
these.  In fact, the typical bottom-up workflow where proteomes are enzymatically 
digested only worsens the complexity.  This is unfortunately a necessary step for 
efficient MS analysis as top-down proteomics on intact proteins has not developed an 
equivalent level of throughput or sensitivity (Moradian et al., 2014).  The requirements 
for increased peptide coverage for more robust quantification, and coverage in more 
complex proteomes, still surpasses the ability of current MS hardware to achieve 
sufficient proteome coverage on a chromatographic time scale.  Although hardware and 
MS acquisition algorithms will no doubt continue to improve, development in this area 
is out of the hands of most proteomics researchers and we are left to develop alternative 
means to dealing with proteome complexity. 
 
4.1.2 Overcoming complexity through sample pre-fractionation 
With the desire to cover the entire proteome, approaches have been devised to 
circumvent the MS limitations - the most common of which is sample fractionation.  
LCMS almost exclusively implies online 1D fractionation with reverse phase 
chromatography, which is used for its high resolution and compatibility with 
electrospray ionisation.  Some alternative online fractionation techniques have however 
been investigated for complex mixtures, such as capillary zone electrophoresis (Zhu et 
al., 2013).  Where a single online peptide separation has been insufficient, additional 
pre-fractionation has been common.  Long standing techniques for protein analysis like 
1D-PAGE and 2D-PAGE are still commonly used prior to LCMS today (Issaq et al., 
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2002).  Strong cation exchange (SCX) was also adopted early and has been adapted for 
automated online 2D fractionation (Washburn et al., 2001).  Additional techniques to 
accompany reverse phase LCMS are continuously being developed, including as high 
pH reverse phase chromatography (Delmotte et al., 2007) and isoelectric focusing (IEF) 
(Hörth et al., 2006).  New chromatographic media are also still being developed to 
improve offline fractionation, such as hydrophilic variants of strong anion exchange 
(Ritorto et al., 2013).  More recent examples attempting to expand proteome coverage 
include extensive fractionation using multiple techniques.  Impressive quantitative 
coverage over the majority of the yeast proteome has been achieved by using solubility 
fractionation, SDS-PAGE, SCX, and isoelectric focusing (de Godoy et al., 2008; Rezgui 
et al., 2013) and combinations of fractionations are also used in series for 3D 
fractionation (Atanassov and Urlaub, 2013).  However, sample fractionation has the 
drawback of creating a significant increase in the samples that require analysing.  Given 
limited MS resources, removing the need for fractionation will enable resources to be 
applied to increasing replicates for improved statistics and quantitative accuracy, and 
increasing the biological scope of research projects to include a wider array of 
biologically informative conditions. 
 
4.1.3 Overcoming complexity without sample pre-fractionation 
Analyses on unfractionated samples have the advantage of requiring smaller sample 
amounts, a more streamline sample processing, and is more amenable to 
automation.  For all these reasons, research is increasingly focusing on 
maximising protein coverage without pre-fractionation.   
 
4.1.3.1 Improvements in MS hardware 
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Mass spectrometers are getting faster, more sensitive, and with increasing 
resolution.  A significant component of the advancements in this area have been 
associated with the release of new and improved MS hardware into the marketplace.  
The increased scan speed alone has had a direct impact on peptide identification rates in 
proteomic analyses (Hebert et al., 2014).  The release of the Thermo Q Exactive made 
high resolution mass spectrometry an even more affordable option for many 
laboratories. Achieving identification of 2500-4000 yeast proteins over 90-240 minute 
gradients is now achievable on relatively inexpensive MS hardware (Michalski et al., 
2011b; Nagaraj et al., 2012; Thakur et al., 2011).  On the newer Thermo Orbitrap 
Fusion, even faster scan speeds enable approximately 4000 yeast proteins in a single 1 
hr analysis (Hebert et al., 2014).  Extensive fractionation previously revealed that there 
are at least 4399 of 6400 yeast open reading frames expressed at one time (de Godoy et 
al., 2008), indicating that we can identify about 90% of the yeast proteome in a short 
analysis time.  This does not imply that we can yet quantify 90% of the yeast proteome.  
It does however highlight that current and future MS hardware will enable sufficient 
coverage of proteomes to reveal insights into biological systems without sample 
fractionations. 
 
4.1.3.2 LCMS acquisition optimisations  
The typical reverse phase LCMS with data-dependent acquisition (DDA) has proven 
to be a valuable means for identifying proteins in both uncharacterised and well 
characterised proteomes.  Although the DDA algorithm is a semi-random peptide 
selection with little control by the user, minor adaptations can be applied to acquisition 
parameters to guide DDA towards an improved proteome coverage.  The sequence 
intensity threshold can be optimised such that it is low enough to identify low 
abundance peptides but above the limits of detection and above an ideal signal to noise 
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threshold to ensure quality spectra acquired (Wong et al., 2009).  Many other 
parameters are also available to MS operators, including isolation window, injection 
time, transient time, scan rates, dynamic exclusion, and optimising can have a positive 
effect on proteome coverage.  However, optimising on total protein coverage can 
potentially be at the expense of sensitivity (Kalli et al., 2013; Kelstrup et al., 2012).  
Such optimisations are also dependent on the sample and the hardware being used, 
therefore re-optimisation is required for each independent scenario for optimal 
performances. 
 
4.1.3.3 HPLC optimisations 
Ultra high pressure nano-flow HPLC with small C18 bead sizes has been shown to 
improve peptide peak capacity, which leads to good peak resolution for long gradients 
(Cristobal et al., 2012).  By improving the chromatographic resolution coupled to MS, 
the sample complexity at any given time during the gradient is reduced.  HPLC 
gradients can also be modified non-linearly to even out peptide elution rates to minimise 
regions of high complexity (Pirmoradian et al., 2013).  HPLC buffer additives have also 
been found to improve peptide sensitivity.  The addition of DMSO (Hahne et al., 2013) 
and benzyl alcohol (Li and Li, 2014) were found to improve peptide ionisation and also 
collapse peptides towards a single charge state (Meyer and A Komives, 2012). 
 
4.1.3.4 Bioinformatic solutions 
Bioinformatic solutions are often aimed at overcoming limitations imposed by DDA 
algorithms, which fail to reproducibly identify peptides within a complex proteome 
sample due to the semi-random nature of peptide selection.  A more targeted approach 
can be used where a preselected list of peptides is determined for subsequent analyses. 
This knowledge can be used for directing the MS to target specific peptides from a list 
 145 
for fragmentation. (Savitski et al., 2010) found that this approach yielded 24% more 
proteins than DDA acquisitions alone.  However, this approach is only applicable if the 
proteome is already well characterised and a predetermined set of peptides can be 
selected from preceding analyses.  A more generic approach to targeting peptides can be 
done by creating inclusions lists containing all unidentified chromatographic features 
observed during initial DDA analyses (Schmidt et al., 2008).  Similarly, in a process 
called post analysis data acquisition (PAnDA), a targeted approach can be achieved by 
subtracting peptides identified by DDA from the targeted feature lists, and iteratively 
subtracting identified features after repeated cycles of targeted MS analyses (Hoopmann 
et al., 2009). 
 
A common theme for each of these approaches is the requirement for repeated 
LCMS acquisitions prior to or during their bioinformatic applications.  From the 
perspective of maximising MS resource efficiency, these approaches do not necessarily 
offer great advantage over fractionation as the additional analyses time could otherwise 
be spent on an equivalent number of sample fractions.  Headway was made towards 
avoiding the repeat acquisition redundancy with the introduction of the “match between 
runs” feature in the MaxQuant software package.  In contrast to previous bioinformatic 
approaches, this feature retrospectively mines for unidentified features, and instead of 
repeating a targeted MS analysis, it acquires identifications from other existing replicate 
or similar analyses for which matching features have been successfully identified.  
Although this feature has not been formally published, it has been used in a number of 
publications (Geiger et al., 2012; Nagaraj et al., 2012; Thakur et al., 2011), and 
highlights the value of acquiring information from similar but non-replicate LCMS 
analyses. 
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4.1.4 The future of proteomics 
It is perhaps inevitable that biological questions will always outweigh the resources 
to answer them.  But the field of proteomics is not unlike genomics prior to the radical 
explosion in sequencing throughput that occurred during the human genome project.  
We are observing rapid developments in MS hardware in terms of capability and value 
for money, suggesting that the potential for high throughput discovery proteomics may 
be a reality in the near future.  With this in sight, we are conceiving of increasing 
numbers of biological states to interrogate; screening for disease biomarkers (Pan et al., 
2005), proteome-wide screening of protein complexes (Gavin et al., 2006), personalised 
proteomes (Marko-Varga et al., 2007), and environmental proteomics (Gotelli et al., 
2012).  To achieve the throughput required, a focus on rapid analysis of unfractionated 
proteomes is essential. 
 
Most publications announcing unprecedented proteome coverage are boasting 
protein identification rates.  However, identification of a protein is rarely useful in 
complex proteome analyses, other than to catalogue expressed genes.  The overlap in 
proteins expressed between different cell types and under differing biological conditions 
indicate that the informative unit of proteomic information is quantitation.  It is 
quantitative proteomics that will enable us to compare proteomic snapshots to elucidate 
responses to genetic perturbation, drug treatments, disease states, and better understand 
normal proteome dynamics within healthy cells.  Future developments in throughput 
proteomics will therefore need to be conducted with quantitation in mind and 
throughput cannot be achieved at the expense of quantitative proteome coverage or 
quantitative precision. 
 
4.1.5 Objectives of research 
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 Presented is a novel sample processing workflow and bioinformatics solution for 
the quantitative analysis of unfractionated proteomes.  This work was carried out to 
fulfil the primary aim of extending the limitations of typical DDA LCMS analyses.  
There were also a set of additional objectives that set the framework for this research.  
As quantitation was a primary focus, solutions were made to be compatible with isotope 
labelling, particularly SILAC as it has been observed to provide a higher precision than 
chemical labelling (Oppermann et al., 2013).  Because advances in this domain of 
research will result from community contributions in multiple academic fields, software 
was intended to be open source, and kept as operating system and MS vendor neutral as 
possible.  Additionally, software solutions should utilise or interface with existing open 
source platforms where appropriate.  Finally, application of any new developments 
should ideally not require extensive mass spectrometry or bioinformatic expertise to 
apply so that solutions can be easily utilised by the general proteomics community. 
 
4.1.6 Biological Application: ELP3 
The majority of the work presented in this chapter can be considered from a 
technical perspective, with the development of new workflows and tools that would 
benefit a broad range of research that relies on proteomics.  To put the work into a 
biological context, the yeast Elongator complex is used as a subject to exemplify the 
impact of this research.  More specifically,  elp3∆ yeast will be investigated to better 
understand the effect ELP3-dependent tRNA modifications have on the proteome. 
 
The Elongator complex is named for its association with actively elongating RNA 
polymerase II (Otero et al., 1999). The Elongator complex is formed through the 
association of two sub-complexes, Elongator complex proteins Elp1p-Elp3p, and Elp4p-
Elp6p (Krogan and Greenblatt, 2001).  Its catalytic member, Elp3p, has 
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acetyltransferase activity and is thought to acetylate nucleosomes, specifically histones 
H3 and H4, in the path of the elongating polymerase (Winkler et al., 2002).  Other 
potential roles for the Elongator complex are wide spread, including cytoplasmic kinase 
signalling (Cohen et al., 1998) and exocytosis (Rahl et al., 2005), and deletions of any 
member of the ELP-complex result in salt, caffeine, and temperature sensitivity (Krogan 
and Greenblatt, 2001).  However, the primary role of the ELP-complex has since been 
proposed to be the modification of tRNAs (Huang et al., 2005).  Previously proposed 
roles in protein acetylation are under question as many phenotypes related to previously 
proposed roles for ELP are in fact suppressed by over expression of ELP targeted 
tRNAs in an elp3∆ background (Esberg et al., 2006). 
 
The ELP-complex is required for formation of 5-carboxymethyluridine (cm5U), 
which is a precursor to 5-methoxycarbonylmethyluridine (mcm5U) and 5-
carbamoylmethyluridine (ncm5U) modifications on uridine-34 of tRNAs.  Deletion of 
any member of the ELP-complex abolishes formation of these modifications (Huang et 
al., 2005).  Figure 4.1 provides an overview of the structure of the uridine 
modifications, and a simplified synthesis pathway (Chen et al., 2011a).  
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Figure 4.1 A model for the formation of mcm5 and ncm5 uridine. 
Structures of uridine, 5-carboxymethyluridine (cm5U), 5-
methoxycarbonylmethyluridine (mcm5U), and 5-carbamoyl- methyluridine (ncm5U). 
The synthesis pathway has not been fully elucidated, but the ELP-complex is required 
for synthesis of the cm5U precursor (Chen et al., 2011a).  U = uridine.  R = ribose. 
 
The 20 amino acids are coded for by 61 codons (not including stop codons), and 
most amino acids are coded for by multiple codons.  Reflecting this redundancy, tRNAs 
have the potential to wobble at the third codon position to recognise near-cognate 
codons as well as their exact matching cognate codon (Crick, 1966).  ELP-dependent 
modifications occur on uridine-34 of tRNAs corresponding to 11 codons, which account 
for almost all of the 13 uridine-34 tRNAs (Table 4.1).  These modifications at the tRNA 
wobble position are important for governing the specificity of codon recognition (Figure 
4.2) and can influence the extent of wobble to restrict recognition to the cognate codon, 
or enhance recognition of near-cognate codons (Agris, 2004).  For example, the mcm5U 
modification on wobble uridines for both tRNA-Arg(UCU) and tRNA-Gly(UCC) are 
important for reading G in the wobble position (JOHANSSON et al., 2008).  
Conversely, the ochre suppressor tRNA that reads the ochre stop codon UAA, requires 
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the mcm5U modification for recognition.  Deletion of ELP3, and therefore inhibition of 
ochre suppressor tRNA modification to mcm5U, prevents recognition of the cognate 
codon (Huang et al., 2005).  The mcm5U and ncm5U tRNA modifications are required 
for accurate and efficient translation and proteins rich in their respective codons are 
poorly translated in the absence of the modifications (Svejstrup, 2007). In fact, 
replacing codons for synonymous ELP-independent codons can restore protein 
expression (Bauer et al., 2012).   
 
 
 
Table 4.1 Table of codons corresponding to ELP-dependent tRNAs. 
Codons are tabulated with amino acids and those corresponding to ELP-dependent 
tRNA modifications are in bold.  tRNA modifications are listed as 5-
carbamoylmethyluridine (ncm5U), 5-methoxycarbonylmethyluridine (mcm5U), 5-
carbamoylmethyl-2'-O-methyluridine (ncm5Um), and the double modification 5-
methoxycarbonylmethyl-2-thiouridine (mcm5s2U). 
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Figure 4.2 Diagrammatic representation of the tRNA anti-codon binding its 
cognate codon. 
In this example, the tRNA-Arg(UCU) recognises its cognate codon AGA.  The grey 
box indicates the site of ELP-dependent uridine modification, mcm5U, and is the site of 
wobble. 
 
 
In higher eukaryotes, neurological disorders occur if the Elongator complex 
dysfunction.  In humans, mutations affecting expression of IKAP (human ELP1) cause 
familial dysautonomia (Anderson et al., 2001).  It has however been proposed that 
neural disorders could be caused by defects in the acetylation of α-tubulin by the 
Elongator complex (Creppe et al., 2009).  In Caenorhabditis elegans, inactivation of 
elpc-1 or elpc-3 cause neurological and developmental dysfunctions (Chen et al., 2009).  
The role for ELP in tRNA modification has only recently been confirmed in mammals, 
as a mouse Ikbkap/Elp1 mutant exhibits wobble uridine tRNA modification defects (Lin 
et al., 2013).  However, it is still not confirmed whether the Elongator complex 
involvement in these diseases is due to its role in tRNA modification or direct 
acetylation of the protein substrates (Chen et al., 2009; Creppe and Buschbeck, 2011). 
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A subset of ELP-modified tRNAs also receive a second modification.  The tRNA-
Leu(UAA) recognising the UUA codon also has an additional methyl group on the 
ribose.  The tRNAs Gln(UUG), Lys(UUU), and Glu(UUC), are thiolated in place of an 
oxygen at position 2 on the uridine-34 resulting in 5-methoxycarbonylmethyl-2-
thiouridine (mcm5s2U).  This modification is catalysed by the ubiquitin-related 
modifier1 (URM1) pathway.  Although URM1 is a UBL, it has a role as a sulphur 
carrier in eukaryotic tRNA modification.  The effects on proteome composition of 
deleting URM1 have been investigated by (Rezgui et al., 2013) who conducted an 
extensive SILAC proteome analysis of urm1∆ vs. wt yeast.  Using sample fractionation 
and 6 biological replicates, in conjunction with an in silico codon bias analysis, a 
correlation between codon biases of AAA, CAA, and GAA, and differential 
composition of the yeast proteome was observed.  This indicated that the lack of tRNA 
thiolation resulted in impaired translation of a subset of genes rich in the three codons 
corresponding to the three thiolated tRNAs.  Although ELP3 was also investigated 
within this paper, an equivalent proteome and codon bias analysis of elp3∆/wt was not 
conducted.  
 
Although similarities in urm1∆ and elp3∆ phenotypes have been reported, the ELP 
pathway mediates a far more extensive range of modifications on tRNAs than the 
URM1 pathway.  In a similar approach to the one conducted by (Rezgui et al., 2013), 
this chapter presents a differential proteome analysis of elp3Δ vs. wt yeast.  A codon 
bias analysis is also used to derive insights into the relationship between ELP-dependent 
tRNA modifications and modulation of the proteome.  However, in contrast to the 
extensive sample fractionation carried out by Rezgui and colleagues, the proteome 
analysis will be conducted without fractionation and utilising the novel methodologies 
developed for increasing proteome coverage. 
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4.2 Materials and Methods 
 
4.2.1 General reagents 
Dithiothreitol, Chloroacetamide, 13C615N4-arginine and 13C615N2-lysine, 
Bicinchoninic acid, formic acid, mass spectrometry grade water and acetonitrile 
(Sigma).  Trifluoroacetic acid,  Dimethyl sulfoxide (Thermo Scientific).  Sequencing 
grade-modified Trypsin (Promega).  C18 microspin columns (The Nest Group).  
PicoTip Emitter (New Objective).  Magic C18AQ 3 µm 200 Å beads (Michrom 
Bioresources).  RapiGest was synthesised in-house. 
 
4.2.2 Yeast growth media 
SD-K-R: 6.7 mg/mL yeast nitrogen base without amino acids and (NH4)2SO4 
(Becton Dickinson), 0.68 mg/mL Triple Dropout CSM Mix -K, -R, -A (Formedium), 
2% (wt/vol) glucose, 0.01% (wt/vol) Adenine, 0.2 mg/mL Pro.  Media is supplemented 
with 0.02 mg/mL arginine or 13C615N4-arginine (Sigma), and 0.03 mg/mL lysine or 
13C615N2-lysine (Sigma) for light or heavy SILAC media, respectively. 
 
4.2.3 Cell culture 
Wild-type (BY4741  lys1∆::KAN, lys2∆::KAN, arg4∆::KAN) and elp3∆ 
(BY4741  lys1∆::KAN, lys2∆::KAN, arg4∆::KAN elp3∆::His3MX) were inoculated 
into SD-K-R supplemented with arginine and lysine, or 13C615N4-arginine and 13C615N2-
lysine.  Pre-cultures were grown overnight from a single colony then diluted to OD600 
~0.05 and grown to OD600 ~0.8.  Light and heavy cultures were either kept separate or 
mixed such that OD x volume were equal, then cells were pelleted and frozen in N2 
prior to further processing.  For ELP3 analyses, 3 SILAC mixed cultures were wt-
light/ELP3-heavy, and an additional 3 label switched to ELP3-light/wt-heavy. 
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4.2.4 Protein and peptide preparation 
Cells were lysed with 2 M NaOH, 1 M β-mercaptoethanol for 5 min on ice, then 
proteins were precipitated with 50% trichloroacetic acid on ice for 10 mins.  Proteins 
were precipitated by centrifugation at 3,000 x g for 5 min and washed twice with cold 
acetone. Pellets were dried and resuspended in 8 M urea, 0.5% RapiGest, 100 mM Tris 
pH 7.5. Protein content was determined by diluting samples 20x in water, 25 µl of 
which was mixed with 1 ml bicinchoninic acid, 0.08% CuSO4 and incubated for 1 hr at 
37 °C before measuring optical density at OD562.  Concentrations were interpolated 
from a standard curve of BSA.  Approximately 40 µg protein was reduced in 5 mM 
DTT for 1 hr at 30 °C, then alkylated with 15 mM chloroacetamide at RT for 30 min in 
the dark.  Samples were diluted 10x in 50mM tris pH 7.5 and digested overnight at 37 
°C with 1:50 sequencing grade-modified Trypsin (Promega).  RapiGest was precipitated 
with TFA, and peptide were purified in C18 microspin columns (The Nest Group).  
Peptides were dried and resuspended in 0.1%TFA. 
 
4.2.5 Mass spectrometry Data acquisition 
1 µg of peptide from ELP3 SILAC or corresponding single channels were injected 
onto a ~45 cm self packed 75 µM inner diameter PicoTip Emitter (New Objective), 
packed with Magic C18AQ 3 µm 200 Å beads (Michrom Bioresources) which was 
heated to 45 °C.  A Dionex Ulitimate 3000 HPLC delivered a 250 nl/min gradient using 
buffers A (0.1% formic acid, 3% DMSO, 2% acetonitrile) and B (0.1% formic acid, 3% 
DMSO, 90% acetonitrile) from 1-40% B over 180 min followed by a 40 min wash and 
equilibration.  Data were acquired on a Velos Orbitrap Pro mass spectrometer (Thermo 
Fisher Scientific) with lockmass off, at 60k Orbitrap resolution, and with a preview scan 
triggering data dependent acquisition (DDA) of the top 15 precursors above a 500 
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precursor intensity threshold.  Peptides were isolated within a 2 m/z window for 
fragmentation by rapid scan ion trap CID.  1:1 and 2:1 yeast control data were acquired 
essentially as above but using a Proxeon HPLC at 200 nL and buffers without DMSO.  
MS acquisition used a 445.120025 m/z lockmass and the top 12 precursors were 
fragmented. 
 
4.2.6 Data analysis 
LCMS raw data files were converted to mzXML format using ReAdW.exe.  MS2 
spectra were assigned to peptide identifications by searching against a S. cerevisiae 
protein database (version 2011-02-03 from SGD http://www.yeastgenome.org/) using 
X!!Tandem release 10-12-01-1 (MPI parallelised version of X!Tandem, 
http://wiki.thegpm.org/wiki/X!!Tandem).  Search parameters included variable 
+15.994915 Da for methionine oxidation, and multi-static modifications of +57.02146 
Da for carbamidomethylcysteine alone or with +8.014199 Da/+10.0082528 Da for 
heavy lysine/arginine.  Peptide precursor tolerance was set to 25 ppm and 0.4 Da for 
MS2 spectra, and semi-tryptic peptides were permitted up to 2 missed cleavages.  
Search results were validated using the Trans-Proteomic Pipeline (TPP) v4.6 running on 
Linux.  Peptide assignments were validated using PeptideProphet and InterProphet, and 
proteins were validated using ProteinProphet and accepted above 1% FDR according to 
MAYU (Reiter et al., 2009).  XPRESS was used for label-free and SILAC peptide 
quantitation at 10 ppm around the observed precursor mass.  Data was further analysed 
using an in-house MySQL database and R for Linux version 3.0.2.  Statistical analysis 
was conducted by Bayes moderated t-test in the LIMMA package from the 
Bioconductor project.  Codon bias analysis was conducted as previously described 
(Rezgui et al., 2013).  In brief, a random forest analysis was conducted with 1000 trees 
and seeds randomly selected between 10-99 using the party package (Strobl et al., 
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2008).  Classification of significantly changing proteins at 1% FDR as up and down 
regulated was based on the absolute count of gene codons.  Randomised analysis was 
repeated after changing log2 protein ratios to 1 or -1.  Gene Ontology analysis was 
conducted using FunSpec (Robinson et al., 2002) using a P-value cutoff of 0.01 and 
using Bonferroni correction.  SILAC label switch peptide filtering was conducted using 
in-house developed R code (described in Result and Discussion section) with a linear 
log2 ratio tolerance of 0.5.  HyperProphet software was executed with PeptideProphet p-
value thresholds of 0.99 (approximately 0% FDR) for chromatographic alignment, 0.85 
(approximately 1% FDR) for peptide transfers, feature intensity minimum of 2000 
counts, and LCMS analysis time ranges were restricted to 10-190 min. 
 
4.2.7 Software development 
Software development was conducted in R for Linux version 3.0.2 and Eclipse 4.3 
(Kepler) using Java 1.6 on Mac OSX and run on both Mac OSX and CentOS linux 
platforms.  External JAR libraries used include jopt-simple-4.3.jar 
(http://pholser.github.io/jopt-simple/), commons-math3-3.0.jar 
(http://commons.apache.org/proper/commons-math/), and jrap_StAX_v5.2.jar 
(http://sourceforge.net/projects/sashimi/). 
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4.3 Results and Discussion 
 
4.3.1 Characterising proteome complexity 
  To serve as a model proteome of moderate complexity, yeast total proteome 
extracts were prepared as single channel samples (unlabelled light and SILAC heavy) 
and as a SILAC mixture at approximately 1:1.  While some proteomes may be of 
greater or lesser complexity, such as mammalian or bacterial proteomes, a yeast 
proteome was selected due to its relevance to the research presented in this chapter.  To 
characterise the effect the sample complexity has on proteome analyses, a single SILAC 
1:1 sample was repeatedly analysed by LCMS. The resulting data was searched against 
the SGD proteome database using the XTandem search engine, then protein 
identifications were accumulated into one through nine merged analyses using the trans-
proteomic pipeline (TPP).  LCMS data was also acquired for fully SILAC labelled 
heavy and non-labelled light single channel samples. 
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Figure 4.3.  Peptide and protein identifications accumulate with repeated 
analysis. 
Protein and peptide identifications were accumulated into one through nine merged 
SILAC LCMS analyses. A cumulative curve is presented for A) total protein 
identifications, B) unique peptides (non-redundant peptide sequences with 
modifications permitted), C) unique peptides per protein, D) unique stripped peptides 
(modifications ignored), and E) unique stripped peptides per protein.  Also included are 
the mean values for two single channel analyses (dashed lines).  All values were 
extracted from TPP’s ProteinProphet and PeptideProphet web interface after filtering at 
1% FDR. Note that InterProphet was used to minimise the accumulation of false 
positives. 
 
Figure 4.3 demonstrates that repeated analysis of a complex mixture yields 
increasing peptide and protein identifications.  The cumulative advantage decreases 
with increased replicates as the detectable proteome is consumed, although when the 
accumulation plateau finally occurs is not evident in this data.  A further comparison 
between SILAC and single channel analyses is revealing about the complexity of these 
samples.  More proteins are identified in single channel analyses than in SILAC 
samples and this holds true even after accumulating proteins over multiple SILAC runs.  
In contrast to the protein level identifications, SILAC analyses appear to have an 
advantage for unique peptides identified and peptides per protein. However, considering 
that peptide modifications are included in the unique peptide count, these numbers are 
inflated due to the duplication of peptides by the inclusion of heavy arginine and lysine.  
On considering the unique peptides after stripping of modifications, SILAC and single 
channel runs have near identical peptides per protein.  While the accumulation of 
unique stripped peptides do overtake numbers observed in single channel analyses, 
surprisingly, this accumulation contributes more to the number of peptides per protein 
than the total proteins identified. This observation is consistent with previous yeast 
SILAC analyses where peptide accumulation also had only modest impact on total 
protein identifications (Nagaraj et al., 2012). 
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The discrepancy between single channel and SILAC analyses is noteworthy since 
they are identical samples other than the SILAC multiplexing. In SILAC labelling, all 
except C-terminal peptides will incorporate a heavy arginine or lysine, thus the total 
proteome complexity is almost doubled.  Reduce proteome coverage is a consequence 
of increased complexity.  Although SILAC labelling may also introduce a small 
reduction in sensitivity, as peak heights will also halve at equal protein load, this 
sensitivity challenge does not appear to become limiting until the plateau begins to 
occur after the analysis of multiple replicates. The cause of the complexity limitation 
appears to be largely due to limited MS cycle time, where the number of peptides 
present simply exceed the sampling rate.  However, other contributing factors are 
related to the nature of DDA, which is a semi-stochastic peptide sampling process.  The 
sensitivity limit, manifested by the plateaux observed in Figure 4.3, may also be the 
ability of the peptide selection algorithm to penetrate the dynamic range of peptides 
rather than the true limit of detection of the mass spectrometer. The observed limit of 
detection can therefore be related to the complexity because peptides of lower 
abundance may not be selected by DDA in regions of high complexity. 
 
It is important to distinguish detectable peptides, those with features detected in 
MS1, and identifiable peptides, those that give assignable MS2 spectra. Given that the 
analysis presented in figure 4.3 is measured by identified peptides and not detected MS1 
features, the complexity limitation can also be contributed to by a failure to assign an 
identity to an MS2 spectrum.  This can occur due to co-isolation of two or more 
peptides within the isolation window of 2 m/z giving a mixed spectrum.  This 
phenomenon may be variable between analyses as the timing of an MS2 event can 
affect the purity of a spectrum for peptides that are only partially overlapping.  
Furthermore, increased complexity by SILAC labelling will increase the frequency of 
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peptide co-elution. While mixed spectra can be assigned to multiple peptides (Wang et 
al., 2010), this is not achieved by standard proteome software.  It should be noted that 
co-eluting peptides within the 2 m/z MS2 isolation window may have clearly resolvable 
MS1 precursor ions making these peptides quantifiable at high resolution.  
 
We can conclude for complex samples in general, that any single analysis only 
identifies a subset of peptides and proteins that are identifiable.  Additionally, replicate 
analyses can improve the total identifications over an experiment.  Furthermore, when 
approaching complexity from a quantitative perspective, it is clear that SILAC 
multiplexing creates a more complex proteomic landscape that negatively impacts the 
proteome coverage. Conversely, the lower complexity of a single channel analysis 
permits a superior dataset for the identification of peptides and proteins.  Thus, if we 
want to benefit from the precise quantitative power of SILAC then we are faced with 
opposing forces between optimal peptide identification and optimal peptide 
quantification. 
 
4.3.2 Managing Proteome Complexity: A New Workflow for SILAC 
Experiments 
Given the identification versus quantification dilemma for SILAC experiments, a 
new workflow is presented to take advantage of both SILAC and non-SILAC samples 
for the efficient analysis of unfractionated proteomes (Figure 4.4).  This proposed 
workflow is distinguished from a typical experiment in two ways, firstly by the 
inclusion of single channel samples (either unlabelled light samples or fully labelled 
heavy samples) providing increased proteome coverage, and secondly, the in silico 
experiment-centric management of peptide and protein identifications. 
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Obtaining single channel samples requires negligible additional effort as these 
samples must already be made in the preparation of SILAC samples. Prior to the mixing 
of light and heavy samples, a portion of each sample should be kept unmixed and 
further processed in parallel to the mixed SILAC samples. Depending on the 
experimental design, collection of single and mixed channel samples may occur during 
cell harvest, or with fully processed light and heavy tryptic peptides.  Although the 
latter requires the least additional processing of samples, mixing SILAC samples as 
early as possible, i.e. immediately after cell harvest, is recommended to ensure 
consistent processing of paired channels. 
 
 
 
 
Figure 4.4 A graphical representation of the proposed new workflow for 
SILAC experiments. 
In addition to SILAC replicates, one or more single channel analyses are included in 
the experiment.  All peptides identifications can be accumulated into a single 
experimental super-set of peptides.  Additional peptides are assigned to individual 
SILAC analyses to aid quantification of peptides that were otherwise not identified. 
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A wide range of SILAC analyses can potentially be included, such as technical 
replicates and biological replicates.  Similar non-replicate samples may also be 
included, such as a set of mutants, various environmental stimuli and drug treatments - a 
prerequisite being that each sample is a quantitate variation on the same proteome.  The 
inclusion of single channel runs is technically optional as this concept is still applicable 
over just SILAC analyses.  However, as outlined in the previous section on proteome 
complexity, single channel analyses offer increased peptide and protein coverage over a 
single SILAC analysis.  Thus, one or more single channels should be included, for 
example, a single sample corresponding to a common reference run present in all 
SILAC analyses.  The inclusion of every sample as a single channel is of course 
possible, although the excessive extra acquisition time on non-quantifiable samples may 
make this approach impractical. 
 
The decoupling of identification and quantification analyses also permits MS 
acquisition to be optimised for their respective purpose.  Settings such as mass 
resolution, preview scan option, MS1 duty cycle length, MS2 trigger intensity threshold, 
and DDA versus targeted acquisition, can dramatically affect search results (Kalli et al., 
2013).  Furthermore, optimal setting can be contradictory for identification and 
quantification.  For example, a long cycle with many MS2 events may give optimal 
proteome coverage but insufficient points across a chromatographic peak for accurate 
quantification.  SILAC samples can therefore be acquired with optimal quantification at 
the sacrifice of MS2 peptide identification scans knowing that adjacent single channel 
analyses can provide the necessary proteome coverage. 
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4.3.3 HyperProphet: a software module enabling mixed single-
channel/SILAC experiments 
The major component of the proposed workflow entails a bioinformatic solution to 
the redistribution and quantification of peptide identifications. The software solution 
presented here is called 'HyperProphet'.  The design of this software module set out to 
fulfil a number of aims; to be operating system independent, MS vendor independent, to 
be open source, to be modular, and to permit interfacing with multiple proteomics 
pipelines.  The Trans-Proteomic Pipeline (TPP), a popular open source proteomics data 
analysis platform from the Institute for Systems Biology (Keller et al., 2005), was 
selected as the initial interfacing pipeline as it shares similar philosophies; it is open 
source, has linux and Windows distributions, is MS vendor neutral, and is built from 
modular tools.  TPP also supports multiple search engines and includes all the necessary 
tools for peptide validation, protein inference, and peptide and protein SILAC 
quantitation.  Specific examples discussed in this chapter and in appendices will refer to 
TPP on a linux platform.  
 
HyperProphet is a command-line interface application developed in Java (an 
operating system independent language).  To keep the software modular (having no 
dependence on other software), the interface to HyperProphet was designed to be solely 
through the mzXML (Pedrioli et al., 2004) and pepXML (Keller et al., 2005) file 
formats (Figure 4.5).  This enables any proteomics pipeline to potentially interface with 
HyperProphet, as long as there is compatibility with the xml formats.  HyperProphet 
operates independently from MS vendors, or the search engines used, which is a 
flexibility that is acquired from the xml formats being used.  The mzXML is a 
standardised, open format for representing MS data.  Vendor supplied and third-party 
converters are available to generate mzXML from vendor specific binary formats 
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(http://www.proteomecenter.org/software.php).  The pepXML format contains peptide 
level information, such as peptide-spectrum-matches (PSMs), and supports multiple 
search engines including Mascot (Perkins et al., 1999), XTandem (Craig and Beavis, 
2004), SEQUEST (Eng et al., 1994), and Comet (Eng et al., 2013).  The pepXML 
format can also contain additional information including statistical validation of 
assignments and quantitative information (Keller et al., 2005). 
 
 
 
Figure 4.5 HyperProphet interfaces with the Trans-Proteomic Pipeline (TPP) 
The HyperProphet module (black) interfaces with TPP modules (grey) though the 
open xml formats mzXML (representing MS data) and pepXML (representing peptide 
assignments, validation, and quantification information).  
 
Although the ultimate purpose of HyperProphet is to enable improved quantification 
of SILAC analyses, HyperProphet does not perform quantification.  The specific 
function of hyperProphet is to manage the collection of peptide identifications over an 
experiment, and to re-assign peptide identifications when missing from individual runs.  
The transfer of a unique peptide identification is used to direct the existing tools to 
perform the quantification. Note that in the context of this work, a peptide refers to a 
unique LCMS feature identification, thus multiple charge and modification states are 
considered as unique peptides. The peptide transfer is conducted by generating a new 
instance of an mzXML file.  This new mzXML file is a composite file containing a 
duplicated set of MS1 spectra and a set of MS2 spectra derived from adjacent runs.  
This file therefore contains identical quantitative information, but unique identifications.  
The transfer of MS2 spectra is carefully managed with chromatographic time alignment 
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and extracted ion chromatograms to ensure that MS2 spectra are inserted within the 
parent feature elution profile.  Each input SILAC analysis in the experiment will 
therefore receive an additional composite mzXML file.  Note that the original data file 
is left unmodified, making the native and the transferred peptide identifications easily 
distinguishable by file origin.   
Note that future references to HyperProphet analyses necessarily implies the use of 
the TPP pipeline as a foundation, and a TPP analysis to be an equivalent analysis 
without the additional use of HyperProphet.  To understand the full process (Figure 
4.6), the inner workings of HyperProphet will be described before discussing the 
interaction with TPP.  
  
4.3.4 Hyperprophet algorithm outline 
The internal functions of HyperProphet can be divided roughly into four main tasks; 
accumulation of high confidence peptide identifications, time alignment of LCMS 
analyses, assignment of missing peptides, and creation of composite mzXML files 
(Figure 4.6, grey box).  A high-level overview of the key decisions and steps 
HyperProphet executes follows. 
 
Accumulation of high confidence peptide identifications: 
⁃ read&in&each&pepXML&file,&filtering&on&a&minimum&input&peptide&
probability&
⁃ remove&duplicate&PSMs&
⁃ duplicates&assigned&to&‘shoulder’&chromatographic&features&of&
lower&intensity&are&discarded&
⁃ preference&then&given&to&highest&probability&and&being&assigned&
to&a&chromatographic&feature&
⁃ alternative&modifications&and&charge&states&are&preserved&as&
unique&chromatographic&features&
⁃ tabulate&unique&peptides&into&an&m&x&n&array&(m&peptides&x&n&analyses)&
⁃ rows&represent&common&peptides&between&analyses,&null&values&
indicate&missing&peptides&
 166 
&
Time alignment of LCMS analysis: 
⁃ for&each&pair&of&analyses,&collect&high&probability&peptides&in&common&
⁃ create&time&alignment&between&runs&using&a&segmented&linear&alignment&
⁃ This&alignment&model&will&be&used&to&determine&insertion&points&
for&unique&peptide&transfers&
&
Assignment of missing peptides: 
⁃ for&each&SILAC&analysis,&determine&set&of&missing&peptides&
⁃ for&each&missing&peptide,&select&best&spectrum&from&adjacent&analyses&
⁃ preference&then&given&to&highest&probability&and&being&assigned&
to&a&chromatographic&feature&
⁃ update&MS2&retention&time&to&that&of&the&recipient&analysis&using&
chromatographic&time&alignment&model&
&
Creation of composite mzXML files:&
⁃ For&each&MS2&to&be&inserted,&create&an&XIC&around&expected&retention&
time&in&recipient&mzXML&file&L&refine&insertion&time&to&correspond&to&
precursor&peak&apex&
⁃ for&each&SILAC&analysis,&create&a&new&mzXML&file&with&duplicated&MS1&
spectra&and&insert&MS2&spectra&at&updated&retention&time&
 
 
 
Figure 4.6 HyperProphet and interaction with TPP 
The workflow begins (solid circle at left, following solid arrows) with the optional 
re-calibration mzXML files, followed by a first pass through TPP up to the peptide level 
validation and label-free quantification for all files in the analysis.  HyperProphet is 
then executed on the set of pepXML and mzXML files generating new mzXML files.  
The new mzXML files are then recalibrated and passed through TPP again (dashed 
arrows), including protein validation and quantification. * denotes the point at which 
native analyses and their HyperProphet analysis partner files are merged into a single 
result. 
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4.3.5 HyperProphet peak selection and peak detection 
 
Accuracy of HyperProphet is partly dependent on the quality of peptides selected 
for transfer.  Although only the MS2 spectra are transferred, identifications assigned to 
quantitative features are preferred to ensure they are bona fide peptides rather than 
incorrectly assigned noise. Redundant peptide identifications are frequently 
encountered, most of which are assigned to the same precursor feature, but some are 
incorrectly assigned to low abundance features.  These incorrect features are detected 
due to erratic signals forming peak shoulders or additional small features in 
chromatographic tails.  As a proxy for feature detection correctness, features are plotted 
as peak area over intensity.  Figure 4.7A displays abnormal features that have 
unexpected peak area-intensity relationship which occurs mostly at low intensity.  The 
abnormal features are discarded by HyperProphet during the selection of high quality 
non-redundant peptide identifications (Figure 4.7B).  For comparison, features detected 
in recipient analyses for peptides transferred by HyperProphet display a similar level of 
quality (Figure 4.7C). 
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Figure 4.7 HyperProphet transfers peptides from high quality 
chromatographic features. 
The correlation between feature apex and area is well correlated and used as a proxy 
for peak detection correctness in a yeast SILAC LCMS analysis.  The set of all features 
detected for high probability peptide identifications (A) have outliers at the lower 
intensity range.  These data points are mostly eliminated after selection of high quality 
non-redundant peptides (B) and upon transfer to a recipient analysis (C). 
 
 
It is critical that HyperProphet generated mzXML files place MS2 spectra within the 
MS1 chromatograph peak profile, as this would necessarily be the case for a DDA 
LCMS analysis and is expected by MS1 quantitation software.  To achieve the feature 
quality indicated in Figure 4.7C, HyperProphet relies heavily on the chromatographic 
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alignment.  An alignment model is constructed using the apex elution times of 
chromatographic features for peptides in common between each analysis (using MS2 
spectra times is also a software option).  An example of a replicate analysis shows that 
there is a very strong correlation (Pearson score R2=0.9986) between analyses with 
consistent chromatography (Figure 4.8).  Although the alignment could be modelled 
with a single linear fit in this case, to adjust for variation during analyses, HyperProphet 
uses a series of contiguous linear fits with outlier removal.  Outliers are defined by a 
user set standard-deviation threshold.  
 
 
 
Figure 4.8 Peptide elution times between replicate analyses are highly 
correlated. 
Peptide feature apex elution times are aligned for two technical replicates of SILAC 
yeast LCMS data filtered at high probability (p>0.99).  The alignment model between 
replicates aids in the prediction of elution times for peptides missing from one replicate. 
 
 
To further fine tune the insertion time of MS2 spectra, extracted ion chromatograms 
(XICs) are determined for mono-isotopes of each transferred peptide in the recipient 
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MS1 scans.  The initial insertion time, derived from the segmented linear alignment 
model, is adjusted to that of the observed peak apex using a greedy hill climbing 
algorithm. Although this does not guarantee to find the true maximum, a local 
maximum is sufficient to ensure the insertion point is within the feature profile range.  
Figure 4.9 demonstrates the effect of the XIC mediated insertion time adjustments.  
Time adjustments are predominantly around zero seconds indicating that the initial 
alignment was precise and little or no adjustment is needed.  In the 3hr LCMS analysis 
presented, +/- 30 seconds is ample tolerance for peak adjustment.  The adjustment of 
precursor intensity (figure 4.9B) reveals that the XIC time adjustment does not alter 
many peptides (y=x correlation) and it improves apex detection for many peptides 
(scatter of increased intensity).  For the remaining peptides, the adjustment is essential 
due to initially missing the peak (x=0). 
 
As a final confirmation of peak detection accuracy, precursor intensities were 
compared to feature apex intensities from the donor analysis.  A strong correlation is 
expected because the light and heavy donor analyses are essentially equivalent to the 
two channels of the 1:1 SILAC recipient, although some variation is expected as each 
sample represents an independent tryptic digest.  Comparing precursor intensity before 
and after XIC time adjustment (Figure 4.9C-D) shows that spectral insertion vastly 
improves.  A small portion of outlier data points appear to have found a local rather than 
global maximum intensity. 
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Figure 4.9 Refinement of spectral insertion time improves peak detection and 
quantification accuracy.  
Chromatographic peak detection metrics are presented for a HyperProphet 
transferring peptides from light and heavy single channel analyses to a 1:1 SILAC 
analysis. A greedy hill climbing algorithm starts at chromatographic alignment time and 
then finds a local maximum XIC apex within donor analyses.  Only a small time 
adjustment is required to find an XIC apex (A).  Comparing initial and adjusted 
precursor intensity indicate an improved apex detection for a subset of peptides (B).  
Precursor intensities are plotted against the observed feature intensity in the donor runs 
single-channel analyses. The expected correlation is observed between similar donor 
recipient intensities (C) which improve after XIC adjustment (D).  Note that the donor 
intensities are approximately twice the intensity (log10(2)=~0.3) of SILAC precursor 
intensities, which is expected due to SILAC signal division. 
 
 
 
4.3.6 Mass calibration of LCMS analyses 
During the development of HyperProphet, it became apparent that there was a 
discrepancy between precursor masses of transferred MS2 spectra and the observed 
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precursor in the preceding MS1 scan in recipient analyses. This inconsistency occurs 
because mass calibrations can vary between analyses, and the original precursor mass 
remains associated with the transferred MS2 spectrum (mzXML stores the precursor 
with the MS2 information).  This presents complications for quantification in 
HyperProphet analyses because peak areas are extracted using MS2 precursor masses 
from non-corresponding MS1 data.  Two potential remedies present themselves; to 
correct MS2 precursor values to the observed precursor in preceding MS1 spectra, or to 
fully recalibrate the LCMS analysis such that all mass values fall within a small mass 
error tolerance. 
 
A simple tool was implemented to correct MS2 precursor values to that of the 
observed MS1 value.  Although this tool was developed with the intent to be applied to 
HyperProphet generated mzXML files, it was in fact useful for native files which also 
contained precursor discrepancies.  This surprising observation occurred only in 
analyses acquired with a preview scan (refer to figure 1.11 for further explanation of 
preview scans).  Although preview scan data is not stored by Orbitrap control software, 
it was reasoned that the MS2 precursor values were derived from the low resolution 
preview scan and not from the high resolution MS1 scans. Data acquired without a 
preview scan were not affected by discrepancy between observed MS1 and reported 
MS2 precursor. The resulting poor mass accuracy affects both database search 
identification rates and quantitation accuracy.  Further investigation into LCMS file 
calibration error revealed that many analyses had very poor calibrations, even when a 
lockmass was used (an internal calibrant, typically a polysiloxane at 445.120025).  
Furthermore, using DMSO as an HPLC buffer modifier suppresses polysiloxane 
ionisation and does not provide a reliable alternative lock mass.  A simple correction for 
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MS2 precursor masses was found to be insufficient in these cases highlighting the need 
for visual inspection of data quality and full recalibration of LCMS data. 
 
Some calibration tools already exists part of other pipelines, such as mMass 
(Strohalm et al., 2010), OpenMS (Kohlbacher et al., 2007), MSinspect (May et al., 
2009), and MaxQuant (Cox and Mann, 2008), but none were deemed suitable due to 
insufficient control over calibration, incompatibility with mzXML file format, operating 
system platform dependence, or lacked tools for visual inspection of calibration status.  
As a result, the calibration software was developed into a stand-alone tool for re-
calibration of mzXML format LCMS. The tool is developed in Java, uses mzXML and 
pepXML input formats, and generates a calibrated mzXML output in addition to log 
files providing data on the calibration results.  Viewing calibration results is done 
graphically calling R scripts.  A general overview of important features are discussed 
here and full options and execution details can be found in Appendix C. 
 
The simplest calibration option is MS2 precursor correction.  As already discussed, 
this option looks for the correct MS2 precursor ions in the preceding MS1 scan and 
assigns this as the MS2 scan.  This option is essential for correcting precursor masses 
for HyperProphet-transferred MS2 spectra, and for improving precision for spectra 
triggered by low precision preview scans.  Although this option does not recalibrate m/z 
or time domains, it does increases the mass precision of a dataset and improves peptide 
identification rates.  An option to remove spectra without detectable precursors in the 
preceding MS1 is also available, which effectively removes non-quantifiable data that 
occurs within the low signal noise range. 
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A more advanced feature is the recalibration of m/z and time axes.  Deviations over 
time can be caused by temperature fluctuations and deviations over the m/z axis may 
also be observed due to detector manufacturing defects.  Also note that the use of a lock 
mass does not correct for m/z distortions.  This option imports peptide identifications 
from pepXML files, with filtering on probability and intensity thresholds.  Peptide mass 
errors are determined for identified peptides (theoretical minus observed mass).  
Alignments are determined for mass error over time and mass error over the m/z axis 
using a segmented linear aligner (multiple contiguous lines of best fit) and the data is 
adjusted to minimise the ppm error based on the alignments.  Although this iterative 
process requires an additional database search after calibration, it offers greater 
calibration precision and the ability to compare the data quality before and after 
recalibration.  Knowledge of the data precision allows informed decision on the mass 
tolerances to use for downstream quantitation. 
 
The most powerful calibration comes from single scan calibrations which 
independently calibrates each individual MS1 scan.  This option compensates for erratic 
fluctuations between scans that cannot be calibrated using a global fit.  As this requires 
a larger dataset to ensure each individual scan has sufficient data points, feature 
detection is usually required to extract data points across each identified 
chromatographic peak.  This calibration function also creates a segmented linear 
alignment, but over the m/z domain for each spectra.  In cases where there are 
insufficient data points, calibration reverts to global m/z-time calibrations.  This 
approach has the added advantage of effectively calibrating even when abrupt changes 
in calibration occur due to errors in lock mass calibration (Figure 4.10). 
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Figure 4.10 Examples of LCMS re-calibration 
(A) An example of input peptide data (m/z and elution time for peptides with 
probabilities >0.99) used for single scan calibration. B-E) An example of an LCMS 
analysis where the lock mass calibration has failed with catastrophic consequences for 
quantification.  PPM mass error over time can be observed at overview and zoomed 
ppm ranges (B,D).  The mean, standard deviation (stdev), and root mean square (RMS) 
errors are vastly reduced after calibration and can be visually inspected for 
improvement (C,E).  An improvement re-calibration can also be observed for analyses 
that are already well calibrated by acquisition-time lock mass calibration (F-I). Note that 
minimising RMS error, rather than just the standard deviation, is important for 
quantitative tools that use a symmetrical mass tolerance around the theoretical peptide 
mass. 
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4.3.7 HyperProphet: usage and interaction with TPP 
 
Details on the use of TPP can obtained from the website wiki 
(http://tools.proteomecenter.org/wiki) and publications (Pedrioli, 2010).  An overview 
with detail on steps that are critical for hyperProphet are discussed here, referring to 
Figure 4.6 for graphical overview.  Although the following individual steps appear 
numerous, they can be grouped into just a few commands by bash scripting and by 
using TPP’s xinteract command wrapper. 
 
The initial steps prior to HyperProphet execution include converting LCMS data to 
mzXML, optional mass recalibration, protein database search (with output to pepXML 
format), and label free feature detection using XPRESS.  HyperProphet is executed, 
taking as input an mzXML and pepXML for each analysis located in the current 
directory.  An example execution on a linux/Mac terminal might be: 
&
jHyperProphet&Ld&./&La&0.99&Lo&0.85&Ls&fileX,fileY&
&
 where ./ denotes the current directory (containing all input data), peptides are 
accepted above p=0.85, only high confidence peptides above p=0.99 are used 
chromatographic alignments, and output is requested for files X and Y (implying that 
the non-specified files are single channels and do not require output).  Full parameters 
options and descriptions can be found in Appendix D. 
 
Output files are named fileX_HP.mzXML, making this a partner file to the input 
fileX.mzXML.  Additional files are also output with information on the parameters used 
and a process report (info.txt), a table of all non-redundant peptides imported over the 
entire experiment (peptideTable.txt), pairwise LC alignments (align-fileX-fileY.txt), 
and a record of peak detection in each recipient file (targetXICs_fileX.txt).  These 
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additional files can be ignored during the analysis but allow the user to later interrogate 
the results for performance and accuracy. Further optional re-calibration of mzXML 
files can occur here to correct MS2 spectra precursors to those found in the MS1 scans - 
recalling that the transferred spectra did not originate from these MS1 spectra. 
 
The aim of the final pass through TPP (Figure 4.6, dashed arrows) is to merge each 
pair of mzXML files.  The new mzXML files are first re-searched against the protein 
database to produce pepXML files. Although these individual spectra have been 
searched before within other files, changes in precursor mass can have a subtle effects 
on the dataset.  Because the HyperProphet files contain a low number of high quality 
MS2 spectra, this search is very rapid. PeptideProphet is used to merge the pepXML 
datasets into a single analysis.  This merging process is a typical step for fractionated 
sample data, although in this case the two datasets are the original pepXML and the new 
HyperProphet derived pepXML.  The final steps are as for a typical TPP analysis, 
including SILAC quantitation with XPress, further statistical peptide validation with 
InterProphet (which provides better management of false positives), and protein 
inference and quantitation with ProteinProphet.  
 
 
4.3.8 Validation on SILAC samples of known protein ratios 
It is important to validate the performance of HyperProphet on samples of known 
composition before applying it to biological samples of unknown state.  To confirm that 
peptide ratios are preserved after transfer by HyperProphet, SILAC light and heavy 
yeast were cultured under identical conditions and mixed at approximately 1:1 ratio 
based on culture optical density.  A HyperProphet analysis was performed on two 
replicate LCMS analyses of the 1:1 SILAC sample, with unique peptide identifications 
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being transferred bi-directionally.  To assess the quantitative accuracy of this analysis, 
resulting peptide and protein quantitations were compared to the quantitative values 
derived from a TPP analysis without the use of HyperProphet (from the ‘first pass’ 
analysis represented in Figure 4.6).  Since it is not the task of HyperProphet to validate 
peptide identifications, analyses were done at a p-value corresponding to approximately 
0% FDR to remove the majority of false positive peptide identifications. Proteins were 
also filtered at approximately 0% FDR and single peptide hits were permitted. 
 
Figure 4.11 compares the SILAC ratios for peptides that are common to both 
replicates and peptide ratios for unique peptides that are transferred by HyperProphet.  
The ratio distributions of peptides are tightly clustered at 1:1 (0 in log2 space) and 
similar distributions are observed between HyperProphet and TPP quantifications.  
Although not all peptides are in agreement between replicates, outliers are observed for 
both TPP and HyperProphet analyses indicating that the majority of these errors occur 
as a result of replicate variation rather than incorrect peptide transfer.  Many peptides 
are observed towards extreme ratios (infinite ratios are represented at -/+10).  These 
outliers could be due to quantitative errors as a result of interfering signals or false 
positive identifications with incorrect arginine/lysine composition.  While it is outside 
the purpose of HyperProphet to correct for these errors, it is important to observe that 
these ratios are preserved between replicates, as indicated by the correlation at x=y. 
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Figure 4.11 HyperProphet preserves SILAC peptide ratios between replicates 
In a test case between two 1:1 SILAC tryptic yeast replicate analyses, peptide ratios 
are well conserved between replicates as indicated by SILAC ratios for peptides in 
common between replicates (A). When using HyperProphet to transfer unique peptides 
(B), the ratio of transferred peptides in their recipient analysis (y axis) correlate well to 
the original SILAC peptide ratio in the donor analysis (x axis). To account for data 
saturation at 1:1 in the scatter plots, histograms over the x and y axis are represented 
above and right of each scatter plot, respectively. 
 
 
 
To further assess the effect of HyperProphet, a 1:1 SILAC replicate dataset was 
analysed for protein ratios before and after receiving peptides from the second replicate.  
Figure 4.12 reveals a similar outcome, where ratios are preserved for the vast majority 
of proteins.  Most of the transferred peptides contributed to existing proteins rather than 
to new proteins, which is consistent with observations made for protein identifications 
in figure 4.1.  Some new proteins have been added though (Fig 4.12 D) and these 
proteins will be predominantly composed of HyperProphet transferred peptides since 
they were not present in the original TPP dataset. The majority of new proteins also 
clusters at the expected 1:1, although outliers appear more conspicuous due to the low 
count in this histogram.  The outlier at a ratio of +2 (labelled with * in Figure 4.12 D) 
gives some concern for the potential introduction of errors.  On inspection of this 
outlier, this protein (YPL225W) is composed of only two peptides; one peptide 
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(K.KIEDYNFGTLLR.T) giving an exact 1:1.00 ratio and the other 
(K.HGLNDWIVGQK.-) an anomalous 1:0.06.  However, the anomalous peptide also 
had an extreme ratio in the donor analysis (1:0.16) indicating that this peptide was likely 
to be a false positive and was not incorrectly quantified.  The propagating of such 
quantitative errors is in fact the correct behaviour to expect from HyperProphet because 
the HyperProphet module does not govern peptide validation or peptide quantitation.  It 
does however highlight a general concern for the quality of SILAC quantitative data, 
particularly for proteins with very low peptide coverage.  Additional control of 
quantitative outliers will be discussed further in the next section. 
 
 
 
Figure 4.12   HyperProphet preserves SILAC protein ratios between replicates 
In a test case comparing protein ratios before and after transferring peptides from a 
1:1 SILAC tryptic yeast replicate analyses, protein ratios are preserved well as indicated 
by (A) a scatter plot of protein ratios either including or not including (TPP analysis) 
HyperProphet derived peptide quantitations.  Note that only proteins in common can be 
plotted in this figure, therefore HyperProphet is contributing more peptides per protein 
and not new proteins.  To assess the impact of HyperProphet on additional proteins, the 
distribution of protein ratios are re-plotted for (B) TPP protein ratios and (C) 
HyperProphet protein ratios, and also for (D) unique proteins only observed as result of 
HyperProphet, and (E) all proteins as a result of HyperProphet. The outlier labelled * is 
referred to in the text. 
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A distinctive feature of the new sample workflow proposed in this chapter is the use 
of single channel samples to aid in SILAC quantitation.  Although a single channel 
sample may be derived from the same cell culture, its independent processing may 
result in variable tryptic digest efficiency and variable chromatography.  Single channel 
samples should be considered as similar samples rather than replicates and it would be 
prudent to independently validate peptide transfers from single channel to SILAC 
samples.  In the previous analysis between replicate SILAC data-sets, peptide ratios 
were compared between donor and recipient replicate analyses with scatter plots.  In 
this analysis however, donor runs lack SILAC ratios.  To observe the impact of 
HyperProphet on this experimental design, peptide ratios are plotted only as histograms 
to indicate the distribution of data (Figure 4.13).  Again, transferred peptides result in 
ratios tightly clustered on 1:1 and have a similar level of precision as natively quantified 
peptides.  At the protein level (Figure 4.14), an increase in the number of new proteins 
is observed, relative to transferring between SILAC analyses.  
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Figure 4.13 HyperProphet accurately transfers peptides from single channel 
analyses 
 Peptide ratio distributions for 1:1 SILAC tryptic yeast are clustered at 1:1 for (A) 
natively quantified peptides, (B) peptides transferred by HyperProphet from light and 
heavy single channel analyses, and (C) the combined set of peptides. 
 
 
Figure 4.14   HyperProphet enables increased SILAC protein ratio 
determination using single channel data 
In a test case comparing protein ratios before and after transferring peptides from a 
light and heavy single channel tryptic yeast replicate analyses, protein ratios are 
preserved well as indicated by (A) a scatter plot of protein ratios either including or not 
including HyperProphet derived peptide quantitations.  The distribution of protein ratios 
are plotted for (B) TPP protein ratios and (C) HyperProphet protein ratios (including 
native and HyperProphet transferred peptide), (D) unique proteins only observed as 
result of HyperProphet, and (E) all proteins combined. 
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Given a potential for errors in HyperProphet derived quantitation, it is possible that 
quantitation of noise could tend towards a 1:1 distribution by chance.  Although this is 
unlikely for high resolution instruments, to rule this out, analyses were repeated for 
SILAC samples mixed at approximately 2:1.  Repeat analyses of figures 4.11-4.14 are 
presented for 2:1 SILAC samples in Figures 4.15-4.18.  Results are equivalent for for 
2:1 analyses indicating that quantitation of native and HyperProphet transferred 
peptides offer a high degree of precision.  Total peptide numbers are slightly reduced in 
the 2:1 analysis compared to 1:1 data, although this is expected due to the reduced 
signal in the heavy channel.  Also note that the data was not normalised, thus the ratio is 
slightly greater than 2:1 reflecting a small error in sample mixing. 
 
 
 
Figure 4.15 HyperProphet preserves SILAC peptide ratios between replicates 
at 2:1 
In a test case between two 2:1 SILAC tryptic yeast replicate analyses, peptide ratios 
are well conserved between replicates as indicated by SILAC ratios for peptides in 
common between replicates (A). When using HyperProphet to transfer unique peptides 
(B), the ratio of transferred peptides in their recipient analysis (y axis) correlate well to 
the original SILAC peptide ratio in the donor analysis (x axis). 
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Figure 4.16 HyperProphet preserves SILAC protein ratios between replicates 
at 2:1 
In a test case comparing protein ratios before and after transferring peptides from a 
2:1 SILAC tryptic yeast replicate analyses, protein ratios are preserved well as indicated 
by (A) a scatter plot of protein ratios either including or not including HyperProphet 
derived peptide quantitations.  To assess the impact of HyperProphet on additional 
proteins, the distribution of protein ratios are re-plotted for (B) TPP protein ratios and 
(C) HyperProphet protein ratios, and also for (D) unique proteins only observed as 
result of HyperProphet, and (E) all proteins as a result of HyperProphet. 
 
 
Figure 4.17 HyperProphet accurately transfers peptides from single channel 
analyses 
 Peptide ratio distributions for 2:1 SILAC tryptic yeast are clustered at 2:1 for (A) 
natively quantified peptides, (B) peptides transferred by HyperProphet from light and 
heavy single channel analyses, and (C) the combined set of peptides. 
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Figure 4.18   HyperProphet enables increased SILAC protein ratio 
determination using single channel data 
In a test case comparing protein ratios before and after transferring peptides from a 
light and heavy single channel tryptic yeast replicate analyses, protein ratios are 
preserved well as indicated by (A) a scatter plot of protein ratios either including or not 
including HyperProphet derived peptide quantitations.  The distribution of protein ratios 
are plotted for (B) TPP protein ratios and (C) HyperProphet protein ratios (including 
native and HyperProphet transferred peptide), (D) unique proteins only observed as 
result of HyperProphet, and (E) all proteins combined. 
 
 
4.3.9 Managing false quantifications - SILAC label switch peptide 
filtering 
During validation of HyperProphet, quantitative outliers were observed that affected 
both HyperProphet and normal TPP datasets.  Extreme outliers may be false positive 
identifications with incorrect R/K compositions resulting in missing light or heavy 
SILAC partners.  Interfering signals may also occur if two co-eluting peptides (or their 
isotopes) occur within the quantitative mass tolerance, a case of greater significance for 
non-fractionated and SILAC labelled samples where the complexity remains high.  
Whether HyperProphet is being used or not, the problem of how to deal with 
quantitative errors is an area of concern. A common approach to deal with unreliable 
quantitation is to use SILAC label switching where one or more replicates in an 
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experiment have their SILAC labels reversed.  Subsequent analysis will require a pair of 
label switched replicates to have an inverse correlation between protein ratios (Butter et 
al., 2013), or more complex statistical analysis apply significance to a protein ratio over 
a set of label switched replicates (Ting et al., 2009).  A protein showing a large 
deviation over the replicates due to label switching indicates unreliable quantification 
and will likely be rejected as being a significantly changing protein.  This approach is 
similar to DNA microarray analyses, an academic field that has contributed to 
bioinformatics for proteomics (Gatto and Christoforou, 2014; Ting et al., 2009).  Unlike 
microarrays, proteomics determines protein ratios from the assembly of peptide ratios 
rather than by direct protein detection.  This fundamental difference allows us to 
approach SILAC label switching at the peptide level. 
 
The concept for the peptide filter was published by (Lo et al., 2013) who presented a 
simple filter for dimethyl labelled bacterial analysis.  In their approach, only two 
biological replicates were processed with opposite labelling orientation.  Relative 
differences in ratios for peptides in common between analyses were calculated and the 
dataset ranked in order of relative difference.  The most inconsistent ratios were 
discarded to preserve the peptides most conserved between label switched samples, 
resulting in an improvement of overall quantification results.  However, their approach 
lacked the ability to filter more than two replicates, and an arbitrary 1.50-fold difference 
was used as a cut-off for up and down regulation, therefore neglecting downstream 
statistics.  Also, an implementation was not supplied. 
 
A label switch peptide filter was implemented in R (co-developed with supervisor, 
Dr. Patrick Pedrioli) to determine a subset of quantitatively reliable peptides over a 
multi-replicate SILAC TPP/HyperProphet analysis.  Experimental design for the 
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peptide label switch is identical to the conventional protein level label switching, where 
SILAC replicates belong to one of two designs; sampleA(light)/sampleB(heavy) or 
label switched sampleB(light)/sampleA(heavy).  Inverting design 2 in silico corrects the 
label switch so that the biological ratio is consistently expressed as sampleA/sampleB 
across all replicates.  In a mathematically ideal scenario, each design will now correlate 
perfectly.  This expected correlation is represented in Figure 4.19A as the dashed line.  
In a realistic sample, analytical variation will cause a deviation from the expected 
correlation, thus a small level of tolerance should be permitted (shaded region in Figure 
4.19A).  Erroneous peptide ratios will not be conserved after label switching and will 
fall outside the tolerance threshold and can be discarded as being quantitatively 
uninformative.  For more advanced filtering, a non-linear tolerance is also permitted to 
account for greater variation with increasing ratios (Figure 4.19B), although a linear 
filter was used for research presented in this chapter.  It should be noted that while 
peptides with large interferences or extreme false positive ratios are removed, genuine 
biological variation that is upheld by the peptide label switch is still maintained.  It is 
inevitable that filtering peptides will result in a reduced proteome coverage, particularly 
due to the requirement for peptide ratios to be observed in each design.  In contrast, 
HyperProphet increases proteome coverage making HyperProphet and the SILAC label 
switch peptide filter an ideal partnership. 
 
A high-level description of the SILAC label switch peptide filter function follows:  
 
⁃ Take&as&input&
⁃ a&set&of&quantified&peptides&for&each&replicate&
⁃ a&design&matrix&(1&or&L1&for&each&replicate)&
⁃ A&quadratic&formula&describing&tolerance&
⁃ Median&normalise&each&set&of&peptide&ratios&
⁃ Divide&replicates&into&design&1&(A/B)&and&design&L1&(B/A)&
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⁃ For&each&design,&determine&set&of&peptide&ratio&groups&(all&peptides&
representing&the&same&ratio,&i.e.&a&light&and&heavy&peptide&can&
represent&the&same&ratio)&
⁃ Determine&mean&ratio&for&each&peptide&ratio&group,&inverting&ratio&for&
design&L1&&
⁃ Pair&corresponding&peptide&ratio&groups&between&designs,&discarding&
nonLpaired&peptides&(data&points&on&scatter&plot&in&figure&4.20A)&
⁃ For&each&data&point,&determine&length&of&orthogonal&projection&on&the&
expected&correlation&line&and&calculate&permitted&tolerance,&t&
⁃ Determine&perpendicular&distance,&d,&from&expected&correlation&line&
⁃ Delete&peptide&ratio&group&if&d&>&t&
⁃ Filter&original&input&data&such&that&peptides&belong&to&remaining&
peptide&ratio&groups&
⁃ Recalculate&protein&ratios&(geometric&mean)&using&remaining&
quantitatively&reliable&peptides 
 
 
 
 
 
Figure 4.19 Conceptual design of SILAC peptide label switch filtering. 
After inversion of SILAC label switched peptide ratios, accurate log2 ratios from 
each design are expected to correlate on x=y (dotted line).  A linear (A) or a polynomial 
(B) function can be applied to define a subset of peptides ratios within a tolerated range. 
The tolerance is a function of the orthogonal projection length on the expected fit line, 
and a point is tolerated if the perpendicular distance from the line is less than the 
tolerance. As all distances are positive, the user defined function is applied in the 
positive quadrant (black line) and is symmetric in all 4 quadrants. 
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To demonstrate the effectiveness of the filter, the filter was applied to 6 biological 
LCMS replicates of elp3∆ yeast (this data will also be used to exemplify HyperProphet 
in the next section).  Three replicates were acquired as elp3∆/wt and 3 further with label 
switching to wt/elp3∆.  All data was process through TPP without the use of 
HyperProphet.  Figure 4.20 provides a graphical overview of the filtering, and is the 
actual output generated when executing the filter.  Pre-filtered peptide ratio groups in 
Figure 4.20A show a dense cluster at 1:1 with a distinct trend at x=y over a range of 
approximately +/- 2-fold.  However, the greatest range of data points is actually at x=-y 
and extends to each extreme ratio from -10/10 and 10/-10.  These extreme ratios are no 
longer present after filtering (Figure 4.20B) and the maximal peptide ratios group means 
are now approximately +/-2 (4-fold in normal space). The impact the filter has on 
peptide ratio distribution for each replicate is displayed in Figure 4.20C-D.  The box 
plots show that the majority of the extreme data points have been removed by the filter. 
 
Many proteomic studies have an interest in the quantitation of individual peptides, 
particularly those investigating post-translational modification such as ubiquitylation 
and phosphorylation. In such cases, this filter can offer improved reliability of 
individual peptide ratios.  For proteomic studies focused on protein quantitation, 
multiple peptides per protein are typically required for quantitation.  To investigate the 
impact on protein ratio calculation, the mean and standard deviation was calculated for 
each protein using peptides assigned to it by TPP.  Surprisingly, the distribution of 
means is only slightly improved after filtering (Fig 4.21 A and B) suggesting that 
peptide errors are being averaged out for proteins with multiple peptide assignments.  
However, the standard deviations are drastically reduced (Figure 4.21C-D) despite the 
removal of peptide by the filtering process (note that reducing a sample size will 
increase a standard deviation).  Increased precision at the peptide level improves protein 
 190 
ratio reliability, which is of particular importance for proteins with only a few assigned 
peptides available for quantitation. 
 
&
Figure 4.20 Demonstration of SILAC label switch peptide filter 
The SILAC label switch filter (linear +/-0.5 tolerance) has been applied to 3 
biological replicates each of elp3∆/wt and wt/elp3∆ yeast. Log2-fold ratios for means of 
peptide ratio groups within design 1 (x-axis) and design -1 (y-axis) are displayed (A) 
before and (B) after filtering.  Distribution of peptide ratios for each replicated (C) 
before and (D) after applying filter demonstrates removal of many extreme outliers in 
peptide datasets. 
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Figure 4.21 SILAC label switch peptide filtering improves precision of protein 
ratios. 
Protein-centric peptide mean and standard deviations are presented for 6 replicates 
of elp3∆. The distribution of means before (A) and after (B) filtering is slightly 
improved.  Standard deviations before (C) and after (D) filtering indicate a striking 
improvement in protein ratio precision. 
 
 
The greatest impact of improved precision is observed during statistical analysis of 
protein ratios over replicates.  Consistent with previous observations for individual 
proteins, the distribution of means for protein ratios over 6 replicates is slightly reduced 
but has vastly improved standard deviations (Figure 4.22).  The importance of the 
reduced deviation becomes evident when considering the purpose of applying a t-test to 
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the SILAC data; to determine if the set of SILAC ratios are significantly different from 
1:1, based on their mean and standard deviations.  Furthermore, an improved population 
error can further impact a Bayes t-test, as is used in this chapter, because error estimates 
are adjusted towards a population estimate. 
 
 
Figure 4.22 SILAC label switch peptide filtering improves experiment-wide 
precision in protein ratios. 
Protein means (A) and standard deviations (B) over 6 replicates of elp3∆ are 
presented pre-filter (left) and post-filter (right). The distribution of protein means is 
slightly improved, whereas standard deviations show a striking improvement.  A 
relative change in standard deviation (B), where pre-filtered standard deviations are 
defined as 1, indicate that deviations have reduced for approximately 75% of the data. 
 
 
Figure 4.23 compares the result of a Bayes moderated t-test on the 6 replicates 
before and after SILAC label switch peptide filtering.  The reduced variation is evident 
in this graphical representation, particularly for non-significant proteins at low 
probability, and has resulted in increased number of significant protein changes with 
detection of smaller fold-changes.  Contrary to conventional protein level SILAC label 
switch filtering, which discards proteins with high variance, the peptide level filtering 
has enabled us to prevent needless rejection of proteins due to anomalous peptide 
quantifications.   
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Figure 4.23 The effect of SILAC label switch peptide filtering on a Bayes 
moderated t-test 
Data from 6 biological replicates of elp3∆ yeast were subjected to SILAC label 
switch peptide filtering and the resulting protein ratios were then subjected to a Bayes 
moderated t-test.  Volcano plots of log2 fold change against FDR-adjusted significance 
are presented for data (A) before and (B) after filtering peptides. The red line indicates a 
1% false discovery rate. 
 
 
4.3.10 Impact of experimental design on proteome coverage 
Various experimental designs have been investigated to assess the impact of using 
the combination of the SILAC label switch peptide filter, transferring peptide 
identifications with HyperProphet, and the use of single channel samples.  Six 
biological LCMS replicates of elp3∆/wt yeast were acquired, 3 replicates elp3∆/wt and 
3  label switched to wt/elp3∆  (as was used to exemplify the label switch filter in the 
previous section).  Two single channel samples were also sampled at the time of mixing 
SILAC samples, wt light (unlabelled) and wt heavy (fully labelled).  Four different 
experimental designs were composed: 
 
TPP6(no filter); 6 SILAC replicates, using a ‘typical’ TPP workflow without 
additional features. 
TPP6; 6 SILAC replicates, using label switch peptide filter (but not HyperProphet). 
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HP6; 6 SILAC replicates, using label switch peptide filter and HyperProphet. 
HP4+2; 4 SILAC replicates and 2 single channels, using label switch filter and 
HyperProphet. 
 
Note that each experimental design builds upon the previous starting with a TPP  
‘first pass’ dataset, and then the addition of peptide filtering, HyperProphet, and single 
channels, respectively.  The label switch peptide filter, where used, was applied with a 
linear +/-0.5 tolerance and HyperProphet was executed with identical parameters other 
than the altered choise of input input files.  Also note that the last experimental design 
maintains a total of 6 LCMS analyses for a fair comparison to another designs.  In 
addition to using a 1% FDR peptide and protein threshold, only quantified peptides 
were used, proteins were also required to have at least 2 quantified peptides, and 
proteins must be observed in at least 4 replicates.  On average, approximately 20% of 
identified proteins did not pass the filter, however, this rigorous filtering  permits 
comparisons to be made strictly from a quantitative perspective. 
 
Figure 4.24 presents peptides and proteins quantified for each experimental design.  
Label switch filtering peptides has an expected negative impact on proteome coverage 
due to discarding peptides.  The reduction in quantifiable peptides can be observed at 
the peptide level for both TPP and HyperProphet analyses (Figure 4.24A).  Likewise, a 
reduction in quantified proteins is observed, however, the loss of proteome coverage is 
more than compensated for by applying HyperProphet to the dataset (Figure 4.24B).  A 
further increase in proteome coverage is observed with the inclusion of single channel 
analyses.  Considering that the final experimental design replaces SILAC samples with 
single channel samples, rather than additional analyses, this boost in proteome coverage 
is clearly a consequence of the supplemental proteome coverage offered by single 
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channel samples.  The use of HyperProphet and single channels has boosted the 
proteome coverage from 1559 to 2112 quantified proteins, which represent a 35% gain. 
 
   
 
Figure 4.24 HyperProphet and the use of single channel analyses increase 
peptide and protein coverage 
(A) Total peptides quantified before (light bars) and after (dark bars) label switch 
peptide filtering demonstrate the advantage HyperProphet has over just TPP when 
transferring peptides from SILAC and single channel analyses.  An similar advantage is 
demonstrated for quantified proteins (B).  Note particularly that HyperProphet analyses 
exceed the proteome coverage of a traditional TPP analysis even after filtering out 
quantitative outliers.  
 
 
4.3.11 Impact of experimental design on statistical significance 
 
While maximising proteome coverage is important for discovery proteomics, the 
power of a statistical analysis is also an important consideration.  Statistical power is the 
ability to detect significant protein changes of a given magnitude, and is function of 
sample size and measurement precision (Levin, 2011).  It follows that increasing 
sampling precision or size will increase the confidence in true protein changes (i.e. 
smaller p-value) or enable detection of smaller changes in the proteome.  Improvement 
of precision has already been demonstrated using the SILAC label switch peptide filter.  
The number of replicates in which a protein has been observed can also increase 
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statistical power.  To this effect, not only does HyperProphet increase proteome 
coverage, but it also reduces null values across replicates. The incidence of 6 out of 6 
observations increased from 88% to 95% between TPP and HyperProphet. This effect 
would also have a positive impact for analyses where null values are particularly 
undesirable, such as time course proteomics. 
 
For a numerical assessment of statistics analysis over replicates, a Bayes moderated 
t-test was conducted for each experimental design.  The resulting total number of 
proteins significantly changing in each test is compared in Figure 4.25A.  Results are 
presented for both 1% FDR and 5% FDR as these are two thresholds commonly used in 
the literature.  The label switch peptide filter increases the number of significantly 
changing proteins considerably in a TPP analysis despite a slight reduction in protein 
coverage (data reproduced from Figure 4.23).  By applying HyperProphet, the detected 
number of proteins changing increase further and proportionately with the increase in 
quantified proteins.  The combination of HyperProphet and label filter have almost 
doubled the number of high confidence 1% FDR changing proteins.  In contrast, the 
experimental design including single channel samples results in a drop in detected 
protein changes despite improving proteome coverage.  This is an intuitive result when 
considering that the number of quantifiable replicates has reduced from six to four.  In 
addition to a drop in quantitative sensitivity, there is also a noticeable difference 
between 1% FDR and 5% FDR.  This is also a consequence of the reduced sample size 
and can be observed in Figure 4.25 B-C as a compression in the higher probability set of 
proteins.  The benefit of this new workflow becomes even more apparent when 
comparing the last experimental design to a typical TPP workflow without 
HyperProphet or the label switch filter.  Even with only four quantifiable replicates, 
there are more significantly changing proteins detected than with 6 replicates without 
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using these tools.  The ability to maintain or increase quantitative sensitivity while 
reducing replicates offers an advantage to studies where sample preparation procedures 
are difficult or expensive. 
 
On designing an experiment, it is clearly advantageous to acquire as many 
quantifiable replicates as is practical to maximise statistical power.  The inclusion of 
single channel samples clearly gives an advantage in proteome coverages.  However, 
these results demonstrate the importance that single channel analyses do not replace 
quantifiable SILAC analyses to avoid loss of statistical power.   
 
Figure 4.25 Impact of experimental design on statistical power 
Total proteins detected as significantly changing at 1% and 5% FDR in a Bayes 
moderated t-test with p-value correction (A) indicate that each design has a large impact 
on the statistical test’s proteome depth.  The impact of replacing SILAC analysis with 
single channels is displayed as volcano plots for HyperProphet analyses of 6 SILAC 
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replicates (B) and 4 SILAC replicates with 2 single channel analyses (C). Proteins 
above the red line are significantly changing at 1% FDR. 
 
4.3.12 Codon bias analysis of elp3∆ 
Deletion of ELP3 results in hypo-modification of tRNAs and reduced translation 
efficiency, therefore a widespread effect on the proteome is expected.  However, the 
volcano plots in Figure 4.25 indicate that there are very few proteins with large 
expression changes and the effect of ELP3 deletion on the proteome is subtle.  As a 
result, we require a sensitive analysis to penetrate as deep into the proteome as possible 
to detect small protein changes.  The HyperProphet analysis using 6 SILAC replicates 
with a 1% FDR threshold was selected for further analysis due to its strongest statistical 
power. 
 
A random forest analysis of gene codon composition was conducted to classify 
proteins as up or down regulated.  Figure 4.26 displays the ranking of each codon, with 
AAA, CAA, AGA, GAA, and AAG being identified as the most important in predicting 
significant changes in protein abundance.  To control for codon bias analysis 
reproducibility, the analysis was repeated 10 times with 10 random seeds (Figure 
4.27A).  The variable importance axis is unit-less and should not necessarily be 
comparable between analyses, thus standard deviations will potentially overestimate 
variability between random forest results.  However, results were found to be highly 
reproducible, with the top six codons remaining in the same order.  Overlapping error 
bars indicate that the exact order of lower ranking codons should not be given too much 
weight.  A repeat analysis using randomised data (Figure 4.27B) failed to reproduce the 
findings.  A few codons were reported above the significance line suggesting a small 
amount of over-fitting can occur, so only codons reported well above the significance 
line should be considered as biologically relevant.  The replicate and randomised 
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controls give support the codon bias results as robust, and also supports the proteomics 
data quality, which is a valuable validation since we are discussing small fold-changes. 
 
  
Figure 4.26 Codon bias analysis of the top 1% FDR proteins changing in 
elp3∆/wt yeast. 
A random forest algorithm determines the gene frequency of AAA, CAA, AGA, 
GAA and AAG to be most important for predicting the up or down expression of 
proteins in elp3∆. 
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Figure 4.27 Replicate and randomised analyses give confidence to elp3∆ codon 
bias analysis. 
(A) Codon bias analyses (as figure 4.26) mean and standard deviations over 10 
repeat analyses using 10 random seeds selected between 10-99. (B) A repeat analysis 
where up or down regulation has been randomised over the same set of proteins in A. 
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4.3.13 elp3∆ codon bias overlaps with urm1∆ 
It is a notable observation that the most biased codons include AAA, CAA and 
GAA, which are the three codons recognised by the doubly modified mcm5S2U tRNAs.  
In a similar codon analysis of urm1∆, the sulphur carrier responsible for thiolating 
tRNA wobble uridines for tRNA-K(UUU), tRNA-Q(UUG), and tRNA-E(UUC), strong 
codon biases were reported for AAA, CAA, AAG, GGG, GAA  (Rezgui et al., 2013).  
A direct comparison to this analysis reveals that, in addition to the three thiolated tRNA 
cognate codons, AAG is also in common.  This overlap suggests that the primary effect 
of deleting ELP3 is strongly related to its involvement in the co-modification of uridines 
with the URM1 pathway.  Observing some overlap is unsurprising given that aberrations 
in these two pathways have similar phenotypes, and there is in-vitro and in-vivo 
evidence that both URM1 and ELP3 are required for efficient translation (Rezgui et al., 
2013). 
 
The AAG codon bias is also of interest as this was also observed in the urm1∆ 
analysis.  AAG, which encodes for lysine, differs from the AAA lysine codon only at 
the wobble position and AAA was the most biased codon.  This suggests that AAG is 
likely to be involved with the modification state of the mcm5S2U modified tRNAs, 
despite the fact that the tRNA recognising AAG is not modified at the wobble position.  
It is unclear why this codon would present a bias under these conditions.  Murphy et al. 
(2004) reports that tRNA-lys(UUU), which binds its cognate codon AAA, can also bind 
its near-cognate AAG codon but only if modified.  The codon bias could be explained 
by the tRNA wobble from AAA to AAG codons being an important mechanism for 
efficient translation of lysine coded by AAG.  An alternative hypothesis could be that 
wobble can occur without modification, contradicting Murphy et al. (2004), but with 
reduced efficiency.  Poor binding to AAG could therefore cause a translational defect 
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for genes rich in this codon.  Over-expression of the unmodified tRNA-lys(UUU) can 
compensate for the lack of modification and ameliorate symptoms of elp3Δ (Esberg et 
al., 2006), despite lacking the modification that aids recognition of the near-cognate 
codon.  It would be interesting to see if the AAG bias remains with over expression of 
tRNA-lys(UUU). 
 
As the elp3Δ codon bias was revealed to have a striking similarity to urm1Δ, it is 
worth considering the cause of the shared phenotypes.  It is clear that both URM1 and 
ELP3 are required to form the doubly modified mcm5s2U (Huang et al., 2008), and the 
presence of at least one modification appears to be essential as double mutants are lethal 
(Costanzo et al., 2010).  The similarities between elp3∆ and urm1∆ phenotypes could 
occur because both tRNA modifications are equally required and removal of either 
mcm5 or s2 impairs translation efficiency.  However, the relationship between these 
modifications is complicated by the fact that disruption of the Elp-complex also results 
in reduced thiolation (Leidel et al., 2009).   
 
 
4.3.14 elp3∆ specific codon bias response 
Of the eleven tRNAs that receive ELP-dependent modifications, eight are 
independent from the doubly modified mcm5S2U tRNAs.  AGA is also ranked highly 
in the codon bias analysis, which is modified by mcm5U and is the most heavily used of 
the 6 arginine codons (Iben and Maraia, 2012).  This codon was not reported in the 
urm1Δ codon bias analysis suggesting that this is a result specifically due to the absence 
of mcm5 modification on tRNA-Arg (UCU).  This observation is aligned well with 
reports of TRM9 deficient cells, which are unable to methylate cm5U to mcm5U, and 
have impaired translation of AGA codons (Begley et al., 2007).  This would suggest 
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that it is specifically the methyl modification that is required but either the loss of 
methylation or complete loss of the modification has a similar effect for this codon.  
There have also been reports that the UCU codon can be thiolated in the bovine liver 
(Keith, 1984).  It could be that tRNA-Arg (UCU), like the mcm5S2U modified tRNAs, 
has a larger dependence on modifications than most tRNAs for efficient translation and 
higher eukaryotes have a developed additional mechanisms to modulate translational 
efficiency. 
 
Given that the yeast strain being used is arginine auxotroph, this yeast strain may be 
very sensitive to arginine availability.  An alternative explanation for the AGA codon 
bias could be a reduced intracellular arginine availability which in turn is limiting 
availability of charged arginine tRNAs.  This would be manifested by an AGA bias, as 
this is one of six arginine codons but represent almost 50% of the arginine codon usage 
(Iben and Maraia, 2012).  Although this appears to be an ELP specific effect, there is no 
evidence to suggest whether this is a direct effect of the tRNA modification or an 
indirect transcriptional effect altering arginine availability.  It would be prudent to 
validate this in an arginine prototroph, which can still be done via SILAC proteomics 
but using only lysine and lysC-endopeptidase. 
 
The remaining codons corresponding to ELP-modified tRNAs did not show a 
noticeable bias over other non-modified codons.  ELP-dependent tRNA modifications 
therefore have negligible impact on translation compared to the dominant codons 
already discussed.  This does not rule out the existence of a translational defect for other 
codons.  It is likely that, if a bias exists for other codons, they were not clearly 
distinguishable by the method used due to a dominant effect from the codons normally 
recognised by mcm5S2U-tRNAs.  To uncover other potential subtle effects on the 
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proteome, it would be necessary to isolate the effect of ELP-mediated modifications 
from effects of the three doubly modified mcm5s2 tRNAs.  This might be achievable by 
over expression of tRNA-K(UUU), tRNA-Q(UUG), and tRNA-E(UUC), which has 
been shown to suppress phenotypes of both elp3Δ and urm1Δ.  A direct comparison 
between elp3Δ and urm1Δ would be the most straight forward approach to remove the 
common codon bias effects.  As previously discussed, a elp3Δ/urm1Δ SILAC 
comparison would be a poor way to differentiate between the mcm5 and s2 
modifications on doubly modified tRNAs due to the interdependence of the 
modification pathways.  It would however provide an opportunity to study ELP-specific 
effects, including codon biases associated with ELP-dependent modifications on non-
thiolated tRNAs. 
 
 
4.3.15 elp3∆ proteome analysis and comparison to urm1∆ 
The quantitative proteome analysis revealed 398 up regulated proteins and 398 
down regulated proteins at 1% FDR.  Very few proteins were observed to change at any 
considerable amount though.  Only 20 proteins were found to be changing by more than 
2-fold.  A gene ontology enrichment (GO) analysis was conducted on the 1% FDR up 
and down regulated proteins using FunSpec (Robinson et al., 2002).  Down regulated 
proteins were enriched for anabolic processes such as translation and glycolysis.  Up 
regulated processes were enriched for catabolic processes such as proteasomal 
degradation, and also amino acid biosynthesis (the full list of proteins and GO results 
are in Appendix E).  The most significant functional and biological processes are in 
common with the urm1Δ GO analysis publish by Rezgui et al. (2013) indicating that 
both elp3Δ and urm1Δ have very similar effects on the proteome.  Furthermore, of the 
six proteins confirmed to be down regulated in urm1Δ cells by western blotting, five of 
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them were also found to be down regulated in elp3Δ (CMS1, YPL199C, FPR4, DEF1, 
BFR1).  The sixth, mcm1, was not quantified in this study. 
 
 It is tempting to speculate upon the biological significance of the protein changing 
in the elp3Δ/wt analysis.  However, given that elp3Δ/wt and urm1Δ/wt proteome 
analyses were found to be highly similar in both the codon bias and GO analyses, it 
follows that the majority of the significant proteome changes are in fact a result of 
codon bias due the convergence of each pathway on the same set of tRNAs.  In a direct 
comparison of  elp3Δ/urm1Δ SILAC by Rezgui and colleagues, proteomes were found 
to be very similar and only 12 proteins were significantly changing.  To determine if 
this observation is supported by this study, elp3Δ/wt was compared to the urm1Δ/wt 
data extracted from Rezgui et al. (2013).  Figure 4.28 displays a scatter plot of proteins 
in common between each analysis.  The correlation is surprisingly strong (R2 = 0.51) 
given that they are of different mutants, the datasets were collected by different means 
(fractionation versus non-fractionated), and the analysis workflow differed 
substantially.  The vast majority of proteins significantly changing are also changing in 
the same direction in the other mutant, indicating that ELP3 and URM1 have very 
similar overall effects on protein expression.    
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Figure 4.28 Comparison of elp3Δ/wt and urm1Δ/wt proteomes 
A scatter plot of protein log2 fold change for proteins in common between datasets 
from elp3Δ (this study) and urm1Δ (Rezgui).  Differences >1.5 fold between datasets 
are in bold and are listed in table 4.1. 
 
There are however obvious differences outside the main cluster of conserved 
proteins.  To identify obvious differences between datasets, an arbitrary cut-off of 1.5-
fold was applied.  To minimise false positive discoveries between datasets, additional 
filtering was applied such that all proteins compared were significantly changing in at 
least one of the studies (resulting proteins are listed in Table 4.2).  REP2, YGP, ADE17 
were found as outliers in this analysis and in the published elp3Δ/urm1Δ analysis.  The 
URM1 deletion was also observed, whereas the expected ELP3 deletion was not 
observed because elp3 was not quantified in this study.  Rtc3, Sds24, Hxk1, Shm2, 
Asn1, and Ald5 were observed in this study, but in contrast to Rezgui et al. (2013), did 
not differ between datasets.  Many of the protein changes are still directionally 
consistent between mutants.  Filtering these proteins to those that change in the opposite 
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direction, representing potentially biologically interesting differences between ELP and 
URM1, reveals only 16 proteins which do not result in any significant GO categories. 
 
It should be cautioned that this comparison between elp3Δ/wt and urm1Δ/wt 
datasets is not a robust analysis as it lacks adequate statistics.  Furthermore, a similar 
number of outliers could be explained as false positives due to the FDR thresholds used 
during the Bayes moderated t-test.  We can however conclude, in agreement with 
Rezgui et al. (2013), that the URM1 and ELP pathways control an overlapping set of 
target proteins, and that the proteome difference between urm1Δ and elp3Δ cells is 
likely to be less than either mutant against wt. 
 
The fact that there are differences between urm1Δ and elp3Δ suggests that there are 
ELP specific functions to investigate.  The differences may related to many aspects of 
the complex phenotype: to mcm5 modification on mcm5S2U tRNAs, mcm5S2U 
independent mcm5 and ncm5 modifications, or to functions not related to tRNA 
modifications.  Given the strong relationship between urm1Δ and elp3Δ due to co-
modification of mcm5S2U, a direct analysis of elp3Δ/urm1Δ is necessary to determine 
if additional ELP specific codon biases or other effects exist.  Given the small number 
of significant protein changes observed in elp3Δ/urm1Δ to date, a more in depth and 
statistically robust analysis is required to gather sufficient proteome coverage for a 
codon bias analysis, which is a future research project that will benefit from the research 
presented here. 
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Systematic 
Name 
Standard 
Name 
logFC 
elp3Δ/wt 
logFC 
urm1Δ/wt 
Calculated 
elp3Δ/urm1Δ 
R0040C REP2 -1.43 0.05 -1.47 
YGR286C BIO2 -0.51 0.80 -1.31 
YNL251C NRD1 -0.94 0.02 -0.96 
YMR120C ADE17 -0.77 0.15 -0.92 
YKL006C-A SFT1 -0.17 0.68 -0.84 
YMR275C BUL1 -0.64 0.19 -0.84 
YBR092C PHO3 -0.61 0.16 -0.78 
YER063W THO1 -0.36 0.35 -0.71 
YDR116C MRPL1 -0.23 0.47 -0.70 
YNL160W YGP1 -2.33 -1.65 -0.68 
YIL015W BAR1 -0.70 -0.07 -0.63 
YDR258C HSP78 0.92 0.31 0.61 
YER152C YER152C 0.75 0.13 0.62 
YJL191W RPS14B 0.79 0.16 0.64 
YJL052W TDH1 -0.73 -1.40 0.67 
YNL036W NCE103 0.51 -0.16 0.67 
YOR367W SCP1 0.54 -0.13 0.67 
YMR305C SCW10 0.85 0.13 0.72 
YOL058W ARG1 0.36 -0.36 0.72 
YJR109C CPA2 1.39 0.59 0.80 
YOL140W ARG8 0.23 -0.58 0.81 
YGL117W YGL117W 1.11 0.25 0.86 
YKL120W OAC1 -0.50 -1.38 0.88 
YGL028C SCW11 1.02 0.12 0.89 
YLR286C CTS1 1.21 0.21 1.00 
YHR137W ARO9 2.05 0.92 1.13 
YPR097W YPR097W 0.22 -1.09 1.31 
YDR380W ARO10 1.92 0.60 1.33 
YKR042W UTH1 1.26 -0.11 1.38 
YOL154W ZPS1 -0.46 -2.04 1.59 
YJL153C INO1 -0.44 -3.25 2.81 
YKL166C TPK3 0.07 -3.52 3.59 
YIL008W URM1 0.46 -3.85 4.31 
 
Table 4.2 List of top 4% most changing proteins between urm1Δ and elp3Δ. 
Proteins listed are from Figure 4.28 (bold dots) sorted by calculated elp3Δ/urm1Δ 
log2 fold change.  elp3Δ or urm1Δ ratios are in bold if they were found to be 
significantly changing in their respective studies.  
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Chapter V 
General Discussion 
 
5.1 SoMBIE 
The SoMBIE methodology has been successfully developed for enriching 
isopeptides to enhance identification by mass spectrometry.  The MIRO1 ubiquitylation 
example demonstrated the methods effectiveness and that even relatively simple in vitro 
reactions can significantly benefit from isopeptide enrichment.  This method also offers 
the ability to enrich NEDD8 and ISG15 isopeptides, as well as N-terminal diglycine 
modifications.  The method did display its limitations though.  Due to the reactivity 
towards mono-glycine, the method is not applicable to highly complex samples.  The 
niche for this method is therefore improving isopeptide sensitivity in samples of low 
complexity, such as in vitro reactions or immunoprecipitations of ubiquitylated 
substrate proteins or complexes. 
 
While this may seem limiting compared to the in-depth analysis of ubiquitin 
isopeptides afforded by the diglycyl-lysine reactive antibodies (Kim et al., 2011; Xu et 
al., 2010), these analyses also have their limitations.  Of the many isopeptides 
identified, it is still not clear which E3 ligases are responsible for mediating the 
conjugation.  To further understand the complex network between E2, E3, and substrate 
specificities, more controlled experiments are required, such as an in vitro screening 
platform. 
 
In previous in vitro screens, such as the E3 Rsp5p screen against a panel of 
expressed yeast proteins (Kus et al., 2005), substrate ubiquitylation was detected at the 
protein level.  The coupling of mass spectrometry to an in vitro screen could offer an 
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increased screen specificity down to lysine reactivity.  In conjunction with some degree 
of multiplexing, or use of rapid MS techniques like MALDI-TOF/TOF, future screening 
platforms incorporating SoMBIE could help elucidate mechanisms of specificity in the 
ubiquitin system. 
 
5.2 ICID 
A novel methodology has been presented for the analysis of UBL isopeptides with 
long remnants.  An implementation has been demonstrated with isotopically heavy 
SUMO2 for in vitro SUMOylation of a well know substrate, Ran GTPase-activating 
protein 1 (RanGAP1), and a potentially novel substrate, RNA guanine-7 
methyltransferase (RNMT).  The synthesis of isotope labelled SUMO, mass 
spectrometry data acquisition, and bioinformatic analysis has been demonstrated to be 
relatively straightforward and can be achieved without the extensive MS or 
bioinformatic expertise formally required for analysis of complex UBL isopeptides.  
Although the method was only demonstrated for SUMO, it can be adapted for 
application to the whole family of ubiquitin like protein modifiers and is of benefit to 
the wider scientific community investigating UBL protein modifications. 
 
The ICID method can also be used for diglycine remnant UBLs (ubiquitin, NEDD8, 
and ISG15) to aid identification of elusive ubiquitin isopeptides.  In this case, ICID and 
SoMBIE are not exclusive technologies.  Isotope coded in vitro ubiquitylation could be 
followed by enrichment of isopeptides for optimal detection and identification.  
 
A variation of the method was also presented that holds promise for the application 
of the same concepts for MS2-independent isopeptide identification to in vivo samples. 
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5.3 HyperProphet 
Presented was a new workflow and software for efficient and accurate quantitative 
SILAC analyses in unfractionated proteomes.  The biological example, elp3Δ yeast, 
demonstrated we can dig deeper into a proteome while avoiding the much overused ‘2-
fold significance threshold’.  The new application, HyperProphet, offers a relatively 
simple integration into TPP and requires minimal expertise to operate.  The final user 
experience is essentially identical to a typical TPP analysis and does not require 
mastering of additional software environments.   
 
A key aspect for improving functionality and robustness of future versions of 
HyperProphet is improvement in feature detection.  This could be achieved by 
validating the isotopic cluster during XIC time adjustments or shifting to third party 
feature detection algorithms such as SuperHirn (Mueller et al., 2007) or Hardklör 
(Hoopmann et al., 2007).  A current assumption about experimental designs is that a 
transfer occurs only between highly similar proteomes.  As analyses become less 
similar, the potential for false positive peptide identification transfer will likely increase.  
A more discerning feature detection will permit co-analyses across samples from 
different experiments, such as unrelated biological conditions or a composite master-
map, with reduced errors.  A more stringent feature detection will also allow for transfer 
of peptide identifications between fractionated samples. While future proteomics 
technologies will likely make the unfractionated proteome the experimental design of 
choice, until technologies are sufficiently advanced, some degree of fractionation of 
highly complex mammalian proteomes will still assist analyses requiring very high 
proteome coverage. 
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Another resource for managing peptide identification events across DDA acquisition 
analyses was very recently published (Bateman et al., 2014).  In this approach, MS1 
extracted ion chromatograms were directly extracted from unidentified features based 
on chromatographic time alignment to additional sample analyses.  Functionalities for 
their approach will be integrated into a future release of Skyline (MacLean et al., 2010).  
The recent developments by Bateman and coworkers, the “match between runs” feature 
in MaxQuant, and Hyperprophet are very different implementations of a similar 
concept.  This is indicative of the proteomics community moving towards a more 
effective use of DDA LCMS information distributed over an experiment.  The research 
presented here not only offers a unique implementation of this concept, but also extends 
the application by demonstrating that the combination of single channels and SILAC 
datasets can have a positive impact on the quantitative proteome coverage. 
 
A recent development in neutron encoding for SILAC labelling utilises very high 
resolution MS instrumentation to measure the 6 mDa difference in mass deficits 
between 13C and 15N isotopes (Hebert et al., 2013).  In this ‘NeuCode’ approach, a 
moderate resolution scan permits identification of unresolved isotope precursor features, 
whereas a very high resolution scan allows for quantitation of resolved stable mono-
isotopes.  This is an elegant solution to dealing with the proteome complexity 
challenges being addressed by HyperProphet.  The NeuCode isotope labelling approach 
is an example of a new technology that will likely become mainstream as very high 
resolution MS instrumentation become common place.  Importantly, while 
developments like NeuCode and HyperProphet are both dealing with proteome 
complexity in very different ways, they are not exclusive technologies.  I foresee that 
combinations of technologies - isotope coding reagents, proteome ‘master maps’, 
targeted proteomics, novel sample acquisition techniques, coupled with rapidly 
 213 
advancing MS hardware - will bring us one step closer to the single-shot complete 
proteome.  The near future will bring us within a stones throw of proteome platforms 
akin to the high throughput DNA sequencing platforms that evolved decades before us, 
and with it will come more ambitious experiments to explore the complexities of 
biological systems. 
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Appendix A: 
Miro1 isopeptides 
 
Evidence for additional Miro1 K153 and K406 isopepetides.  K572 is presented in 
the main text of chapter 2. 
 
 
Extracted ion chromatograms are indicated (*, or ? for uncertain or absent signal) 
for Miro1 K153 isopeptides NLK(GG)NISELFYYAQK (922.98m/z,!2+)!and 
NLK(GG)NISELFYYAQKAVLHPTGPLYCPEEK (884.95,!4+) before and after 
isopeptide     
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MS2 spectral support for identification of K153 isopeptides 
NLK(GG)NISELFYYAQK (922.98m/z,!2+)!and 
NLK(GG)NISELFYYAQKAVLHPTGPLYCPEEK (884.95,!4+) 
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Extracted ion chromatograms are indicated (*, or ? for uncertain or absent signal) 
for Miro1 K406 isopeptides DKK(GG)IDLQK (551.32m/z,!2+)!before and after 
enrichment with MS2 spectral support. 
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Appendix B: 
ICID use details 
 
&
Execution&on&mac/linux&terminal:&
&
cd&/usr/bin/java/VKJLib/bin&
java&LXmx1024m&Lclasspath&.:joptLsimpleL4.3.jar:jrap_StAX_v5.2.jar&
PeakPicker.PeakPicker&Lp&paramfile&Lm&mzXMLfile&Lf&fastaDBfile&>ouput.txt&
&
&
&
&
Parameter&file&template,&with&comments&(currently&set&for&tryptic&SUMO2):&
——————————————————————————————
————————— 
#the&isotopic&difference&between&label(s).&Must&be&a&space&delimited&list&of&masses&
if&more&than&one&label&expected.&
#Examples:&
#mTRAQ&4.0070994&8.0141988&16.0283976&
#N15sumo2/3&=&37.88733&tryp,&5.98220982&for&chymo&QQQTGG&
#heavyLPhe:&13C=+1.00335483,&13C6=6.020129,&2*13C6F=12.040258,&3*13C6=18.060387&
#& due&to&missed&cleavage&you&will&need&to&do&both&12.040258&and&18.060387&
#heavyLTyr:&13C9&=&9.03019347&
deltaMasses&=&12.040258&18.060387&
&
#the&modifying&mass(es)&of&the&light&isotope&label(s).&&Must&be&one&for&each&
deltaMasses&entry&above.&
#Must&be&a&space&delimited&list&of&masses.&
#t_SUMO2/3&(FR)FDGQPINETDTPAQLEMEDEDTIDVFQQQTGG&3549.53652,&3565.531435&Mox,&
3852.70604&1mc,&3868.70094&Mox+1mc&
#Only&need&one&per&isotope&label&though&(ie&Mox&does&not&change&labelling)&
#eg&140.094963&for&mTRAQ&&
#599.266339&for&chymo_SUMO2/3&CLterm&pep&
#0&for&silac&
#STLHLVLRLRGG&=&1302.78841,&ESTLHLVLRLRGG&=&1431.83100&
labelMasses&=&3549.53652&3852.70604&
&
&
#########&parameters&for&detecting&isotope&coded&feature&pairs&
#&interLspectrum&mass&error&L&used&between&spectra&while&finding&features&(ideally&
~2*instrument&error.&The&mass&difference&between&peaks&could&be:&m/z+err&L&m/zLerr&=&
2*err)&
ppmError&=&10.0&
&
#&intraLspectrum&ppm&error&to&use&during&isotope&pair&matching&(inLspectrum&will&have&
a&higher&mass&accuracy&than&between&spectra)&
ppmErrorDeltaMass&=&2.0&&
&
#&ppm&error&used&when&comparing&masses&within&isotope&clusters&(ie&compare&
monoisotope&and&second&isotope&within&the&same&spectrum)&
ppmErrorIsotopes&=&2.0&
&
#&feature&apex&must&be&above&this&threshold&
intensityCutoff&=&10000&
&
#min&and&max&charge&states&to&consider& &
minZ&=&3&
maxZ&=&9&
&
#chromatographic&time&deviation&to&consider.&Units&=&mins.metric&(ie&0.05=3seconds),&
the&time&permitted&between&apices&to&be&considered&as&a&coLeluting&isotope&pair&
maxTimeDeviation&=&0.05&
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&
#&these&values&are&log2(L/H)&(eg&L1&L>&1&is&a&2Lfold&tolerance)&L&permits&nonL
symmetric&ratios&if&labels&were&not&mixed&at&50:50&
featureRatioMinLog2&=&L1&
featureRatioMaxLog2&=&1&
&
#&true&permits&feature&recognition&from&only&2&peaks,&otherwise&3&or&more&points&are&
required&for&an&apex&(only&use&true&if&you&want&to&really&dig&into&the&noise).&
permitDoubletFeature&=&false&
& &
#&if&true,&small&interference&surrounding&a&major&peak&are&removed.&&Done&at&the&peak&
picking&stage&(before&finding&feature&pairs.&Satellite&params&only&take&effect&if&&
#&will&look&+/LppmSatellites&for&a&much&larger&peak&(the&real&peak)&and&remove&this&
peak&if&less&than&percentSatellites&relative&to&the&major/real&peak&
removeSatellitePeaks&is&true.&
removeSatellitePeaks&=&true&
ppmSatellites&=&80&
percentSatellites&=&2.5&&
&
############&params&for&filtering&noise&out&of&the&featureLpair&list&
#&Removes&isotope&feature&pairs&where&another&isotope&feature&pair&exists&at&the&
expected&lower&isotope&mass&(only&checks&within&feature&set)&
#&what&does&this&first&param&do?&
deisotopeFeatureSet&=&false&
#&remove&isotope&features&where&the&low&feature&is&clearly&not&the&monoisotopic&peak&
deisotopeLowMass&=&true&
#&remove&isotope&features&where&the&high&feature&is&clearly&not&the&monoisotopic&peak&
(should&not&do&if&impure&N15/silac)&
deisotopeHighMass&=&false&
#&mins&from&the&peak&apex&at&which&a&lower&intensity&isotope&pair&will&be&removed&
(only&keep&the&most&intense&feature&pair)&
chromatographicPeakTolerance&=&1.5&
&
&
##########&parameters&regarding&what&to&output&to&the&inclusion&list&
#&mins.metric&elution&time&will&be&centered&at&inclListTimeWindow/2&
inclListTimeWindow&=&3&&
#&at&least&one&of&includeLowMass&or&includeHighMass&must&be&true&
includeLowMass&=&true&&
includeHighMass&=&false&
#&minimum&intensity&for&a&feature&to&be&output&to&inclusion&list.&Will&only&have&an&
effect&if&>&intensityCutOff&
includeFromIntensity&=&0&&
#&maximum&intensity&for&a&feature&to&be&output&to&inclusion&list.&&Use&a&very&large&
number&(eg&1.7976931348623157E308&=&Double.MAX_VALUE&=&default)&for&all&peaks&
includeToIntensity&=&1.7976931348623157E308&
& &
#&info&required&to&digest&the&fasta&file&into&peptides.&DB&must&be&given&as&separate&
terminal/cmd&param&(enzyme&is&assumed&to&be&trypsin)&
ppmPeptide&=&10.0&
——————————————————————————————
————————— 
&
&
&
&
&
&
To&compile&SUMmOn&results&with&ICID&results,&a&list&of&summon&directories&are&
required,&one&per&line&in&a&text&file&
ICID&results&are&optional&if&you&just&want&to&consolidate&SUMmOn&search&results&
&
&
Execution&on&mac/linux&terminal:&
&
cd&/usr/bin/java/VKJLib/bin&
java&Lcp&.:joptLsimpleL4.3.jar&vk.proteomics.summon.SummonResultSet&Ls&
inputSummonDirectoryListFile&Lo&outputResultsFile&Li&ICIDresultsFile&
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&
&
Parameters&(with&defaults&assigned):&
numIsotopes&=&5&
isotopeDelta&=&1.003355&
ppmErrorTolerance&=&10.0&
useModHyperlinks&=&true&
useCandHyperlinks&=&false&
minModScore&=&0.8&
minCandidateScoreWithAccurateMass&=&0.5&
minCandidateScoreWithoutAccurateMass&=&999.0&
minOrphanModScore&=&999.0&
scanTolerance&=&250&
&
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Appendix C: 
Calibrator use details 
 
 
Calibrator parameters: 
 
Usage:!
java!8cp!.:jopt8simple84.3.jar:commons8codec81.6.jar:commons8
math383.0.jar:jrap_StAX_v5.2.jar!LCMSrecalibration.Calibrator!
params!
! !
8m!string! path!to!mzXML!input!file!(centroid!data)!
8p!string! path!to!pepXML!input!file!8!MS1!spectra!will!be!recalibrated!using!peptide!IDs!(no!recalibration!occurs!without!this!option)!
8v!double! minimum!p8value!required!to!import!an!ID!from!the!pepXML!input!file!(optional,!accepts!081,!default!=!1.0,!only!valid!if!using!option!p)!
8i!double! minimum!intensity!of!ms2!precursor!ion!required!to!import!ID!(default!=!0.0)!
8s![int]!
minimum!data!points!required!to!do!a!single8scan!calibration!(only!
valid!if!using!option!f;!Default!=!25;!no!value!turns!single!scan!
calibration!off)!
8d![string]!
decoy!substring!as!part!of!protein!accession!to!filter!out!
reverse/random!DB!hits!(no!param!turns!filtering!off;!default!string!=!
rev_)!
8x!m|t! which!axis!to!calibrate.!m!=!MZ!axis,!t!=!time!axis.!(Default!=!both!MZ!and!time!axes)!
8l!double! lockmass!m/z.!!Only!use!spectra!with!a!lockmass!for!mz!calibration!and!correct!ppm!before!calibration!
8L!double! lockmass!m/z.!!Only!use!spectra!with!a!lockmass!for!mz!calibration!but!DO!NOT!correct!ppm!before!calibration!
8T!double! lockmass!ppm!tolerance.!Only!required!if!using!l!or!L!(default!=!10.0!ppm)!
8t!double! ppm!tolerance!used!during!precursor!detection!and!correction!(optional;!default!=!25.0!ppm)!
8f!
use!features!from!label8free!XPress!quant!to!calibrate!with!precursor!
m/z!over!the!chromatographic!elutions.!Requires!XPress!LF!quant!in!
pepxml.!(Default=false)!
8c! correct!MS2!precursor!m/z!values!from!observed!MS1!spectra!(useful!if!ms2!precursors!were!determined!from!preview!scans)!
8z!
[double]!
zero!MS2!precursor!m/z!if!no!ms1!precursor!observed!above!the!
specified!intensity!(default=0),!and!do!not!use!in!calibration!(only!
valid!if!using!8c)!
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8r! restrict!recalibration!to!IDs!with!corrected!precursors!(only!valid!if!using!options!p!and!c)!
8a! average!the!ppm!from!multiple!data!points!from!a!single!scan!(default!=!natural8log8intensity!weighted!PPM!average)!
8w! suppress!writing!of!mzXML!file!(useful!if!you!just!want!to!see!the!stats!output!to!optimise!settings)!
8h! print!this!help!info!
88atl! alignment!of!time,!max!number!of!Lines!(default!=!10000)!
88atd! alignment!of!time,!min!number!of!Data!points!per!subset!(default!=!100)!
88ats! alignment!of!time,!remove!outliers!if!outside!n!Standard!deviations!(default!=!4.0)!
88aml! alignment!of!m/z,!max!number!of!Lines!(default!=!50)!
88amd! alignment!of!m/z,!min!number!of!Data!points!per!subset!(default!=!200)!
88ams! alignment!of!m/z,!remove!outliers!if!outside!n!Standard!deviations!(default!=!3.0)!
! !
Example:! 8crzfa!8v!0.95!8s=20!8i5000!8t!15.0!8drev_!8l!519.138816!8T!10.0!8m!'mzXMLfilePath'!8p!'pepXMLfilePath'!
&
&
 
For convenience, use a bash script called ‘jCalibrator.sh’ to manage classpath 
details 
 
#!/usr/bin/env&bash&
#&To&execute,&just&call&
#& & jCalibrator.sh&[params]&&
cd&/usr/bin/java/VKJLib/bin/&
java&Lcp&.:../../joptLsimpleL4.3.jar:../../commonsLcodecL1.6.jar:../../commonsLmath3L
3.0.jar:../../jrap_StAX_v5.2.jar&LCMSrecalibration.Calibrator&$*&
&
&
&
&
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Appendix D: 
HyperProphet use details 
 
 
HyperProphet parameters: 
 
Usage:! java!8cp!.:jopt8simple84.3.jar:commons8math383.0.jar:jrap_StAX_v5.2.jar!HyperProphet.HyperProphet!params!
! !
8d!string! data!directory!(containing!*.pep.xml!and!corresponding!*.mzXML!files)![required]!
8i!double! input!min!p8val!(peptide!ID!p8val,!eg!1%FDR!to!prevent!unnecessary!ID!transfer)![optional;!default!=!8o!output]!
8a!double! alignment!min!p8val!(used!for!time!alignment)![optional;!default!=!0.99]!
8o!double! output!min!p8val!(for!assignment!to!other!aligned!runs).!Must!be!>=!input!p8val.![optional;!default!=!0.85]!
8m!double! minTimeSecs![optional;!default!=!300]!
8x!double! maxTimeSecs![optional;!default!=!a!very!big!number!=!the!end!of!the!run]!
8s!string!
subset!to!output!new!mzXML!files!for,!as!a!comma!separated!list!
without!spaces![optional;!default!=!all!files].!Do!not!include!both!
light!and!heavy!single!channel!runs!that!cannot!be!aligned!together!
8l!
align!using!MSn!time!where!LabelFreeQuant!unavailable![optional;!
default!=!only!use!label8free!apex!time].!This!option!will!include!IDs!
with!missing!quant.!Also!permits!processing!files!without!having!
done!XPressLableFreeQuant!(not!recommended).!
e![double]!
do!not!export!using!MSn!time!where!LabelFreeQuant!unavailable!
[optional;!default!=!do!export!using!MSn!time!if!LabelFreeQuant!
apex!time!unavailable].!If!the!value!is!specified,!features!must!also!
have!an!apex!greater!than!this!intensity!(default!=!0,!ie!all!spectra!
with!detected!features)!
8g!
use!a!segmentedAligner!for!chromatographic!alignment![optional;!
default!=!use!averagingAligner!which!enforces!contiguous!best!fit!
lines]!
88al!int! Align!with!max!Lines![optional,!default!=!50]!
88ad!int! Align!with!min!Data!points!per!line![optional,!default!=!200]!
88as!double! Align!with!removal!of!outliers!if!ouside!this!Stdev![optional,!default!=!2]!
8p!double! set!max!ppm!tolerance!(+/8)!for!peptide!IDs!to!be!transfered![optional;!default!=!5ppm]!
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8T!double!
set!max!time!tolerance!(+/8seconds)!for!seeking!precursor/feature!
in!target!extracted!ion!chromatogram!traces.!Seeking!better!
transfer!time!turned!off!if!set!to!zero![optional;!default!=!30]!
8p!double! set!max!ppm!tolerance!(+/8)!for!extracting!ion!chromatogram!traces![optional;!only!used!if!t>0;!default!=!10]!
8i!double!
set!intensity!threshold!for!target!extracted!ion!chromatogram!
traces.!!Any!trace!<=!to!this!will!not!be!transferred![optional;!default!
=!1000]!
8c!
suppress!output!of!the!file!containing!extracted!ion!Chromatogram!
file!containing!traces!and!MS2!tansfer!points![optional;!default!=!
true]!
8b! set!m/z!to!theoretical!for!seeking!precursor/feature!in!target!extracted!ion!chromatogram!traces![optional;!default!=!observed]!
8h! print!this!help,!which!is!pretty!useless!since!you're!already!reading!this!
 
 
For convenience, use a bash script called ‘jHyperProphet.sh’ to manage 
classpath details 
 
#!/usr/bin/env&bash&
#&To&execute,&just&call&
#& & jHyperProphet.sh&[params]&&
cd&/usr/bin/java/VKJLib/bin&
java&Lcp&.:joptLsimpleL4.3.jar:commonsLmath3L3.0.jar:jrap_StAX_v5.2.jar&
HyperProphet.HyperProphet&$*&
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Appendix D: 
 
Gene ontology results for down regulated proteins in elp3/wt at 1%FDR (followed by list of proteins) 
 
funspec:!P8value!
cutoff=0.01!with!Bonferroni!
correction!
! ! ! !
! ! ! ! !
GO Molecular Function 
(1646 categories) ! ! ! !
! ! ! ! !
Category p-value In Category from Cluster k f 
nucleotide binding 
[GO:0000166] 
9.18E
-11 
CDC19 ADE1 MIS1 TEF2 GRS1 
CDC28 SSE2 ISW1 CDC10 
PGK1 DBP10 PSA1 VMA1 NOP6 
SHS1 SES1 RLI1 SRP101 
YDR341C YRA1 EFT2 HPT1 
TIF35 SAM2 GIN4 EMI2 GCD11 
ARB1 MOT2 ACT1 PMA1 LSG1 
INO80 HXK2 ADE6 TYS1 ADE3 
PFK1 YGR250C STE20 SBP1 
GPA1 DED81 YHR020W CDC12 
YCK1 TIM44 THS1 CCT8 
YJL055W GSH1 CCT7 MET3 
PTK2 ADO1 MET14 URA6 YNK1 
LHS1 OXP1 VPS1 ACS2 CDC42 
RCK2 YEF3 MYO5 PFK2 HRB1 
PUB1 NOP15 NOP13 RHO5 
SSB2 YNL247W NRD1 MCK1 
ACC1 NOP12 RFC4 EFT1 RFC1 
MYO2 PRT1 NOG1 SSE1 
CDC60 CBC2 RVB2 GLN1 TEF1 
RHO1 
9
1 
7
7
8 
RNA binding 
[GO:0003723] 
3.39E
-08 
NCL1 LSM2 RPS11B PAT1 
DBP10 TRM8 NOP6 RPS11A 
MRPL1 TMA64 YRA1 EFT2 
TIF35 THO1 MOT2 LSM4 
TIF4632 KEM1 TAN1 TIF4631 
YGR250C SBP1 LSM12 SCP160 
LSM1 SUI2 TMA22 CBF5 YEF3 
RPL6B HRB1 PUB1 NOP15 
LSM7 NOP13 NRD1 PUS4 BRE5 
NOP12 EFT1 BFR1 PRT1 
RPS9A NOP53 CBC2 PUS1 
SRP68 
4
7 
3
3
7 
translation initiation factor 
activity [GO:0003743] 
1.55E
-07 
RPG1 RLI1 TMA64 TIF35 
GCD11 TIF4632 YGR054W 
TIF4631 SUI2 TMA22 TIF34 
NIP1 PRT1 
1
3 
3
8 
tubulin binding 
[GO:0015631] 
3.08E
-07 
NUM1 GIM4 PAC10 GIM5 GIM3 
RBL2 6 7 
! ! ! ! !
! ! ! ! !
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GO Biological Process 
(2062 categories) ! ! ! !
! ! ! ! !
Category p-value In Category from Cluster k f 
translational initiation 
[GO:0006413] 
1.24E
-08 
RPG1 RLI1 TMA64 TIF35 
GCD11 TIF4632 YGR054W 
TIF4631 SUI2 TMA22 CLU1 
TIF34 NIP1 SIS1 PRT1 
1
5 
4
3 
glycolysis [GO:0006096] 2.81E-07 
CDC19 PGI1 PGK1 EMI2 HXK2 
PFK1 KGD1 TDH2 PFK2 GPM3 
YOR283W 
1
1 
2
8 
translation [GO:0006412] 2.25E-06 
RPS11B TRM7 RPG1 TEF2 
GRS1 RPS6B SES1 RPS11A 
RLI1 MRPL1 YDR341C EFT2 
TIF35 GCD11 RPL22B TIF4632 
YGR054W TIF4631 TYS1 
RPL8A DED81 YHR020W THS1 
RSM25 SUI2 YEF3 RPL6B TIF34 
NIP1 RPL9B SSB2 YNL247W 
BRX1 RPL3 TMA46 EFT1 PRT1 
RPS9A RPS6A CDC60 TEF1 
4
1 
3
1
8 
'de novo' IMP 
biosynthetic process 
[GO:0006189] 
3.32E
-06 
ADE1 ADE8 ADE6 ADE13 
ADE17 ADE4 6 9 
ribosomal subunit export 
from nucleus 
[GO:0000054] 
3.43E
-06 
RLI1 LSG1 ZUO1 RNA1 SSB2 
NOC2 NOG1 7 
1
3 
purine nucleotide 
biosynthetic process 
[GO:0006164] 
4.16E
-06 
ADE1 MIS1 ADE8 ADE6 ADE3 
ADE13 ADE17 ADE4 8 
1
8 
tubulin complex 
assembly [GO:0007021] 
4.43E
-06 GIM4 PAC10 GIM5 GIM3 RBL2 5 6 
 
List of all proteins down regulated in elp3/wt at 1%FDR 
 
Systematic!Name! Standard!Name! logFC! adj.P.Val!
YBR093C! Pho5p! 82.4642! 3.0500E806!
YNL160W! Ygp1p! 82.3280! 7.2523E804!
R0040C! Rep2p! 81.4263! 7.0000E806!
YPL199C! ! 81.1242! 2.4100E806!
YIL063C! Yrb2p! 81.1084! 2.7600E805!
YMR278W! Prm15p! 81.0254! 2.6338E804!
YML123C! Pho84p! 81.0188! 9.7700E805!
YNL251C! Nrd1p! 80.9419! 7.1334E804!
YCR005C! Cit2p! 80.9092! 2.8100E805!
YDL147W! Rpn5p! 80.8990! 2.9285E804!
YHR087W! Rtc3p! 80.8959! 2.4626E803!
YKL157W! Ape2p! 80.8844! 4.0200E805!
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YKL001C! Met14p! 80.8808! 1.4261E804!
YBR169C! Sse2p! 80.8782! 3.7934E804!
YAR042W! Swh1p! 80.8550! 1.5251E804!
YLR354C! Tal1p! 80.8436! 1.1100E805!
YKR016W! Fcj1p! 80.8375! 1.9673E804!
YLR002C! Noc3p! 80.8329! 1.1455E804!
YMR205C! Pfk2p! 80.8171! 7.0000E806!
YDL213C! Nop6p! 80.7964! 1.0067E804!
YPL019C! Vtc3p! 80.7961! 1.6700E805!
YOR206W! Noc2p! 80.7764! 3.6700E805!
YJL088W! Arg3p! 80.7762! 1.5786E803!
YDR507C! Gin4p! 80.7754! 7.1334E804!
YMR120C! Ade17p! 80.7741! 1.9359E804!
YPR072W! Not5p! 80.7662! 3.2400E805!
YFR030W! Met10p! 80.7658! 2.7600E805!
YNL180C! Rho5p! 80.7618! 7.8600E805!
YGR233C! Pho81p! 80.7410! 2.7600E805!
YLR206W! Ent2p! 80.7335! 5.3256E804!
YKL065C! Yet1p! 80.7312! 5.7800E806!
YHR107C! Cdc12p! 80.7234! 1.6086E804!
YJR007W! Sui2p! 80.7098! 1.4500E805!
YDR233C! Rtn1p! 80.7054! 7.0000E806!
YIL015W! Bar1p! 80.7027! 7.8900E806!
YOR198C! Bfr1p! 80.6952! 4.9900E806!
YLR248W! Rck2p! 80.6794! 3.8206E804!
YFL034C8A! Rpl22Bp! 80.6730! 7.0000E806!
YOR163W! Ddp1p! 80.6708! 7.0700E806!
YGL232W! Tan1p! 80.6571! 4.5700E805!
YDR117C! Tma64p! 80.6482! 5.1400E805!
YNL231C! Pdr16p! 80.6454! 1.6900E805!
YMR275C! Bul1p! 80.6448! 5.9226E803!
YJR137C! Met5p! 80.6408! 7.6300E806!
YER044C! Erg28p! 80.6401! 5.0900E805!
YGL173C! Xrn1p! 80.6392! 7.4800E806!
YPL081W! Rps9Ap! 80.6382! 2.9300E805!
YMR047C! Nup116p! 80.6362! 7.9055E804!
YML094W! Gim5p! 80.6323! 2.9400E805!
YNL168C! Fmp41p! 80.6238! 3.4000E805!
YHR005C! Gpa1p! 80.6238! 5.6800E805!
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YMR072W! Abf2p! 80.6230! 1.7000E805!
YHR201C! Ppx1p! 80.6202! 2.7600E805!
YEL071W! Dld3p! 80.6190! 1.0500E805!
YBR092C! Pho3p! 80.6113! 2.7600E805!
YFL045C! Sec53p! 80.6104! 7.0000E806!
YGL150C! Ino80p! 80.6062! 3.5000E805!
YHR113W! Ape4p! 80.6016! 1.4696E804!
YLR003C! Cms1p! 80.6014! 5.7960E804!
YFR041C! Erj5p! 80.5984! 1.0200E805!
YLR449W! Fpr4p! 80.5947! 2.8300E805!
YER091C! Met6p! 80.5931! 1.8400E805!
YHR135C! Yck1p! 80.5840! 1.6927E803!
YLR418C! Cdc73p! 80.5829! 4.3100E805!
YDL201W! Trm8p! 80.5811! 3.1600E805!
YGL253W! Hxk2p! 80.5750! 3.5423E804!
YNL134C! ! 80.5749! 1.5977E803!
YDR481C! Pho8p! 80.5733! 5.1300E805!
YBR159W! Ifa38p! 80.5681! 3.8100E805!
YHR097C! ! 80.5671! 7.3903E803!
YNR016C! Acc1p! 80.5667! 6.3900E805!
YPR032W! Sro7p! 80.5647! 1.0372E804!
YAR015W! Ade1p! 80.5626! 1.3000E805!
YLR229C! Cdc42p! 80.5611! 8.7100E805!
YJL124C! Lsm1p! 80.5577! 9.9100E806!
YGR082W! Tom20p! 80.5540! 1.7406E803!
YLR153C! Acs2p! 80.5531! 7.0700E806!
YGR019W! Uga1p! 80.5483! 1.6203E803!
YGL206C! Chc1p! 80.5477! 7.2300E806!
YOL012C! Htz1p! 80.5434! 5.8100E805!
YOR054C! Vhs3p! 80.5428! 1.1903E803!
YDR150W! Num1p! 80.5352! 5.2567E803!
YER043C! Sah1p! 80.5316! 3.6700E805!
YOR116C! Rpo31p! 80.5301! 2.2692E804!
YLR249W! Yef3p! 80.5280! 1.8810E804!
YIL022W! Tim44p! 80.5261! 3.3200E805!
YEL003W! Gim4p! 80.5247! 1.0232E804!
YPR060C! Aro7p! 80.5179! 1.0623E803!
YDL074C! Bre1p! 80.5136! 8.9838E803!
YJR010W! Met3p! 80.5129! 1.5490E804!
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YKL179C! Coy1p! 80.5123! 5.2244E804!
YMR173W! Ddr48p! 80.5100! 9.5900E805!
YGR286C! Bio2p! 80.5074! 4.8348E803!
YMR099C! ! 80.5048! 2.7200E805!
YDR153C! Ent5p! 80.5021! 7.5600E805!
YLR309C! Imh1p! 80.5019! 1.0459E803!
YJR051W! Osm1p! 80.4940! 6.9919E804!
YDR170C! Sec7p! 80.4929! 8.7300E805!
YPL231W! Fas2p! 80.4905! 2.4900E805!
YML017W! Psp2p! 80.4890! 1.4696E804!
YML074C! Fpr3p! 80.4890! 3.6000E805!
YDR098C! Grx3p! 80.4886! 3.2489E803!
YKR003W! Osh6p! 80.4829! 5.6579E804!
YMR307W! Gas1p! 80.4792! 1.0498E804!
YKL104C! Gfa1p! 80.4787! 7.3900E805!
YDR091C! Rli1p! 80.4766! 1.4666E804!
YPL210C! Srp72p! 80.4764! 8.3401E804!
YHR049W! Fsh1p! 80.4748! 6.4400E805!
YKL182W! Fas1p! 80.4740! 1.6100E805!
YDR518W! Eug1p! 80.4703! 8.0845E804!
YGL049C! Tif4632p! 80.4672! 1.3325E804!
YNL147W! Lsm7p! 80.4650! 2.2764E803!
YPL146C! Nop53p! 80.4644! 2.7609E803!
YJL012C! Vtc4p! 80.4643! 3.1000E805!
YBR222C! Pcs60p! 80.4638! 1.0453E804!
YEL015W! Edc3p! 80.4636! 3.1100E804!
YNL141W! Aah1p! 80.4624! 5.1243E804!
YDR516C! Emi2p! 80.4605! 7.2176E804!
YAL023C! Pmt2p! 80.4600! 2.0627E804!
YJL053W! Pep8p! 80.4573! 6.3400E805!
YGR009C! Sec9p! 80.4551! 1.7325E804!
YOR265W! Rbl2p! 80.4538! 2.7400E805!
YMR012W! Clu1p! 80.4528! 5.1086E804!
YJL080C! Scp160p! 80.4524! 1.3000E805!
YLR175W! Cbf5p! 80.4511! 2.2100E805!
YIL138C! Tpm2p! 80.4497! 9.0661E804!
YGL153W! Pex14p! 80.4496! 3.8100E805!
YMR235C! Rna1p! 80.4444! 4.0141E803!
YLR033W! Rsc58p! 80.4344! 8.2481E804!
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YHR039C! Msc7p! 80.4317! 1.9815E803!
YER112W! Lsm4p! 80.4276! 3.6700E805!
YDR023W! Ses1p! 80.4263! 3.6700E805!
YBR109C! Cmd1p! 80.4261! 1.0397E804!
YHR019C! Ded81p! 80.4255! 3.6700E805!
YJL167W! Erg20p! 80.4235! 6.5300E805!
YDR502C! Sam2p! 80.4226! 3.6500E805!
YIL038C! Not3p! 80.4149! 1.2481E804!
YIL078W! Ths1p! 80.4139! 2.1900E805!
YER110C! Kap123p! 80.4125! 3.4000E805!
YMR016C! Sok2p! 80.4123! 4.2231E804!
YJR117W! Ste24p! 80.4073! 3.8152E804!
YDL052C! Slc1p! 80.4068! 1.2781E804!
YHR020W! ! 80.4065! 8.1458E804!
YDR408C! Ade8p! 80.4059! 8.6969E803!
YNL004W! Hrb1p! 80.4041! 2.1185E803!
YDL225W! Shs1p! 80.4027! 3.5002E803!
YCR016W! ! 80.4022! 6.5077E803!
YDL130W8A! Stf1p! 80.4017! 2.0680E803!
YBR234C! Arc40p! 80.4000! 2.1171E804!
YGR054W! ! 80.3999! 4.3800E805!
YMR027W! ! 80.3997! 1.9243E803!
YDR292C! Srp101p! 80.3990! 7.2316E803!
YLR095C! Ioc2p! 80.3975! 2.9410E804!
YBR245C! Isw1p! 80.3942! 3.7600E805!
YFL004W! Vtc2p! 80.3940! 2.2494E803!
YKL073W! Lhs1p! 80.3925! 1.4652E803!
YER068W! Mot2p! 80.3922! 5.5924E804!
YDR145W! Taf12p! 80.3920! 8.3500E805!
YEL042W! Gda1p! 80.3917! 6.1783E803!
YDL145C! Cop1p! 80.3910! 2.5121E804!
YGR240C! Pfk1p! 80.3909! 2.9300E805!
YNL313C! Emw1p! 80.3904! 1.4065E804!
YGR061C! Ade6p! 80.3877! 3.5136E804!
YKL067W! Ynk1p! 80.3866! 2.2683E803!
YGR185C! Tys1p! 80.3824! 3.1000E805!
YNL175C! Nop13p! 80.3821! 6.7600E805!
YGR250C! ! 80.3813! 2.1785E803!
YLR045C! Stu2p! 80.3809! 2.0413E803!
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YCR030C! Syp1p! 80.3769! 1.9873E803!
YBR160W! Cdc28p! 80.3704! 4.8545E804!
YCR012W! Pgk1p! 80.3701! 2.8300E805!
YPR080W! Tef1p! 80.3687! 5.8100E805!
YBR118W! Tef2p! 80.3687! 5.8100E805!
YBR079C! Rpg1p! 80.3677! 3.1000E805!
YJR009C! Tdh2p! 80.3667! 5.0900E805!
YPL094C! Sec62p! 80.3650! 1.0764E804!
YDR399W! Hpt1p! 80.3632! 5.1300E805!
YAR007C! Rfa1p! 80.3617! 4.9380E804!
YPR108W! Rpn7p! 80.3607! 3.8100E805!
YBR281C! Dug2p! 80.3582! 1.0809E803!
YNL138W! Srv2p! 80.3572! 1.2986E803!
YER063W! Tho1p! 80.3568! 1.9890E804!
YDL099W! Bug1p! 80.3565! 2.0513E804!
YFL010C! Wwm1p! 80.3563! 5.3037E803!
YBR084W! Mis1p! 80.3558! 1.1816E803!
YDR099W! Bmh2p! 80.3533! 4.6161E804!
YPR128C! Ant1p! 80.3525! 9.6078E803!
YMR300C! Ade4p! 80.3511! 1.4854E804!
YDL161W! Ent1p! 80.3509! 9.4179E804!
YHL007C! Ste20p! 80.3507! 1.2379E803!
YIR037W! Hyr1p! 80.3445! 1.0498E804!
YKR065C! Pam17p! 80.3437! 8.3424E804!
YPR029C! Apl4p! 80.3419! 2.6197E803!
YGR208W! Ser2p! 80.3412! 2.8467E803!
YOR341W! Rpa190p! 80.3411! 6.6265E804!
YGR218W! Crm1p! 80.3399! 1.2034E804!
YNL110C! Nop15p! 80.3392! 8.3424E804!
YKL054C! Def1p! 80.3363! 4.0249E804!
YOR212W! Ste4p! 80.3363! 7.4578E803!
YGL099W! Lsg1p! 80.3352! 2.0772E804!
YER025W! Gcd11p! 80.3325! 4.5200E805!
YMR296C! Lcb1p! 80.3316! 4.4909E803!
YBR112C! Cyc8p! 80.3315! 4.3462E803!
YOR217W! Rfc1p! 80.3295! 3.2409E803!
YPR073C! Ltp1p! 80.3289! 5.3180E803!
YMR243C! Zrc1p! 80.3284! 1.0498E804!
YIL053W! Gpp1p! 80.3273! 3.5019E803!
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YDR238C! Sec26p! 80.3265! 1.8544E804!
YJL158C! Cis3p! 80.3254! 8.5650E803!
YOR326W! Myo2p! 80.3237! 9.5816E803!
YBR205W! Ktr3p! 80.3237! 6.8100E805!
YDL040C! Nat1p! 80.3237! 7.6805E804!
YPL093W! Nog1p! 80.3234! 1.6086E804!
YBR061C! Trm7p! 80.3232! 2.3278E803!
YKL164C! Pir1p! 80.3230! 1.8559E803!
YER182W! Fmp10p! 80.3218! 5.1243E804!
YDL174C! Dld1p! 80.3215! 1.4546E804!
YDR207C! Ume6p! 80.3199! 6.3306E803!
YOR091W! Tma46p! 80.3191! 1.4189E804!
YKL013C! Arc19p! 80.3183! 5.0876E803!
YER034W! ! 80.3179! 6.5219E803!
YBL091C! Map2p! 80.3167! 9.2092E804!
YOR133W! Eft1p! 80.3164! 6.6900E805!
YDR385W! Eft2p! 80.3164! 6.6900E805!
YMR183C! Sso2p! 80.3127! 3.9359E804!
YPR133C! Spn1p! 80.3116! 1.8544E804!
YBL024W! Ncl1p! 80.3083! 2.2104E804!
YPL063W! Tim50p! 80.3066! 4.3152E804!
YJR132W! Nmd5p! 80.3030! 4.8323E803!
YDR341C! ! 80.3026! 5.7154E804!
YCR077C! Pat1p! 80.3023! 1.7669E803!
YOL059W! Gpd2p! 80.3004! 9.0661E804!
YNL247W! ! 80.2998! 1.3045E804!
YMR109W! Myo5p! 80.2991! 4.5288E803!
YPR165W! Rho1p! 80.2978! 7.6513E804!
YOL109W! Zeo1p! 80.2967! 2.8526E803!
YKL215C! Oxp1p! 80.2965! 4.6514E803!
YOL111C! Mdy2p! 80.2959! 2.9362E803!
YKL082C! Rrp14p! 80.2950! 4.5971E804!
YLR179C! ! 80.2898! 1.1486E803!
YIL070C! Mam33p! 80.2893! 2.2692E804!
YDL031W! Dbp10p! 80.2890! 5.0046E803!
YNL007C! Sis1p! 80.2871! 1.2832E804!
YGR078C! Pac10p! 80.2867! 1.4334E803!
YMR083W! Adh3p! 80.2849! 7.1496E804!
YML106W! Ura5p! 80.2832! 1.6807E804!
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YCR084C! Tup1p! 80.2827! 1.3632E804!
YLR359W! Ade13p! 80.2821! 1.9379E804!
YER081W! Ser3p! 80.2791! 1.2867E803!
YDR381W! Yra1p! 80.2791! 1.6487E804!
YHR183W! Gnd1p! 80.2781! 1.4189E804!
YPL243W! Srp68p! 80.2781! 5.3037E803!
YBR088C! Pol30p! 80.2781! 1.9890E804!
YGR193C! Pdx1p! 80.2772! 1.8224E804!
YPL145C! Kes1p! 80.2734! 2.2692E804!
YNL208W! ! 80.2718! 1.4666E804!
YEL047C! Frd1p! 80.2716! 3.1803E804!
YPL129W! Taf14p! 80.2697! 3.5754E804!
YBL007C! Sla1p! 80.2696! 1.7669E803!
YPR010C! Rpa135p! 80.2688! 5.3037E803!
YOL077C! Brx1p! 80.2670! 7.4158E803!
YKL212W! Sac1p! 80.2669! 7.0346E804!
YJR014W! Tma22p! 80.2665! 1.8386E803!
YCR009C! Rvs161p! 80.2656! 3.3111E804!
YNL016W! Pub1p! 80.2638! 1.6522E803!
YIL125W! Kgd1p! 80.2629! 3.7632E804!
YKL172W! Ebp2p! 80.2612! 5.7737E803!
YHR066W! Ssf1p! 80.2607! 2.4626E803!
YDL122W! Ubp1p! 80.2596! 4.8262E803!
YNR051C! Bre5p! 80.2593! 5.8027E803!
YHL033C! Rpl8Ap! 80.2568! 1.8051E804!
YLR301W! Hri1p! 80.2564! 6.4538E804!
YNR035C! Arc35p! 80.2564! 1.1903E803!
YDR388W! Rvs167p! 80.2552! 1.4686E803!
YKL032C! Ixr1p! 80.2548! 1.9815E803!
YOR283W! ! 80.2531! 4.0973E803!
YGR204W! Ade3p! 80.2529! 1.5675E804!
YOL056W! Gpm3p! 80.2515! 8.5644E803!
YPR183W! Dpm1p! 80.2503! 2.7806E804!
YBR196C! Pgi1p! 80.2496! 5.6077E804!
YIL083C! Cab2p! 80.2491! 1.8329E803!
YBR035C! Pdx3p! 80.2488! 1.5487E804!
YHR104W! Gre3p! 80.2486! 1.9311E803!
YER036C! Arb1p! 80.2476! 1.2481E804!
YJR059W! Ptk2p! 80.2468! 2.3731E803!
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YDR060W! Mak21p! 80.2462! 9.6444E804!
YMR273C! Zds1p! 80.2450! 3.2409E803!
YGR155W! Cys4p! 80.2440! 4.0251E804!
YPL106C! Sse1p! 80.2423! 8.8301E804!
YOL051W! Gal11p! 80.2407! 7.6513E804!
YPR181C! Sec23p! 80.2403! 2.1263E804!
YKR001C! Vps1p! 80.2385! 1.5404E803!
YPL212C! Pus1p! 80.2379! 2.5662E803!
YPL235W! Rvb2p! 80.2365! 1.6086E804!
YER148W! Spt15p! 80.2362! 3.3613E803!
YJL111W! Cct7p! 80.2356! 3.5136E804!
YCL028W! Rnq1p! 80.2352! 5.3203E803!
YNL121C! Tom70p! 80.2352! 9.7496E804!
YNR050C! Lys9p! 80.2346! 1.5462E803!
YDR116C! Mrpl1p! 80.2335! 2.0352E803!
YOR164C! Get4p! 80.2328! 2.1229E804!
YGL055W! Ole1p! 80.2327! 2.7141E803!
YLR372W! Sur4p! 80.2299! 5.1544E803!
YJL081C! Arp4p! 80.2296! 4.4440E803!
YER107C! Gle2p! 80.2294! 9.0478E803!
YPR040W! Tip41p! 80.2294! 9.8699E803!
YGR119C! Nup57p! 80.2282! 2.2314E804!
YJL186W! Mnn5p! 80.2274! 1.6505E803!
YDR101C! Arx1p! 80.2242! 8.3424E804!
YGR162W! Tif4631p! 80.2242! 2.2692E804!
YAL060W! Bdh1p! 80.2239! 8.5473E803!
YMR315W! ! 80.2225! 6.3982E803!
YIL021W! Rpb3p! 80.2216! 9.2692E803!
YJR060W! Cbf1p! 80.2211! 8.3424E804!
YGR116W! Spt6p! 80.2195! 2.9541E804!
YML071C! Cog8p! 80.2186! 6.6362E803!
YJL026W! Rnr2p! 80.2184! 8.9813E804!
YOR239W! Abp140p! 80.2180! 1.8415E803!
YFL039C! Act1p! 80.2172! 4.4073E804!
YMR309C! Nip1p! 80.2163! 2.0485E804!
YGL087C! Mms2p! 80.2159! 5.9226E803!
YDL135C! Rdi1p! 80.2158! 2.0485E804!
YOR361C! Prt1p! 80.2153! 5.6579E804!
YLR448W! Rpl6Bp! 80.2151! 7.1334E804!
 251 
YBR154C! Rpb5p! 80.2145! 3.1872E803!
YAL038W! Cdc19p! 80.2134! 1.0641E803!
YML012W! Erv25p! 80.2131! 7.0584E803!
YPR148C! ! 80.2127! 6.9316E803!
YLL011W! Sof1p! 80.2122! 2.1583E803!
YER125W! Rsp5p! 80.2106! 6.5700E803!
YER048C! Caj1p! 80.2105! 5.8324E804!
YBR121C! Grs1p! 80.2104! 2.6352E803!
YER087C8B! Sbh1p! 80.2104! 6.6362E803!
YLR109W! Ahp1p! 80.2097! 5.6954E804!
YDR486C! Vps60p! 80.2087! 3.6846E803!
YJL055W! ! 80.2068! 3.4326E803!
YNL153C! Gim3p! 80.2040! 3.5529E804!
YLR378C! Sec61p! 80.2023! 3.9541E803!
YDR189W! Sly1p! 80.2012! 5.6711E803!
YJR105W! Ado1p! 80.2006! 1.3954E803!
YJL101C! Gsh1p! 80.1993! 5.9044E804!
YOL041C! Nop12p! 80.1971! 8.6969E803!
YLR044C! Pdc1p! 80.1968! 7.4561E803!
YOR310C! Nop58p! 80.1931! 1.4537E803!
YDR025W! Rps11Ap! 80.1919! 1.3458E803!
YBR048W! Rps11Bp! 80.1919! 1.3458E803!
YLR216C! Cpr6p! 80.1913! 1.3778E803!
YBL050W! Sec17p! 80.1905! 1.5462E803!
YDR429C! Tif35p! 80.1901! 1.7707E803!
YNL292W! Pus4p! 80.1898! 5.0631E803!
YKL024C! Ura6p! 80.1888! 2.3312E803!
YDL053C! Pbp4p! 80.1879! 4.5148E803!
YBL026W! Lsm2p! 80.1877! 6.1743E803!
YPR154W! Pin3p! 80.1869! 7.7452E803!
YDL185W! Vma1p! 80.1847! 8.3654E803!
YPR035W! Gln1p! 80.1841! 1.1486E803!
YOL094C! Rfc4p! 80.1825! 5.8008E803!
YLR118C! ! 80.1791! 4.2546E803!
YER133W! Glc7p! 80.1786! 4.3313E803!
YKL009W! Mrt4p! 80.1776! 1.5938E803!
YML079W! ! 80.1776! 6.3093E803!
YMR311C! Glc8p! 80.1760! 3.7046E803!
YDL103C! Qri1p! 80.1737! 3.2409E803!
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YAL007C! Erp2p! 80.1709! 5.9794E803!
YGL244W! Rtf1p! 80.1681! 3.5927E803!
YNL209W! Ssb2p! 80.1677! 2.9362E803!
YKL006C8A! Sft1p! 80.1661! 3.2172E803!
YNL307C! Mck1p! 80.1655! 3.5310E803!
YHL034C! Sbp1p! 80.1651! 9.2692E803!
YNL067W! Rpl9Bp! 80.1646! 6.8005E803!
YER009W! Ntf2p! 80.1641! 5.3037E803!
YMR153W! Nup53p! 80.1634! 4.0973E803!
YGL207W! Spt16p! 80.1606! 3.2294E803!
YPL160W! Cdc60p! 80.1598! 4.3462E803!
YIL075C! Rpn2p! 80.1589! 5.3203E803!
YER089C! Ptc2p! 80.1581! 4.5022E803!
YER136W! Gdi1p! 80.1578! 2.1785E803!
YJR069C! Ham1p! 80.1551! 1.7539E803!
YHR121W! Lsm12p! 80.1519! 4.3084E803!
YMR161W! Hlj1p! 80.1516! 4.7747E803!
YBR106W! Pho88p! 80.1511! 3.0487E803!
YIL093C! Rsm25p! 80.1505! 3.6846E803!
YGL008C! Pma1p! 80.1499! 9.8881E803!
YDR427W! Rpn9p! 80.1491! 1.6203E803!
YDL055C! Psa1p! 80.1478! 8.1899E803!
YML126C! Erg13p! 80.1471! 1.7614E803!
YKL193C! Sds22p! 80.1470! 6.9725E803!
YMR146C! Tif34p! 80.1424! 2.1525E803!
YDL205C! Hem3p! 80.1358! 8.1899E803!
YDR510W! Smt3p! 80.1317! 8.4459E803!
YAR002C8A! Erp1p! 80.1305! 6.3421E803!
YJL008C! Cct8p! 80.1261! 5.7223E803!
YGR285C! Zuo1p! 80.1253! 8.0464E803!
YCR002C! Cdc10p! 80.1235! 5.3203E803!
YPL090C! Rps6Ap! 80.1227! 5.2956E803!
YBR181C! Rps6Bp! 80.1227! 5.2956E803!
YPL178W! Cbc2p! 80.1179! 6.2778E803!
YOR063W! Rpl3p! 80.1127! 4.8992E803!
YPR074C! Tkl1p! 80.1002! 8.1899E803!
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Gene ontology results for up regulated proteins in elp3/wt at 1%FDR (followed by list of 
proteins) 
 
funspec:!P8value!
cutoff=0.01!with!
Bonferroni!correction!
! ! ! !
! ! ! ! !
GO Molecular 
Function (1646 
categories) 
! ! ! !
! ! ! ! !
Category p-value In Category from Cluster k f 
threonine-type 
endopeptidase activity 
[GO:0004298] 
1.03E-
11 
PRE1 PUP3 SCL1 PRE9 PUP2 PRE3 
PRE8 PRE6 PUP1 PRE10 PRE2 
1
1 
1
4 
catalytic activity 
[GO:0003824] 
1.50E-
10 
CYS3 COR1 ETR1 PTC4 HIS7 NFS1 
THR4 PTC1 HNT1 LYS21 LYS20 ARO3 
ARO10 UBA2 UTR4 FMP52 ARG5,6 
YER152C BNA6 ERG26 TRP5 SCW11 
ARO8 LSC2 CPD1 SCW4 BGL2 YHI9 
PTC7 UBA4 ARO9 OYE2 ERG9 IMD2 
HIS6 BNA3 ILV3 CPA2 MAE1 UBA1 
URA1 YKR070W MTD1 MEU1 AAT2 
ALT1 PNP1 CTS1 EXG1 ARG7 
YMR226C FAA4 SCW10 ADH6 IDH1 
LEU4 RIO2 ZWF1 LSC1 ERG10 FCY1 
SPE3 QCR2 
6
3 
4
5
5 
endopeptidase activity 
[GO:0004175] 
1.59E-
10 
PRE1 PUP3 SCL1 PRE9 PUP2 RPN1 
PRE3 PRE8 PRE6 PUP1 PRE10 PRE2 
1
2 
2
0 
oxidoreductase activity 
[GO:0016491] 
7.39E-
07 
COX2 PRX1 ETR1 MXR2 IDP1 YFH1 
YPR1 MXR1 ARG5,6 ALD5 LPD1 
ERG26 ERG1 AIM17 SOD2 OYE2 
ERG9 IMD2 BNA1 SOD1 MAE1 URA1 
CCP1 MTD1 TSA1 PGA3 ERO1 NDE1 
YMR226C ADH6 IDH1 ZWF1 CAT5 
PRO2 CIR2 ALD4 GLR1 YPR127W 
3
8 
2
7
2 
metal ion binding 
[GO:0046872] 
1.08E-
06 
COX2 COR1 PTC4 MXR2 PRD1 
YCR087C-A PTC1 RPS29B IDP1 GCS1 
LYS4 ARO10 UBA2 RIB3 UTR4 PCM1 
PMI40 PRS2 MDJ1 OTU1 YFR006W 
DUG1 COX4 SPT4 ZPR1 PRS3 AIM17 
SOD2 COX6 PTC7 UBA4 IMD2 AGE2 
ACO2 ILV3 BNA1 SOD1 CPA2 MAE1 
MSN4 CCP1 DRE2 SAM1 MAP1 URA4 
GLO1 APT1 IRC21 SCJ1 ADH6 
NCE103 IDH1 YDJ1 DMA2 ADE12 
PRS5 MET22 CYT1 CAT5 CIR2 ERG10 
GRX5 CAR1 IDI1 ISU1 SAM4 FCY1 
SUA7 QCR2 
6
9 
6
4
7 
proton-transporting 
ATPase activity, 
rotational mechanism 
[GO:0046961] 
4.02E-
06 
ATP3 ATP5 TIM11 VMA7 ATP2 ATP7 
ATP14 VMA6 ATP4 ATP15 
1
0 
2
9 
! ! ! ! !
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! ! ! ! !
GO Biological Process 
(2062 categories) ! ! ! !
! ! ! ! !
Category p-value In Category from Cluster k f 
proteasomal ubiquitin-
independent protein 
catabolic process 
[GO:0010499] 
1.03E-
11 
PRE1 PUP3 SCL1 PRE9 PUP2 PRE3 
PRE8 PRE6 PUP1 PRE10 PRE2 
1
1 
1
4 
cellular amino acid 
biosynthetic process 
[GO:0008652] 
5.88E-
11 
CYS3 HIS7 ILV6 THR4 LYS21 LYS20 
ARO3 LYS4 TRP4 UTR4 HOM3 HIS1 
ARG5,6 TRP2 TRP5 ARO2 ASN2 HIS6 
ILV3 CPA2 ARG7 LEU4 ARG1 PRO2 
SAM4 ASN1 
2
6 
9
8 
metabolic process 
[GO:0008152] 
6.80E-
11 
ETR1 HIS7 ILV6 NFS1 THR4 HNT1 
LYS21 LYS20 DAS2 ARO3 PAA1 LYS4 
TRP4 UBA2 UTR4 FMP52 HOM3 
ARG5,6 ALD5 DUG1 BNA6 ERG26 
TRP5 SCW11 ERG1 LSC2 SCW4 
BGL2 PTC7 UBA4 OYE2 ERG9 IMD2 
HIS6 ACO2 ILV3 BNA1 CPA2 MAE1 
UBA1 URA1 YKR070W MTD1 CTS1 
EXG1 UNG1 ARG7 YMR226C FAA4 
SCW10 ADH6 IDH1 LEU4 ZWF1 DSE4 
LSC1 PRO2 ALD4 ERG10 POS5 FCY1 
6
1 
4
2
5 
proteolysis involved in 
cellular protein catabolic 
process [GO:0051603] 
7.23E-
10 
PRE1 PUP3 SCL1 PRE9 PUP2 PRE3 
PRE8 PRE6 PUP1 PRE10 PRE2 
1
1 
1
8 
proteasomal ubiquitin-
dependent protein 
catabolic process 
[GO:0043161] 
1.16E-
09 
SHP1 SEM1 PRE1 PUP3 RPN11 SCL1 
PRE9 PUP2 PRE3 PRE8 PRE6 PUP1 
PRE10 PRE2 
1
4 
3
2 
ubiquitin-dependent 
protein catabolic 
process [GO:0006511] 
1.23E-
08 
RPT2 RPN6 CDC48 CDC53 SEM1 
RPT3 DDI1 UBP6 RPN12 SCL1 PRE9 
PUP2 RPN1 RPN10 RPT1 PRE8 PRE6 
RPT5 PRE10 
1
9 
6
9 
protein folding 
[GO:0006457] 
1.68E-
07 
PDI1 TAH1 CCT4 TCP1 FPR2 MDJ1 
PHB1 PHB2 ESS1 SSC1 SBA1 SSA2 
TSA1 CPR3 ERO1 HSC82 SCJ1 YDJ1 
HSP10 STI1 HSP82 
2
1 
9
6 
oxidation-reduction 
process [GO:0055114] 
7.39E-
07 
COX2 PRX1 ETR1 MXR2 IDP1 YFH1 
YPR1 MXR1 ARG5,6 ALD5 LPD1 
ERG26 ERG1 AIM17 SOD2 OYE2 
ERG9 IMD2 BNA1 SOD1 MAE1 URA1 
CCP1 MTD1 TSA1 PGA3 ERO1 NDE1 
YMR226C ADH6 IDH1 ZWF1 CAT5 
PRO2 CIR2 ALD4 GLR1 YPR127W 
3
8 
2
7
2 
biosynthetic process 
[GO:0009058] 
2.33E-
06 
ARO3 GCD6 TRP2 YER152C ARO8 
CAB4 YHI9 ARO9 ERG9 BNA3 AAT2 
ALT1 
1
2 
4
0 
ATP synthesis coupled 
proton transport 
[GO:0015986] 
2.44E-
06 
ATP3 ATP5 TIM11 ATP2 ATP7 ATP14 
ATP4 ATP15 8 
1
7 
! ! ! ! !
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! ! ! ! !
MIPS Functional 
Classification (459 
categories) 
! ! ! !
! ! ! ! !
Category p-value In Category from Cluster k f 
protein processing 
(proteolytic) [14.07.11] 
3.79E-
11 
RPT2 RPT3 PRE1 PUP3 RPN11 
RPN12 SCL1 PRE9 PUP2 RPN1 
RPN10 PRE3 RPT1 MAP1 PRE8 PRE6 
RPT5 PUP1 RPT4 PRE10 PRE2 
2
1 
6
3 
proteasomal 
degradation 
(ubiquitin/proteasomal 
pathway) [14.13.01.01] 
2.88E-
10 
SHP1 RPT2 RPN6 CDC48 CDC53 
SEM1 RPT3 PRE1 PUP3 DDI1 OTU1 
RPN11 RPN12 SCL1 PRE9 PUP2 
RPN1 RPN10 PRE3 RPT1 UBA1 
SEC13 PRE8 PRE6 RPT5 PUP1 RPT4 
PRE10 PRE2 
2
9 
1
2
8 
electron transport 
[20.01.15] 
1.87E-
09 
COX2 ATP3 ATP5 TIM11 ARO2 COX4 
VMA7 COX6 OYE2 ATP2 ATP7 URA1 
CCP1 COX12 ATP14 VMA6 ERO1 
NDE1 CYT1 GRX5 ATP4 ATP15 
2
2 
8
3 
electron transport and 
membrane-associated 
energy conservation 
[02.11] 
2.61E-
08 
COX2 COR1 ATP3 ATP5 TIM11 QCR7 
ALD5 COX4 COX6 ATP2 ATP7 COX12 
ATP14 NDE1 ATP4 ATP15 QCR2 
1
7 
5
8 
protein folding and 
stabilization [14.01] 
4.45E-
07 
PDI1 TAH1 CCT4 CDC37 TCP1 HSP78 
FPR2 MDJ1 ESS1 SSC1 SBA1 SSA2 
CPR3 ERO1 HSC82 SCJ1 YDJ1 
HSP10 STI1 HSP82 
2
0 
9
3 
energy generation (e.g. 
ATP synthase) 
[02.45.15] 
1.48E-
06 
ATP3 ATP5 TIM11 ATP2 ATP7 ATP14 
CYT1 ATP4 ATP15 9 
2
1 
biosynthesis of 
tryptophan 
[01.01.09.06.01] 
1.65E-
05 TRP4 TRP2 PRS2 TRP5 PRS3 PRS5 6 
1
1 
! ! ! ! !
! ! ! ! !
MIPS Phenotypes (142 
categories) ! ! ! !
! ! ! ! !
Category p-value In Category from Cluster k f 
Respiratory deficiency 
[42.25.20] 
3.93E-
06 
COX2 PIM1 PET9 ATP3 PTC1 YFH1 
ATP5 TIM11 QCR7 MDJ1 LSC2 MMF1 
ACP1 COX12 ATP14 CPR3 SEC65 
COX14 NDE1 IDH1 POR1 CIT1 CAT5 
ATP4 ATP15 SRP54 QCR2 
2
7 
1
7
3 
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Systematic!Name! Standard!Name! logFC! adj.P.Val!
YHR137W! Aro9p! 2.0511! 2.4100E806!
YDR380W! Aro10p! 1.9244! 1.5000E805!
YJR109C! Cpa2p! 1.3913! 2.9300E805!
YHR216W! Imd2p! 1.3522! 4.0200E805!
YKR042W! Uth1p! 1.2639! 3.6846E803!
YJL200C! Aco2p! 1.2349! 1.3570E804!
YOR374W! Ald4p! 1.2211! 2.2202E804!
YLR286C! Cts1p! 1.2073! 1.2175E804!
YER073W! Ald5p! 1.1444! 2.0245E804!
YGL117W! ! 1.1144! 4.9380E804!
YMR062C! Arg7p! 1.0767! 3.6700E805!
YOR125C! Cat5p! 1.0233! 5.1400E805!
YGL028C! Scw11p! 1.0153! 2.0093E803!
YML004C! Glo1p! 0.9966! 1.2781E804!
YKL062W! Msn4p! 0.9760! 5.4045E804!
YDR234W! Lys4p! 0.9716! 3.3000E805!
YDR258C! Hsp78p! 0.9190! 4.9900E806!
YDL131W! Lys21p! 0.8956! 3.3000E805!
YDL182W! Lys20p! 0.8824! 4.2300E805!
YMR305C! Scw10p! 0.8535! 4.4073E804!
YHR029C! Yhi9p! 0.8346! 4.9900E806!
YLR300W! Exg1p! 0.8057! 4.9900E806!
YPR145W! Asn1p! 0.8024! 7.3299E804!
YMR318C! Adh6p! 0.7958! 2.1174E804!
YBR256C! Rib5p! 0.7940! 4.3152E804!
YJL191W! Rps14Bp! 0.7932! 3.3791E804!
YKR076W! Ecm4p! 0.7821! 3.0388E803!
YGR247W! Cpd1p! 0.7468! 4.9367E804!
YER152C! ! 0.7467! 2.1602E803!
YOR176W! Hem15p! 0.7438! 1.0194E803!
YOR222W! Odc2p! 0.7318! 3.6700E805!
YKL216W! Ura1p! 0.7258! 1.7200E805!
YER052C! Hom3p! 0.7103! 1.6708E804!
YEL060C! Prb1p! 0.7086! 6.7300E805!
YCR087C8A! ! 0.7043! 2.0178E804!
YNR046W! Trm112p! 0.7024! 3.6700E805!
YPL273W! Sam4p! 0.7009! 5.0513E803!
YOL143C! Rib4p! 0.6981! 7.4900E805!
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YBL045C! Cor1p! 0.6977! 7.6300E806!
YHL021C! Aim17p! 0.6546! 3.0600E805!
YER055C! His1p! 0.6495! 3.1000E805!
YPL135W! Isu1p! 0.6432! 5.1748E804!
YPL245W! ! 0.6393! 1.2850E804!
YAL044C! Gcv3p! 0.6371! 1.6952E803!
YKR048C! Nap1p! 0.6221! 1.1400E805!
YER004W! Fmp52p! 0.6169! 3.1000E805!
YNL149C! Pga2p! 0.6158! 7.0000E806!
YOR157C! Pup1p! 0.6148! 5.9044E804!
YDR365C! Esf1p! 0.6146! 2.8100E805!
YPR127W! ! 0.6096! 8.7758E803!
YLR055C! Spt8p! 0.6091! 1.4046E804!
YNL104C! Leu4p! 0.6087! 4.3152E804!
YKR066C! Ccp1p! 0.6067! 1.7200E805!
YBR101C! Fes1p! 0.5967! 5.0400E805!
YER042W! Mxr1p! 0.5963! 1.1153E804!
YKL126W! Ypk1p! 0.5934! 4.2100E805!
YER090W! Trp2p! 0.5928! 1.1600E805!
YDL173W! Par32p! 0.5884! 8.7652E804!
YLR038C! Cox12p! 0.5810! 6.3900E805!
YJR103W! Ura8p! 0.5803! 3.1085E803!
YOR362C! Pre10p! 0.5800! 2.7600E805!
YBL058W! Shp1p! 0.5781! 5.7700E805!
YFL028C! Caf16p! 0.5761! 1.2542E804!
YFR006W! ! 0.5704! 8.3500E805!
YGL026C! Trp5p! 0.5694! 7.0000E806!
YDR019C! Gcv1p! 0.5658! 8.7300E805!
YMR178W! ! 0.5605! 3.2900E805!
YEL056W! Hat2p! 0.5561! 5.1243E804!
YOR259C! Rpt4p! 0.5486! 2.0900E805!
YPL170W! Dap1p! 0.5463! 1.3632E804!
YFL016C! Mdj1p! 0.5462! 2.3800E805!
YDL125C! Hnt1p! 0.5429! 2.9344E804!
YOR367W! Scp1p! 0.5428! 1.2379E803!
YDL006W! Ptc1p! 0.5425! 2.9512E804!
YHL011C! Prs3p! 0.5386! 2.3300E805!
YGR063C! Spt4p! 0.5375! 3.1000E805!
YDR354W! Trp4p! 0.5354! 1.7381E804!
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YCR060W! Tah1p! 0.5352! 1.5700E805!
YDL198C! Ggc1p! 0.5336! 7.6513E804!
YDR487C! Rib3p! 0.5319! 1.4854E804!
YDR394W! Rpt3p! 0.5258! 1.0500E805!
YMR226C! ! 0.5243! 3.6700E805!
YHL031C! Gos1p! 0.5241! 3.3200E805!
YDR390C! Uba2p! 0.5210! 5.2300E805!
YOR251C! Tum1p! 0.5183! 1.3000E805!
YJL001W! Pre3p! 0.5166! 1.6708E804!
YNL036W! Nce103p! 0.5147! 1.4189E804!
YLR257W! ! 0.5138! 3.2400E805!
YPR086W! Sua7p! 0.5109! 4.8500E805!
YKL040C! Nfu1p! 0.5109! 2.7600E805!
Q0250! Cox2p! 0.5098! 1.9205E803!
YER094C! Pup3p! 0.5097! 9.4400E805!
YHR051W! Cox6p! 0.5060! 1.1100E805!
YEL032W! Mcm3p! 0.5052! 1.1968E804!
YPR103W! Pre2p! 0.5043! 1.6708E804!
YBL022C! Pim1p! 0.5039! 5.6800E805!
YPL117C! Idi1p! 0.4994! 1.4298E804!
YKL191W! Dph2p! 0.4963! 2.9344E804!
YDR035W! Aro3p! 0.4960! 1.2040E804!
YER143W! Ddi1p! 0.4947! 5.0575E804!
YGR244C! Lsc2p! 0.4910! 5.8100E805!
YGR038W! Orm1p! 0.4907! 3.6700E805!
YNR067C! Dse4p! 0.4843! 5.5401E804!
YBR125C! Ptc4p! 0.4828! 4.9380E804!
YFL044C! Otu1p! 0.4808! 1.7381E804!
YDR531W! Cab1p! 0.4806! 9.5557E804!
YHR076W! Ptc7p! 0.4804! 1.2542E804!
YDR129C! Sac6p! 0.4784! 2.4669E804!
YDL120W! Yfh1p! 0.4777! 3.3006E803!
YPR191W! Qcr2p! 0.4776! 3.9600E805!
YOR356W! Cir2p! 0.4736! 1.3325E804!
YCL009C! Ilv6p! 0.4662! 5.0400E805!
YJR016C! Ilv3p! 0.4661! 8.5451E803!
YHR190W! Erg9p! 0.4646! 1.7300E805!
YER099C! Prs2p! 0.4616! 3.1085E803!
YIL008W! Urm1p! 0.4592! 2.6302E804!
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YOR209C! Npt1p! 0.4588! 2.8300E805!
YPL059W! Grx5p! 0.4570! 2.7600E805!
YBR177C! Eht1p! 0.4563! 1.0988E804!
YDL007W! Rpt2p! 0.4562! 1.1570E804!
YHR027C! Rpn1p! 0.4534! 1.6700E805!
YML101C! Cue4p! 0.4479! 3.1234E804!
YDR056C! ! 0.4478! 1.6408E803!
YPR016C! Tif6p! 0.4473! 1.0453E804!
YOR370C! Mrs6p! 0.4466! 5.4500E805!
YKL029C! Mae1p! 0.4438! 5.6077E804!
YIL002W8A! ! 0.4408! 8.8700E805!
YKL007W! Cap1p! 0.4388! 3.6700E805!
YMR236W! Taf9p! 0.4380! 6.0011E804!
YKL145W! Rpt1p! 0.4341! 1.4189E804!
YLR025W! Snf7p! 0.4331! 4.5200E805!
YMR276W! Dsk2p! 0.4321! 2.8300E805!
YNL035C! ! 0.4318! 2.9332E803!
YER156C! ! 0.4302! 1.1204E804!
YNR001C! Cit1p! 0.4299! 3.2400E805!
YML130C! Ero1p! 0.4297! 2.9541E804!
YKL096W! Cwp1p! 0.4282! 1.1283E803!
YKL192C! Acp1p! 0.4249! 1.6905E803!
YOR229W! Wtm2p! 0.4235! 3.1872E803!
YBR026C! Etr1p! 0.4232! 1.0453E804!
YHR111W! Uba4p! 0.4227! 1.2839E803!
YFR049W! Ymr31p! 0.4204! 2.0627E804!
YGL187C! Cox4p! 0.4191! 1.6962E804!
YDR211W! Gcd6p! 0.4157! 1.0397E804!
YOR323C! Pro2p! 0.4152! 9.4400E805!
YPR034W! Arp7p! 0.4149! 3.6700E805!
YML021C! Ung1p! 0.4140! 1.5641E804!
YPR069C! Spe3p! 0.4139! 2.4900E805!
YMR214W! Scj1p! 0.4118! 3.6020E803!
YJR125C! Ent3p! 0.4103! 5.2165E804!
YNL115C! ! 0.4099! 1.1129E803!
YLR209C! Pnp1p! 0.4093! 3.7129E803!
YJR104C! Sod1p! 0.4080! 6.8100E805!
YEL058W! Pcm1p! 0.4079! 2.7600E805!
YOR117W! Rpt5p! 0.4018! 2.2000E805!
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YOR115C! Trs33p! 0.4014! 8.8700E805!
YIL041W! Gvp36p! 0.4006! 2.7600E805!
YLR225C! ! 0.4002! 1.0444E803!
YNL241C! Zwf1p! 0.3984! 2.7600E805!
YDR517W! Grh1p! 0.3983! 3.7600E805!
YGR211W! Zpr1p! 0.3973! 3.1872E803!
YHL039W! Efm1p! 0.3966! 1.4224E803!
YCL043C! Pdi1p! 0.3966! 1.1702E804!
YPL239W! Yar1p! 0.3948! 3.7447E804!
YDR020C! Das2p! 0.3948! 5.1028E803!
YLR370C! Arc18p! 0.3931! 7.8561E804!
YAL042W! Erv46p! 0.3931! 1.6994E804!
YHR012W! Vps29p! 0.3915! 1.1310E803!
YNL220W! Ade12p! 0.3912! 1.3395E804!
YGR132C! Phb1p! 0.3907! 3.4000E805!
YFR044C! Dug1p! 0.3887! 4.8800E805!
YLR212C! Tub4p! 0.3881! 4.0071E803!
YEL038W! Utr4p! 0.3870! 1.9890E804!
YLR195C! Nmt1p! 0.3825! 1.6983E804!
YCR059C! Yih1p! 0.3817! 1.2379E803!
YER183C! Fau1p! 0.3807! 4.7845E803!
YKR080W! Mtd1p! 0.3723! 1.8463E804!
YKL210W! Uba1p! 0.3698! 9.0900E805!
YGL106W! Mlc1p! 0.3690! 2.8000E805!
YGR124W! Asn2p! 0.3672! 2.7600E805!
YCL011C! Gbp2p! 0.3671! 2.9400E805!
YGL221C! Nif3p! 0.3665! 9.4134E804!
YLL001W! Dnm1p! 0.3663! 1.8544E804!
YAR014C! Bud14p! 0.3630! 5.2131E803!
YCL057W! Prd1p! 0.3630! 5.6579E804!
YNL207W! Rio2p! 0.3602! 7.1334E804!
YOL058W! Arg1p! 0.3601! 6.0709E803!
YBL064C! Prx1p! 0.3585! 4.3228E803!
YGL202W! Aro8p! 0.3555! 6.4300E805!
YOR243C! Pus7p! 0.3548! 1.4662E804!
YML058W! Sml1p! 0.3525! 2.3724E803!
YGR001C! ! 0.3521! 2.1143E803!
YBR122C! Mrpl36p! 0.3494! 6.8371E803!
YFR004W! Rpn11p! 0.3485! 1.9859E804!
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YGL242C! ! 0.3478! 7.7386E804!
YGR282C! Bgl2p! 0.3476! 1.3679E804!
YDR322C8A! Tim11p! 0.3468! 2.2683E803!
YIL044C! Age2p! 0.3457! 3.7615E804!
YPL012W! Rrp12p! 0.3454! 5.9226E803!
YDR363W8A! Sem1p! 0.3453! 1.7263E803!
YCR073W8A! Sol2p! 0.3438! 7.8257E804!
YLR208W! Sec13p! 0.3437! 8.8700E805!
YFR047C! Bna6p! 0.3435! 7.9220E803!
YGR231C! Phb2p! 0.3426! 6.8100E805!
YDR529C! Qcr7p! 0.3423! 1.0397E804!
YPR062W! Fcy1p! 0.3408! 6.9042E804!
YNR032C8A! Hub1p! 0.3402! 2.1473E803!
YIL020C! His6p! 0.3395! 1.9572E803!
YIL051C! Mmf1p! 0.3387! 9.0464E804!
YML092C! Pre8p! 0.3385! 3.9300E805!
YGL112C! Taf6p! 0.3380! 1.1740E803!
YIL034C! Cap2p! 0.3376! 3.0833E804!
YGR086C! Pil1p! 0.3371! 5.0513E803!
YKL130C! She2p! 0.3364! 1.5977E803!
YOL052C! Spe2p! 0.3349! 7.4067E803!
YMR073C! Irc21p! 0.3347! 1.7445E803!
YOL070C! Nba1p! 0.3309! 1.5977E803!
YBR230C! Om14p! 0.3303! 9.6444E804!
YBR162C! Tos1p! 0.3287! 2.3613E803!
YBL047C! Ede1p! 0.3285! 2.6424E803!
YAL025C! Mak16p! 0.3274! 3.6303E803!
YDR168W! Cdc37p! 0.3265! 1.2850E804!
YDR361C! Bcp1p! 0.3258! 3.8181E803!
YHR008C! Sod2p! 0.3253! 3.4157E804!
YHR179W! Oye2p! 0.3246! 8.3810E803!
YML129C! Cox14p! 0.3235! 1.0232E804!
YOL149W! Dcp1p! 0.3226! 3.8441E804!
YNR029C! ! 0.3223! 7.1496E804!
YJL123C! Mtc1p! 0.3217! 1.0067E804!
YEL036C! Anp1p! 0.3213! 8.0845E804!
YLR244C! Map1p! 0.3197! 5.0575E804!
YDR368W! Ypr1p! 0.3196! 2.2202E804!
YKR071C! Dre2p! 0.3186! 2.9018E803!
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YNL055C! Por1p! 0.3172! 5.2244E804!
YKR070W! ! 0.3152! 8.9813E804!
YGL148W! Aro2p! 0.3149! 1.0758E803!
YLR017W! Meu1p! 0.3143! 1.0665E804!
YNR053C! Nog2p! 0.3139! 3.4157E804!
YPL188W! Pos5p! 0.3132! 3.3370E803!
YPL111W! Car1p! 0.3112! 1.0067E804!
YPR088C! Srp54p! 0.3112! 1.2728E804!
YOR007C! Sgt2p! 0.3075! 5.6077E804!
YPL169C! Mex67p! 0.3070! 8.6795E803!
YMR145C! Nde1p! 0.3057! 7.4647E803!
YMR002W! Mic17p! 0.3057! 7.5263E803!
YDR167W! Taf10p! 0.3055! 1.2040E804!
YNL287W! Sec21p! 0.3042! 9.4341E804!
YOR197W! Mca1p! 0.3037! 5.2803E804!
YGR277C! Cab4p! 0.3031! 6.5044E803!
YPL211W! Nip7p! 0.3027! 2.9560E803!
YPR041W! Tif5p! 0.3025! 2.2381E804!
YOR298C8A! Mbf1p! 0.3011! 3.7725E804!
YPL240C! Hsp82p! 0.2995! 3.7615E804!
YJR144W! Mgm101p! 0.2985! 2.6278E803!
YKR018C! ! 0.2962! 6.9327E804!
YKL142W! Mrp8p! 0.2961! 6.8317E803!
YDL226C! Gcs1p! 0.2935! 1.0453E804!
YOR286W! Rdl2p! 0.2920! 4.9380E804!
YHR200W! Rpn10p! 0.2917! 9.8100E805!
YGR279C! Scw4p! 0.2910! 2.5808E803!
YDL066W! Idp1p! 0.2896! 1.0728E804!
YFL018C! Lpd1p! 0.2872! 2.5882E804!
YGL100W! Seh1p! 0.2837! 1.0623E803!
YGR020C! Vma7p! 0.2826! 2.2202E804!
YJL069C! Utp18p! 0.2821! 6.0551E804!
YGR253C! Pup2p! 0.2815! 3.9397E804!
YML105C! Sec65p! 0.2811! 1.0952E803!
YDL192W! Arf1p! 0.2804! 2.9541E804!
YKL117W! Sba1p! 0.2799! 1.0498E804!
YER012W! Pre1p! 0.2793! 7.6805E804!
YJR085C! ! 0.2793! 3.2623E803!
YAL012W! Cys3p! 0.2762! 4.9031E804!
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YHR199C! Aim46p! 0.2758! 1.0308E803!
YOR224C! Rpb8p! 0.2726! 1.5490E804!
YKL094W! Yju3p! 0.2715! 9.2092E804!
YLR420W! Ura4p! 0.2715! 3.2294E803!
YJR065C! Arp3p! 0.2706! 6.7732E803!
YJR025C! Bna1p! 0.2705! 3.2426E803!
YLL024C! Ssa2p! 0.2697! 1.3281E803!
YER074W8A! Yos1p! 0.2684! 2.9670E803!
YGL001C! Erg26p! 0.2683! 1.9171E803!
YLR330W! Chs5p! 0.2678! 7.4330E803!
YPR187W! Rpo26p! 0.2668! 1.4389E803!
YOR357C! Snx3p! 0.2668! 8.9196E803!
YNR038W! Dbp6p! 0.2585! 4.5148E803!
YCL017C! Nfs1p! 0.2554! 4.0513E804!
YLR447C! Vma6p! 0.2552! 9.4134E804!
YML069W! Pob3p! 0.2547! 5.1584E804!
YLR314C! Cdc3p! 0.2535! 1.3632E804!
YNL116W! Dma2p! 0.2523! 3.0042E804!
YLR027C! Aat2p! 0.2523! 5.0176E804!
YFR010W! Ubp6p! 0.2517! 2.1263E804!
YLR285W! Nnt1p! 0.2510! 1.1486E803!
YNL244C! Sui1p! 0.2501! 3.9347E804!
YOL039W! Rpp2Ap! 0.2498! 4.6415E803!
YOR021C! Sfm1p! 0.2496! 5.5401E804!
YMR039C! Sub1p! 0.2495! 6.9919E804!
YML125C! Pga3p! 0.2486! 1.4854E804!
YJR077C! Mir1p! 0.2468! 5.4557E804!
YOL061W! Prs5p! 0.2463! 6.9554E804!
YPL091W! Glr1p! 0.2458! 1.5587E803!
YLR083C! Emp70p! 0.2456! 1.3878E803!
YDR212W! Tcp1p! 0.2440! 2.2081E804!
YIR012W! Sqt1p! 0.2435! 6.6174E804!
YER120W! Scs2p! 0.2418! 5.0849E804!
YCL033C! Mxr2p! 0.2417! 3.1234E804!
YNL064C! Ydj1p! 0.2405! 1.1229E803!
YDR519W! Fpr2p! 0.2387! 1.8722E804!
YER003C! Pmi40p! 0.2377! 1.4662E804!
YML022W! Apt1p! 0.2368! 5.0143E804!
YNR043W! Mvd1p! 0.2347! 2.4011E804!
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YOR074C! Cdc21p! 0.2341! 5.6077E804!
YPL050C! Mnn9p! 0.2338! 5.6497E803!
YDL126C! Cdc48p! 0.2337! 5.2171E803!
YLR351C! Nit3p! 0.2332! 5.2567E803!
YGR074W! Smd1p! 0.2318! 4.7571E803!
YGL245W! Gus1p! 0.2305! 2.2314E804!
YLR199C! Pba1p! 0.2303! 1.5079E803!
YGR207C! Cir1p! 0.2301! 1.1679E803!
YNR017W! Tim23p! 0.2296! 4.2834E803!
YDL143W! Cct4p! 0.2280! 2.3901E804!
YLR089C! Alt1p! 0.2279! 4.4120E803!
YNL037C! Idh1p! 0.2277! 4.4900E803!
YER088C! Dot6p! 0.2272! 1.7991E803!
YKL016C! Atp7p! 0.2261! 7.1334E804!
YGL105W! Arc1p! 0.2253! 2.2692E804!
YBR247C! Enp1p! 0.2232! 1.0758E803!
YOL038W! Pre6p! 0.2229! 1.9890E804!
YMR246W! Faa4p! 0.2228! 3.7776E803!
YPL010W! Ret3p! 0.2218! 7.8561E804!
YPR097W! ! 0.2206! 3.5980E803!
YML010W! Spt5p! 0.2195! 2.0037E804!
YMR186W! Hsc82p! 0.2191! 8.1202E804!
YPL271W! Atp15p! 0.2186! 2.7147E804!
YJL174W! Kre9p! 0.2186! 6.6495E803!
YDL195W! Sec31p! 0.2148! 1.9815E803!
YDR194C! Mss116p! 0.2145! 8.5644E803!
YJL173C! Rfa3p! 0.2100! 4.1753E803!
YNL084C! End3p! 0.2079! 9.7369E804!
YGR261C! Apl6p! 0.2078! 4.7366E803!
YLR275W! Smd2p! 0.2043! 7.3324E803!
YOR027W! Sti1p! 0.2039! 1.0488E803!
YOR142W! Lsc1p! 0.2030! 9.0722E803!
YOL064C! Met22p! 0.2027! 1.9243E803!
YLR397C! Afg2p! 0.2025! 6.3052E803!
YJL060W! Bna3p! 0.2023! 4.0549E803!
YBR039W! Atp3p! 0.2007! 2.1212E803!
YJR045C! Ssc1p! 0.1995! 9.0464E804!
YGL011C! Scl1p! 0.1985! 3.5136E804!
YER069W! Arg5,6p! 0.1981! 5.2131E803!
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YNL157W! Igo1p! 0.1963! 5.8500E803!
YDL132W! Cdc53p! 0.1957! 7.3490E803!
YDL086W! ! 0.1940! 6.1412E803!
YDR299W! Bfr2p! 0.1898! 5.7126E803!
YBL030C! Pet9p! 0.1888! 3.6846E803!
YGR175C! Erg1p! 0.1878! 5.2665E803!
YNL044W! Yip3p! 0.1872! 2.5168E803!
YPR163C! Tif3p! 0.1871! 3.0757E803!
YML124C! Tub3p! 0.1864! 4.2468E803!
YOL016C! Cmk2p! 0.1858! 1.2289E803!
YOL123W! Hrp1p! 0.1808! 6.8345E804!
YBR164C! Arl1p! 0.1798! 9.6582E803!
YOR168W! Gln4p! 0.1792! 1.1267E803!
YBR198C! Taf5p! 0.1783! 1.0880E803!
YPL218W! Sar1p! 0.1769! 1.9987E803!
YDR071C! Paa1p! 0.1764! 7.8561E804!
YOR046C! Dbp5p! 0.1763! 1.0084E803!
YLR295C! Atp14p! 0.1749! 4.5258E803!
YJL159W! Hsp150p! 0.1742! 6.2778E803!
YKR043C! Shb17p! 0.1733! 6.6077E803!
YOL097C! Wrs1p! 0.1723! 4.4346E803!
YDL061C! Rps29Bp! 0.1714! 5.5340E803!
YDR298C! Atp5p! 0.1703! 3.0757E803!
YLR180W! Sam1p! 0.1702! 2.1890E803!
YCR053W! Thr4p! 0.1694! 5.0186E803!
YDL097C! Rpn6p! 0.1685! 3.8971E803!
YDR378C! Lsm6p! 0.1685! 9.8172E804!
YBR248C! His7p! 0.1677! 3.8758E803!
YGL097W! Srm1p! 0.1662! 2.1583E803!
YDR028C! Reg1p! 0.1646! 6.5700E803!
YNL075W! Imp4p! 0.1635! 2.3736E803!
YJR121W! Atp2p! 0.1609! 7.4605E803!
YML078W! Cpr3p! 0.1576! 2.1108E803!
YOR230W! Wtm1p! 0.1556! 1.9342E803!
YJR017C! Ess1p! 0.1526! 4.9281E803!
YPL078C! Atp4p! 0.1523! 3.0381E803!
YDR321W! Asp1p! 0.1509! 2.9560E803!
YOR065W! Cyt1p! 0.1492! 2.8791E803!
YOR020C! Hsp10p! 0.1478! 1.6408E803!
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YML028W! Tsa1p! 0.1458! 1.1903E803!
YFR052W! Rpn12p! 0.1455! 8.6548E803!
YGR135W! Pre9p! 0.1432! 5.0488E803!
YMR125W! Sto1p! 0.1429! 8.4474E803!
YDR174W! Hmo1p! 0.1399! 4.7366E803!
YLR324W! Pex30p! 0.1375! 6.0232E803!
YFR016C! ! 0.1346! 4.8806E803!
YPL028W! Erg10p! 0.1209! 4.7415E803!
YPR033C! Hts1p! 0.1033! 5.6661E803!
 
 
 
